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agement strategies.
Keywords: electroneuromyography, effectiveness,
demand management strategy, diagnostic testing,
healthcare, significance
Publishing language: English
N. Välimaa ii
AALTO UNIVERSITY SCHOOL OF SCIENCE ABSTRACT OF THE
Degree Programme in Industrial Engineering and Management MASTER´S THESIS
Tekijä:
Norma Välimaa
Työn nimi:
Elektroneuromyografia tutkimusten strateginen kysynnänhallinta: analyysi diagnostisten testien vai-
kuttavuuteen vaikuttavista tekijöistä.
Sivumäärä:
109
Päiväys:
27.5.2015
Työn sijainti:
TU
Professuuri:
Strateginen johtaminen
Koodi:
TU-91
Työn valvojat:
Antti Peltokorpi, TkT, Professori (professuuri: Rakentamisen tuotantotalous)
Erika Kirveskari, LT, Apulaisprofessori
Työn ohjaaja:
Jens Schmidt, Professori
Tutkimuksessa on tarkoituksena selvittää diagnostisten testien vaikuttavuutta, ja millä kysynnän
hallinnan strategioilla vaikuttavuutta voitaisiin parantaa. Tämä tutkimus keskittyy selvittämään
elektroneuromyografiatutkimusten (ENMG) merkitsevyyttä, mikä lopulta vaikuttaa kysynnän hal-
linnan strategian valintaan. Oletuksena työssä on, että diagnostinen tutkimus on merkityksetön, jos
se ei vaikuta potilaan diagnosointiin, hoitopäätöksen tekoon, tai ei tuo lisäarvoa lähettävälle lääkä-
rille. Kohdeyritys on suomalainen HUS Kuvantamisen liikelaitos, joka tuottaa kuvantamisen palve-
luita Suomen suurimmalle sairaanhoitopiirille: Helsingin ja Uudenmaan sairaanhoitopiirille.
Kirjallisuuskatsaus keskittyy terveydenhuollon vaikuttavuutta tutkivaan kirjallisuuteen. Terveyden-
huollon vaikuttavuutta tarkastellaan usein potilaan hoitotuloksen kautta, ja tämä tutkimus kartoittaa,
miten vaikuttavuutta mitataan diagnostisten testien osalta. Muutama aiempi tutkimus on esittänyt
mittareita tähän tarkoitukseen. Koska tutkimuksen tarkoituksena on vähentää merkityksettömien
tutkimusten määrää kysynnän hallinnan strategioiden avulla, tarkastellaan kirjallisuuskatsauksessa
tarkemmin sekä merkityksettömän diagnostisen tutkimuksen määritelmää ja erilaisia kysynnän hal-
linnan strategioita.
Metodeina käytämme case- ja kyselytutkimusmenetelmiä. Case-tutkimusmenetelmillä tutkitaan pai-
kallisia mielipiteitä ja tekijöitä, jotka vaikuttavat tutkittuun ilmiöön. Mittaustiedon kerääminen suo-
ritettiin kyselytutkimuksilla. Kyselyt suoritettiin sekä lähettäville lääkäreille että neurofysiologeille.
Lisäksi suoritettiin kolme haastattelua alan asiantuntijoille löydösten tueksi. HUS:n kliinisen neuro-
fysiologian (KNF) yksiköistä kerättiin suoritetietoja vuosilta 2011–2014. Data analysoitiin tilastolli-
sin menetelmin khiin neliötesteillä, ordinaalisella regressiomallilla ja Studentin t-testillä.
Tuloksemme osoittavat, että noin 11 % HUS:n KNF-laboratoriossa Meilahdessa suoritetuista
ENMG-tutkimuksista on merkityksettömiä. Tutkimuksen mukaan lähettävä taho vaikuttaa tutki-
muksen merkitsevyyteen: perusterveydenhuolto ja fysiatrian poliklinikka tilaavat merkityksettö-
mämpiä ENMG-tutkimuksia kuin muut erikoissairaanhoidon poliklinikat. Lisäksi tämän tutkimuk-
sen tulokset vahvistavat aiempien tutkimusten tuloksia koskien lähetteen kysymyksenasettelun tär-
keyttä merkitsevyyden kannalta. Tämän vuoksi suosittelemme, että diagnostisia testejä tuottavat yk-
siköt korostaisivat selkeän lähetteen merkitystä, järjestäisivät koulutusta lähettäville tahoille, sekä
käyttäisivät eri kysynnänhallintakeinoja eri lähettäville tahoille. Lopuksi ehdotamme muita toimia,
joilla voidaan nostaa ENMG-testien merkitsevyyttä sekä ottaa käyttöön kysynnän hallinnan strategi-
oita.
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1. Introduction
1.1 Background
The effectiveness of healthcare services has become an ever more important issue during the past years,
as the population structure is shifting in most western countries; the working ages are diminishing while
at the same time, the population is ageing and demand for healthcare services is increasing (Rechel et
al. 2013; Timonen & Kautto 2014). This leads to cost pressures and lack of resources. Furthermore,
physicians rely more and more on diagnostic tests rather than on pure clinical examination of a patient
due to uncertainty (Fuller 2005), causing an increase in the demand for diagnostic tests. Further, diag-
nostic tests have become more accessible, faster and inexpensive which makes a larger number of re-
quests possible compared to the past (Fuller 2005). Besides the increased number of patients, reasons
for the increased demand identified in the literature include physicians’ inexperience, uncertainty, lack
of awareness of the current guidelines, pressure from patients who nowadays have more information
about their condition and therefore may demand certain tests, medico-legal reasons, and the current
culture among the new generation of physicians of relying mainly on instrumental evidence (Di Fabio
et al. 2013; Sood et al. 2007; Solomon et al. 1998). All in all, diagnostic imaging, and especially ad-
vanced imaging and diagnostic tests, contribute to healthcare costs, thus their more appropriate use will
improve the whole healthcare system (Blackmore et al. 2011). Because the current situation of increas-
ing demand and limited resources, as well as the lack of effectiveness research in the healthcare sector,
it is interesting and valuable to research this phenomenon and gather information from literature con-
cerning effective healthcare services.
The effectiveness of a diagnostic tool is hard to measure. This is because diagnostic tests do not impact
the patient outcome directly, in contrast to i.e. surgical treatment, but rather enable the formulation of
appropriate diagnoses and treatment plans (Neumann & Weinstein, 2010.) Thus, the diagnostic tool
functions as a small but crucial part in the patient’s treatment pathway. According to the literature review
conducted as part of this study, this field of research seems to be underdeveloped. Effectiveness studies
in healthcare commonly use a method where the outcomes of two medical tools or treatment methods
are compared (Gazelle et al. 2011; Lee et al. 2010), or comparing costs – called cost-effectiveness anal-
ysis (CEA) (Singer, M.E. & Applegate, K.E., 1996). Contrastingly, this study explores and measures
effectiveness through the volume of insignificant examinations.
The aim of this paper is to study the effectiveness of electroneuromyography (ENMG) tests. An ENMG
test is an electrodiagnostic test which examines electrical functioning of nerves and muscles. According
to my knowledge, the Finnish public healthcare sector has not conducted such effectiveness studies
before. However, effectiveness of services is currently listed as one of the key strategies in the hospital
district of Helsinki and Uusimaa (HUS) (Helsingin ja Uudenmaan Sairaanhoitopiiri 2012), which is the
largest hospital district in Finland. Internationally, few studies have examined inappropriate ENMG test
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requests within the field of clinical neurophysiology (Cocito et al. 2006; Di Fabio et al. 2013; Mondelli
et al. 2014; Podnar 2005; Rigler & Podnar 2007; Mondelli et al. 1998). These studies have been con-
ducted in Turkey, Slovakia, the U.S., and Italy (Di Fabio et al. 2013; Mondelli et al. 1998; Mondelli et
al. 2014; Cocito et al. 2006; Podnar 2005; Shepherd 2010; Karadag et al. 2014), countries that have very
dissimilar healthcare systems from Finland. Thus, this study is the first of its kind in a welfare country
such as Finland.
The effectiveness of diagnostic test relates closely to the definition of significant tests and appropriate
test requests (Fryer & Smellie, 2013). The research about the criteria and characteristics of inappropriate
diagnostic tests is wide (van Walraven & Naylor 1998). The identification of inappropriate tests is im-
portant, because it provides guidance to requesting; which test requests should be reduced in order to
make healthcare services more effective. In the present study, the concept of significance means that the
test is judged by a physician to be significant if it helps the physician to either diagnose the patient or
decide the treatment for the patient. In this study, the concept of significance does not concern technical
aspects, such as whether the test functions technically as it should or if the test is performed technically
correctly. The definition of an inappropriate test request and an insignificant test are described in more
detail in the sub-chapter 1.5.
The definition of an inappropriate test brings us to the strategic goal of a clinical neurophysiology (CN)
laboratory: they need to manage demand by prioritizing test requests that are relevant and appropriate.
Demand management studies have been widely conducted in the context of laboratories in general (Fryer
& Smellie 2013; Janssens 2010), but not in the field of CN laboratories specifically. Demand manage-
ment and demand control are separate concepts: demand control methods aim to reduce the number of
requests, while demand management mainly strives to ensure appropriate requests. Thus, demand man-
agement has an inherent quality aspect at its core, and does not necessarily lead to fewer, but more
appropriate, requests. (Fryer & Smellie 2013, p.62.) Overall, with a valid demand management strategy,
a CN laboratory is able to ensure sufficient resources to meet the critical demand while keeping a high
level of quality of care.
The present study is initiated by the public utility HUS Medical Imaging Center’s CN laboratory  in
Meilahti, operating in the Hospital District of Helsinki and Uusimaa (HUS), Finland. The present re-
search observes HUS as a whole, which includes eight CN laboratories. The demand of ENMG tests in
HUS has increased significantly during the last few years, resulting in increasing costs. An ENMG test
is labor intensive, requiring 30 to 60 minutes of specialist time per test. During the last few years, HUS
has tried to reduce costs through reducing the number of outsourced physicians, and shorten waiting
times through Lean methodologies (Womack et al. 1992) and extra tests conducted outside office hours.
However, these efforts have not been sufficient to tackle the problem.
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Although much has been made in order to increase the ENMG test supply, it is not enough, as demand
is growing constantly. To this point also the effectiveness of healthcare services plays a huge role in
providing the sufficient supply. In a situation where we have to balance between limited resources and
great number of patients in need for the services, we minimize the waste of resources and ensure the
quality of care by effective services. By studying the effectiveness of a healthcare service we might be
able to prioritize the demand and focus the service to those patients who present actual and real need for
the service. It is essential to provide the maximal health benefit with the limited resources we have. The
effectiveness of healthcare services and the usage of appropriate demand management strategies make
both cost savings and more efficient resource allocation possible, which benefit both the service orderer
and producer.
1.2 Objective of the study
The aim of this research is to gain understanding of how effective electroneuromyography (ENMG)
tests are in the light of diagnostics and treatment plan decision-making, and then to develop strategies
to increase the effectiveness and the value of these diagnostic tests for end-customer. These strategies
are mostly meant for managing the demand by controlling and guiding the behavior of referring physi-
cians. First, this study identifies and then tries to reduce the number of inappropriate ENMG test requests
and insignificant ENMG tests by proposing various demand management strategies. These strategies
are explored in more detail in the literature review section. Additionally, the concept and characteristics
of an insignificant ENMG test is important to identify and determine in order to select appropriate strat-
egies. The concept of insignificant diagnostic test is firstly clarified in the literature review and then
based on this  search,  similarities  and differences are searched from the gathered data  by analyzing it
with qualitative and quantitative methods.
The evaluation of effectiveness of ENMG tests is subjective, thus this study will evaluate it from three
different viewpoints: 1) referring physician, 2) neurophysiologist and 3) experienced referring clinical
specialist. In contrast to prior studies this study explores the significance of ENMG test from both sides:
test orderer and test producer.
The postulate is that an insignificant ENMG test does not affect patient treatment plan or diagnosis and
that the significance is highly dependent on the formulation and focus of referral query. Before perform-
ing this research a few hypotheses concerning the characteristics of insignificant ENMG test were con-
cluded.  The first  hypothesis  is  that  primary care order  ENMG tests  with unfocused question setting,
while more specialized outpatient clinics within secondary care, mainly formulate more focused referral
queries. The second hypothesis is that unfocused referral questions result in insignificant ENMG tests.
This is due to the assumption that general and unfocused referral queries force neurophysiologist to
perform more extensive ENMG tests, because neurophysiologist has to examine several limbs in order
to find the part of body that causes the symptoms.
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In order to achieve the goal of the study, the following research questions are set. Answering our main
question first requires that we answer sub-questions. The questions are listed below, and the hierarchy
between the questions is presented in Figure 1.
· What strategies could be used to reduce the number of insignificant diagnostic tests in healthcare?
o What are the characteristics of insignificant ENMG test?
§ What are the main factors contributing to ENMG tests’ insignificance?
§ Does the opinion about ENMG tests’ significance vary between referring physicians
and neurophysiologists?
o What number of ENMG test requests and ENMG tests are insignificant in Meilahti CN labora-
tory and do referring units differ in this?
Figure 1 Hierarchy of the research questions
1.3 Research design
This study is a case study focusing on HUS Meilahti CN laboratory and ENMG tests utilizing survey
research approach. First, a academic literature review is compiled in order to explore demand manage-
ment strategies, previous effectiveness studies and characteristics of an insignificant diagnostic test.
Second, the data is collected and analyzed. The main data is collected via two surveys made for neuro-
physiologists and referring physicians. Also, three interviews are conducted to clinical specialists ex-
perts in diagnostic test requesting to support the findings of survey data analysis. Performance data of
CN laboratories within HUS area is gathered in order to analyze the reasons for increased demand and
the differences between the CN laboratories. The data analysis is done with ordinal logistic regression
model, chi-square test and Student’s t-test. Lastly, the answers to research questions are presented with
What	are	the	characteristics	of	insignificant	ENMG	test? •Main	factors	contributing	to	insignificance?•Variance	in	opinions	between	referring	physicians	and	neurophysiologists?
What	is	the	number	of	insignificant	ENMG	tests	in	Meilahti	CN	laboratory? •Are	there	differences	between	referring	units?
What	strategies	could	be	deployed	to	reduce	the	number	of	insignificant	diagnostic	tests?
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conclusions by combining the findings from literature to the findings of data analysis. The findings were
confirmed by the focal organization of Meilahti CN laboratory.
The literature review is conducted by thorough search of academic articles and other literature. These
were search from three main databases among some others; Google scholar, EBSCO e-books (EBSCO-
host), Proquest and PubMed. The most relevant keywords used for literature search were among others
“EMG testing”, “Effectiveness of healthcare”, “NCS testing”, “inappropriate EMG”, “inappropriate di-
agnostic testing” and “Demand management strategy”. The literature search was performed in two
phases. First, the most relevant articles and other literature found with key words was gathered, and then
additional relevant papers were identified in the reference lists of these articles.
1.4 Scope of the study
The focus of the study was decided by public utility of HUS Medical Imaging Center. Because all eight
CN laboratories within HUS area differ from each other compared by main referring quarters, length of
waiting time, and test volumes, it would have been good to gather data from all of CN laboratories and
to  analyze  HUS area  as  whole.  However,  as  a  master’s  thesis,  the  scope  had  to  be  limited.  The  CN
laboratory operating in Meilahti and Laakso hospital was selected as a focus, due to the fact that this CN
laboratory  is  the  largest  CN unit  in  HUS area  as  it  has  the  highest  test  volume  and  also  the  longest
waiting times.
This study focuses on the most typical ENMG tests, with the extent of the test ranging from less exten-
sive to more extensive – ENMG-1, ENMG-2 and ENMG-3 tests. Despite of the fact that CN laboratory’s
test volumes consist of also numerous other electrodiagnostic tests, the focus of analysis is set to ENMG,
because it accounts for 45 % of all electrodiagnostic tests performed and there is a long waiting time to
ENMG tests. Furthermore, the number of ENMG tests has increased during the past years and ENMG
requires a lot of time from neurophysiologist, thus it binds a large percentage of neurophysiologist re-
sources.
In addition to above scopes, this research analyses Meilahti CN laboratory performance data from year
2011 to year 2014. This outline of years is done in order to keep in the limits of master’s thesis. More-
over, Meilahti CN laboratory put a digital test report system into operation during year 2010, thus the
test information is only reliable from year 2011.
This study focused to limited number of referring quarters, with whom a survey was conducted. How-
ever, referring units requesting the most ENMG tests annually were selected for this research. A digital
version of the survey was sent to all referring quarters attached to ENMG test result statements during
November 2014, and a paper version of the same survey was sent to only to 10 most active referral
quarters, which request ~50% of Meilahti CN laboratory’s annual ENMG tests performed.
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The object of analysis is neurophysiologists’ and referring physicians’ evaluation concerning the signif-
icance of ENMG tests. Exploring the difference of their opinions is one of the focuses of this study.
Furthermore, this research provides interesting information about the phenomenon of how the variation
between individual referring physicians affects the whole picture of effectiveness and ordering of un-
necessary diagnostic tests (Mindemark et al. 2010).
One possibility was to analyze treatment pathways of single patients who have been examined by
ENMG test, and then evaluate how ENMG test affected the overall patient outcome. However, treatment
pathway analysis is omitted from this research due to time and resource limitations of this study and
such evaluation would require a lot of work including selecting control groups etc. in order to determine
when ENMG test is significant from the patient outcome point of view.
As this study is highly related to effectiveness research, a more detailed study about the effects of finan-
cial incentives would have been interesting to conduct and determine the extent to which financial asym-
metry explains the ineffectiveness of our healthcare system. In a welfare country, the Finnish healthcare
system does not charge the healthcare service requester (referring physician or patient), but the
healthcare cost is covered by municipality. In other words, referring physicians have personal financial
motives while requesting diagnostic tests. This creates a financial asymmetry between the service pro-
ducer and orderer: the service requester has no incentives to reduce the costs and the number of services
ordered. Due to the limitations of this study, it was not possible to analyze financial incentives. None-
theless, the focus of the present study is set to be the patient cases instead of the cost of the test, and
whether the ENMG test is helpful for a physician making a diagnosis or treatment plan decision. In other
words, this research focuses more on the benefit and value creation of a diagnostic test from the patient
case point of view, without taking the cost aspect into account.
1.5 Definitions
The key construct in this research is the inappropriate ENMG test request and the insignificant ENMG
test. In order to understand these concepts, one has to understand what electroneuromyography (ENMG)
test examines and what resources it requires. The notion of effectiveness of healthcare services is im-
portant since the aim of this research is to improve effectiveness and measure it through the metrics of
effectiveness. Finally, while this research will provide understanding of the amount and characteristics
of insignificant ENMG tests, the focal organization desires to reduce the number of such tests, thus the
notion of demand management strategy is important.
Electroneuromyography (ENMG) test – ENMG test is an electrodiagnostic test, which examines the
electrical functions of nerves and muscles. ENMG tests are done in clinical neurophysiology (CN) la-
boratories by neurophysiologists. The duration of one ENMG test varies from 30 to 60 minutes, requir-
ing this time from neurophysiologists to perform, thus the ENMG tests are labor-intensive and expen-
sive. From the patient’s perspective, an ENMG test is uncomfortable since it includes needles inserted
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into muscles and electric stimulation. The most common diagnoses examined by ENMG test are upper
limb neuropathies, e.g. carpal tunnel syndrome and lower back radiculopathy. Clinical neurophysiology
units within HUS area altogether perform approx. 8 550 ENMG tests annually. The extent of an ENMG
test varies between levels 1–3 depending on how many muscles, limbs or clinical questions are exam-
ined. Level 1 presents an ENMG test where either 1-4 muscles or one nerve segment is examined. Level
2 presents an ENMG test where one limb or one problem is examined, while level 3 includes examina-
tion of many limbs or many clinical questions.
Figure 2 The ordering process of an ENMG test within primary care
Figure 2 presents the ordering process of an ENMG test within primary care. The ordering of an ENMG
test differs slightly when ordered by outpatient clinic within secondary care. Firstly, ENMG test referrals
from secondary care are often accepted without neurophysiologist’s evaluation of test referral, while
ENMG test referrals from primary care require neurophysiologist’s acceptation before patient is called
to  ENMG test.  Secondly,  an  ENMG test  is  ordered  for  different  reasons  depending  on  the  referring
quarter. Within secondary care, ENMG tests are usually ordered to determine the correct treatment plan,
which is either an operation, therapy, additional examinations, observing the healing progress of a pa-
tient (control test) or to diagnose a patient. Usually, primary care physicians order ENMG tests to de-
termine a diagnosis and often ENMG tests are ordered for referrals to secondary care.
Effectiveness of healthcare service – An effective healthcare service is a service, which provides max-
imum health benefit with minimum resources and costs. The common effectiveness metrics are the cost
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per Quality Adjusted Life Year (QALY), morbidity, and functional status of a patient (Räsänen et al.
2006; Singer & Applegate 2001). However, the effectiveness, health benefit, and value are hard to de-
termine in diagnostic testing due to the indirect nature of its effect on patient outcome (Lee et al. 2010;
Neumann et al. 2010). Thus, we measure effectiveness through the diagnostic thinking efficacy and
clinical efficacy measures presented by Fryback & Thornbury (1991). Diagnostic thinking efficacy
measures effectiveness through the impact of a diagnostic test on diagnosing. Clinical efficacy measures
the impact on treatment plan decision-making (Fryback & Thornbury 1991.) Diagnostic tests that do not
affect either diagnosing or treatment plan decision-making are considered insignificant. As a result, the
proportion of insignificant tests in the present study will determine the effectiveness of CN laboratory.
Insignificant ENMG test and inappropriate ENMG test request – Even though the goal of this re-
search is to identify the characteristics of an insignificant ENMG test, there are a few general opinions
about which test is considered an insignificant diagnostic tests. Insignificant ENMG tests that are per-
formed to a patient whose diagnosis is obvious already beforehand, without performing ENMG test.
Such a diagnosis is called a self-evident diagnosis. In addition, insignificant ENMG tests include tests
that are ordered without proper clinical examination, or a clinical question or symptoms that cannot be
examined by an ENMG test. An insignificant ENMG test does not affect referring physician’s decision-
making about patient’s diagnosis or treatment plan.
An inappropriate ENMG test request refers to referrals without clear, focused or relevant referral ques-
tion setting. An inappropriate ENMG test request may result in insignificant ENMG test if neurophysi-
ologist has to do a wide search, called screening, to a patient with the ENMG test device, because the
referral does not include a specific symptom or clinical question to be examined. Furthermore, such
unfocused referral queries require a lot of neurophysiologists time to interview and clinically examine
the patient before performing the test, which additional time is taken from the ENMG examination.
Normal results (where the test shows normal function of the muscles and nerves) from ENMG tests are
sometimes considered necessary, if the result gives valuable information to the referring physician and
helps them in the diagnostics and to plan a treatment for the patient i.e. in pre or post operative situations
and when excluding diagnoses. Alternatively, if the ENMG test result is assumed to be normal before
performing ENMG test, referred to self-evident normal result, then the test is considered to be insignif-
icant. These listed characteristics of insignificant diagnostic test are compared to the final findings of
this study.
Demand management strategy – Demand management strategy refers to a selection of approaches
used to manage demand and ensure appropriate requesting increasing the effectiveness of the service. It
differs from demand control, which refers to explicitly reducing the volume of requesting (Fryer &
Smellie 2013.) In the present study, demand management strategy aims at producing appropriate ENMG
test that provide the maximum health benefit for the minimum resources spent in producing the ENMG
test. Common approaches within diagnostic testing include informing referring physicians about test
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appropriateness and correct test frequencies (Fryer & Smellie 2013), giving feedback concerning the
costs and test usage and emphasizing the importance of dialogue between the service orderer and pro-
ducer (Gama et al. 1992). Demand management has been reported not to worsen clinical outcomes, even
though it in many cases succeeded in reducing the number of test requests (Warren et al. 2010).
1.6 Structure of the master’s thesis
This thesis is organized into nine sections (Figure 3). Introduction presents the background and aims of
this study. Literature review is divided into three sections, which discuss the topics of demand manage-
ment strategy, effectiveness of healthcare systems and insignificant diagnostic tests. The research design
presents the qualitative and quantitative analysis methods and surveys used in this study. After present-
ing the research design, the results from surveys, interviews and data gathered from ENMG test report
systems is analyzed and presented. The discussion chapter concludes the findings from qualitative and
quantitative data analysis and discusses the possible suggestions to the research problem. Validity and
reliability of this study are discussed. Finally, the last chapter summaries the findings of this study an-
swering to the research questions presented. In addition, the areas for future research are also discussed
in the last chapter.
Figure 3 Structure of this study
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2 Literature
Firstly, this chapter explores the approaches of demand management strategy. The characteristics
of demand management strategy approaches and its ways to achieve effectiveness in services are
reviewed in order to identify the most suitable demand management strategy to reduce the amount
of insignificant testing and create more effective services. Secondly, to determine what charac-
teristics effective healthcare services possess, the metrics of effectiveness within healthcare ser-
vices is explored through prior research. Metrics varies depending on the type of healthcare ser-
vice, thus the specific metrics for diagnostic testing will be discussed in this chapter. Lastly, due
the objective of this research and to identify ineffectiveness within focal organization, concepts
and criteria of an insignificant diagnostic test are discussed and presented based on previous re-
search. In addition, previous similar studies are explored to provide a framework for this study
and to identify the challenges and research gaps within this specific field.
2.1 Demand management strategy
This chapter first discusses different demand management methods. The second sub-chapter focuses on
exploring the effect of financial incentives on physician’s test ordering behavior to provide insight why
test ordering is difficult to manage and to affect in welfare countries like Finland. Lastly, this chapter
explores the outcomes of demand management strategy.
2.1.1 Approaches to demand management
In this sub-chapter the demand management methods including communication, education and feed-
back, test request form redesigning, reflex and reflecting testing and guidelines and protocols are dis-
cussed. In order to build more effective services, service producers need demand management ap-
proaches to focus resources towards patients with the greatest need for it. Demand management strate-
gies have been studied mainly in the field of general laboratory (Fryer & Smellie 2013; Janssens 2010;
Lang 2013; Lee et al. 2013). The present study explores and applies the demand management approaches
discussed in literature to the field of advanced diagnostic testing such as ENMG testing.
Demand management approaches affect various parts of the test ordering process presented in chapter
(Figure 2). One approach is to affect already referring physician’s clinical examination and interview
procedures by giving feedback or educating physicians (Thomas et al. 2006; Miyakis et al. 2006; Fryer
& Smellie 2013; Janssens 2010), so that a referring physician is more critical while ordering diagnostic
tests. Another approach is to improve the quality of test referrals. Quality of test requests is improved
by redesigning the request form (Bailey et al. 2005; Fryer & Hanna 2009; Fryer & Smellie 2013;
Janssens 2010), which then allows referring physician to make more appropriate test referrals according
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to  new  request  form.  All  in  all,  as  the  present  study  manages  to  identify  the  characteristics  and  the
number of insignificant tests, with demand management approaches such tests can be reduced. This
results in treatment plan decision-making and diagnosing of a patient to become more accurate and
easier as through more effective services larger number of diagnostic tests will provide value to referring
physicians as these tests are more significant and carefully requested.
Dialogue between the key stakeholders – test orderers and test producers – is considered extremely
important, as the dialogue enables test producer to educate and give feedback to test orderer, which
encourages more significant tests to be ordered and produced (Fryer & Smellie 2013; Janssens 2010;
Lang 2013). Especially Lang (2013) claims that real-time notification of inappropriate test request
should be sent to the referring physician immediately, so that the physician can either reform the request
or alternatively decide not to have the test.
Furthermore, educating the referring physicians is one of the most used and effective demand manage-
ment strategies (Fryer & Smellie 2013; Janssens 2010; Lang 2013; Lee et al. 2013), although controver-
sial results of education’s effectiveness has also been presented (Solomon et al. 1998). Solomon et al.
(1998) claim that educating referring physicians about test requesting as well as rewarding physicians
for improved requesting behavior only has short-term effects on requesting behavior. One of the reasons
why educating physicians is ineffective is that it will only have a local effect (Fryer & Smellie 2013),
and  educating  all  referring  physicians  requires  a  lot  of  resources.  Due  to  this  it  would  be  ideal  that
physicians learn adequate test requesting principles already in medical school (Janssens 2010). Fryer &
Smellie (2013) present effective educational interventions such as face-to-face sessions, guideline edu-
cation, information technology, linked information and data feedback which have either reduced labor-
atory test volumes, costs or insignificance.
On the other hand, today, patients can be demanding and they have more information about their condi-
tion than before the internet era, thus patients may no longer rely on physicians’ evaluation, but demand
for more tests to be performed (Thom et al. 2002). Demanding is related to the level of trust of patient-
physician relationship. Low level of trust increased patient’s dissatisfaction, and therefore causing pa-
tient  to  demand  for  more  healthcare  services  such  as  diagnostic  tests  (Thom et  al.  2002;  Bertakis  &
Azari 2011). Consequently, teaching patients and forming more stable patient-physician relationships
within primary care are possible approaches to reduce inappropriate testing even though it is challenging
and the effects are not substantial (Fryer & Smellie 2013; Bertakis & Azari 2011). Accepting patients’
every wish, intuitively, increases the number of insignificant tests (Lysdahl & Hofmann 2009). In con-
trast, when patients learn about the consequences of tests and treatments they may even cancel the test,
because being afraid that it hurts (Kernick 1998). Reducing pain and discomfort caused to patients un-
necessarily, is a valid goal of demand management. Patient education could then be a double-edged
sword: it could produce the unwanted effect of having patients refuse ENMG testing because of fear of
pain.
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In addition to education, giving feedback is considered a useful tool for managing demand (Thomas,
Croal & Ramsay, 2006). In order to change physicians’ ordering behavior, one should translate feedback
into practice (Solomon, Hashimoto, Daltroy, & Liang, 1998). The feedback information could then con-
sist  of  costs  and  volumes  of  the  tests  a  certain  physician  has  ordered,  plus  other  easily  and  cheaply
acquired information. Disadvantages of giving feedback is that forming individual feedback for individ-
ual physicians requires a lot of resources (Janssens 2010). Furthermore, while feedback is given to in-
dividual physician, it requires stability from the referring quarter in order to keep the learning within the
unit and develop it constantly. The feedback information of costs and its effect on physician’s requesting
behavior is controversial and explored in more detail in Chapter 2.1.2. Local physician turnover may be
high, as physicians tend to conduct parts of their training in varying locations, which makes the feedback
giving rather challenging. Nonetheless, education and feedback has been shown to be inefficient when
performed alone, and Miyakis et al. (2006) showed that only the proper combination of both of these
two approaches is effective in managing demand. Furthermore, due to the cost and resource pressure,
IT systems including computers and patient information systems tend to be the focus of cost savings
(Anderson et al. 2006), thus these systems are not updated constantly to be the latest version. Due to
this,  IT  systems  are  not  agile  enough  to  give  easily  formulated  and  accessible  feedback  to  referring
physicians, which does not improve communication between stakeholders.
In addition to feedback, redesigning request forms is widely listed as an effective demand management
strategy approach according to literature (Bairstow et al. 2006; Solomon et al. 1998; Janssens 2010;
Fryer & Smellie 2013; National Coalition of Public Pathology 2012; Shalev et al. 2009; Bailey et al.
2005). Solomon et al. (1998) claim request form design to be an effective approach, which provokes
change in physician’s test ordering behavior. The greatest potential in request form is achieved, if the
request is electronic, giving it the ability to provide information in real-time about retest intervals, or
notify referring physician if the request is missing information of patient’s symptoms (Fryer & Smellie,
2013). According to Bairstow et al. (2006), electronic test request form maximizes the appropriateness
of referrals. In order to succeed with the referral reduction with a new request form design, one must do
it carefully; if the request form is too broad and does not make referring physician to ask the right ques-
tions from patient concerning the assumed diagnosis of patient, it will not have the effect of reducing
the referrals and does not function as a checklist for the physicians (Janssens 2010).
 In addition to request form redesigning, including a patient’s pain drawing to the referral would help
with the evaluation of test appropriateness. Studies have shown that the patient’s pain drawing helps
physician with the evaluation of pain of a patient, since pain is a subjective measure (Felix et al. 2010;
Sanders et al. 2006; Spyridonis et al. 2013). Such chart includes a figure of human body to which patient
colors his pain, numbness and weakness. This method is widely used in Europe to evaluate the level of
pain and what the pain indicates, because only spoken description of pain is inaccurate and may mislead
physician with diagnosis formulation. (Spyridonis et al. 2013.)
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As mentioned, the electronic request form may inform physician about appropriate retest intervals. No-
tifying the referring physician about the tests that are requested too often could reduce the number of
tests done (Fryer & Smellie 2013; National Coalition of Public Pathology 2012). Unnecessary control
tests are difficult to identify as the minimum retest interval varies depending on the patient’s clinical
status (Janssens 2010). Effective minimum retest intervals have been studied in the field of general
laboratory, such as the research of effective retest interval for HbA1c testing for monitoring the Type I
and Type II diabetes (Driskell et al. 2012). While retests and unnecessary controls are easier to imple-
ment in the general laboratory setting and in their request forms, the optimal retest interval is difficult
to determine for ENMG tests as it highly depends on the patient’s clinical status. The control test interval
for ENMG test is advised to be approx. 2-4 months as if neurophysiologist recommends it (Heikkilä &
Oja 2015). Nonetheless, control test interval for ENMG test varies depending on the patient’s symptoms
and disease (ibid.).
Reflective and reflex testing is used widely for laboratory test demand management. These two ap-
proaches provide effective and efficient diagnoses to be made. In reflective testing, the test-performing
physician adds tests to an order without consulting the referring physician, based only on the clinical
question asked. In reflex testing, the test-performing physician automatically performs additional more
specific and expensive tests to patient if the first performed cheap and explorative test gives an abnormal
result. (Srivastava et al. 2010). According to Janssens (2010), reflective and reflex testing prevents use-
less screening with expensive tests, but it requires that the clinical examination is done properly before
referring to any diagnostic tests. Reflective testing is actually an approach of demand management neu-
rophysiologists want to avoid, as they do not want to perform any additional expensive tests to patient,
rather they prefer to have patients, who are in advance meant to be examined with especially ENMG
test. This reduces the time spent per patient, shifts responsibility away from neurophysiologist, and pro-
vides resource savings. On contrary, neurophysiologists tend to use the reflex testing, as they begin with
the less extensive cheaper ENMG test and then if the result is abnormal, they conduct more extensive
ENMG test. In other words, neurophysiologists aim to focus ENMG test specifically as possible, and if
the cause is not found, then more extensive search with ENMG is required. ENMG test itself is already
a very specific and expensive test, thus conducting more common and explorative tests before referring
to ENMG is advisable. According to Finnish national Current Care Guidelines, referring i.e. a carpal
tunnel syndrome patient to operational treatment based only on ENMG test is not recommended, but the
referring physician needs to have other evidence to back ENMG test results before the patient is operated
(Suomalainen Lääkäriseura Duodecim 2013).
Besides reflective and reflex testing, different test combinations and packages are offered as one test
product to referring quarters, especially in laboratories. These test packages are predefined and usually
these are tailor-made to test the function of a specific organ. (Fryer & Smellie 2013; Janssens 2010.)
However, Fryer & Smellie (2013) claim that test packages should be made according to diagnosis, thus
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it would enable more efficient and effective testing if the requestor defines which diagnosis he/she is
looking for with the tests. Albeit test packages might be seen as threat of misdiagnosis, according to
demand management literature review by Solomon et al. (1998) they may also remind the referring
physician to order the right tests given that they have an expected diagnosis, and thus reduce the number
of superfluous requesting. Like test request forms, predefined test packages should not be overly restric-
tive, as then referring physicians tend to order additional extra tests to the package which increases the
number of inappropriate tests (van Wijk et al. 2001; Janssens 2010).
Although guideline and protocol development is presented as one of the most effective demand man-
agement strategy approaches (Solomon et al. 1998), it is regarded to be very slow and burdensome, as
formulating and communicating a new guideline or protocol in medicine requires years of research and
commitment (Janssens 2010). However, Warren et al. (2010) succeeded to reduce laboratory test de-
mand by 20% by reformulating the clinical protocol. If redesigning the guidelines and clinical protocols
is not possible with the limited resources, the dialogue between the test producer and test requestor could
be a good enough method to achieve the same outcome (Janssens 2010).
Besides clinical protocols, some test referrals require acceptance by a diagnostic test specialist before
the test is performed. This approach of demand management is called test request vetting. Fryer &
Smellie, (2013) stated that urine toxicology screening test request vetting reduced the number of insig-
nificant tests and resulted in cost savings of 30 000 pounds in general laboratory (Figure 4). According
to Mondelli et al. (1998), ENMG referrals from a neurosurgeon, neurologist, orthopedist, rheumatologist
or physiatrist should be accepted directly by the CN laboratory, and referrals by other physicians such
as primary care physicians should be evaluated by neurologist before sending a patient to ENMG test to
CN laboratory. Mondelli et al. (1998) claimed that this approach would enable reduction in electromy-
ography (EMG) requests by 25 % in Siena, Italy at the time of the study. Electromyography (EMG) tests
examine the function of muscles, while electroneurography (ENG) examines the function of nerves also
referred to as nerve conduction study (NCS).
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Figure 4 Figure adapted from Fryer & Smellie (2013, p.64). Implementing test request vetting for urine
toxicology screening tests in June 2006, resulting in reduced request volume and cost savings of approx. 30
000 pounds per year.
According to literature, the costs and charges of tests has been shown to affect physicians’ test ordering
(Gama et al. 1992; Seguin et al. 2002). In contrast, Solomon et al. (1998) presented that providing cost
feedback alone is not as effective as combining different demand management methods. Furthermore,
Hoey et al. (1982) presented that many tests are requested due to certain patient condition reasons, and
price information does not affect these kinds of tests. The effect of financial incentives on test ordering
behavior is examined in more detail in Chapter 2.1.2.
2.1.2 The effect of diagnostic tests’ charges on physician’s test ordering behavior
The financial asymmetry between healthcare service orderer and producer causes a part of ineffective-
ness within welfare countries’ healthcare system, because the referring physician has no personal cost
pressure or performance-related pay affected while ordering and purchasing healthcare services for pa-
tients. Due to the interesting phenomenon of financial asymmetry, the effect of financial incentives is
discussed in this chapter. The outcome and result from financial incentive driven healthcare system is
discussed in more detail in chapter 2.1.3.
The feedback of charges of diagnostic tests given to referring physicians reduces the number of diag-
nostic laboratory tests ordered (Tierney et al. 1990; Seguin et al. 2002; Miyakis et al. 2006; Gama et al.
1992; Sood et al. 2007; Cummings et al. 1982), thus balances the financial asymmetry. The feedback of
the costs of diagnostic laboratory tests was usually given to the physicians via the request form (Seguin
et al. 2002;Cummings et al. 1982). However, according to Seguin et al. (2002) the most expensive and
unnecessary diagnostic laboratory tests reduced, but the volume of some tests stayed the same. These
tests were seemingly considered absolutely essential for the patient diagnosis. The cost information did
not affect the volume of clinically absolute diagnostic tests, thus some tests should still be considered
as price insensitive tests.(Seguin et al. 2002.) The same trend was found in a research done in a cardiac
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care unit by Warren et al. (2010). Both of the aforementioned studies examined the volumes of common
laboratory tests, which might have been more price sensitive, unnecessary tests.
However, electrodiagnostic tests are more specialized tests, and thus might be seen more price insensi-
tive. On the other hand, Seguin et al. (2002) came to the conclusion that the volume reduction occurred
especially among the most expensive tests, which trend might also function among the more expensive
electrodiagnostic tests like ENMG test. All things considered, physicians’ test ordering was affected by
the cost information (Tierney et al. 1990; Seguin et al. 2002; Miyakis et al. 2006; Gama et al. 1992;
Sood et al. 2007; Cummings et al. 1982). On the other hand, physicians act on the behalf of a patient
(Eisenberg 2002), thus physicians are expected to order all the tests required to diagnose the patient with
high quality. This expectation and the role of physicians result in price insensitivity, which may be one
reason for the difficulty of reducing the number of insignificant tests.
Although available cost information affects physician’s test ordering, physicians were often unaware of
the costs of diagnostic tests even though the tests were commonly used (Miyakis et al. 2006; Seguin et
al. 2002; Allan & Lexchin 2008). The lack of cost information was especially noticed among trainee
physicians (Miyakis et al. 2006), who even tend to order more tests than seniors (Winkens et al. 1995).
Reasons for this could include knowledge on modern test technologies and services, or weaker self
confidence and thus increased reliance on diagnostic tests (Winkens et al. 1995). On the other hand,
Miyakis et al. (2006) noticed that the most expensive test in their research was used more appropriately
than the other tests even though physicians were unaware of the charges of these tests. As a result, it
seems that cost unawareness does not cause the inappropriate use of tests (Miyakis et al. 2006). How-
ever, these studies were made with common and mostly price sensitive laboratory tests, thus physicians
ordering behaviors with more expensive and specialized electrodiagnostic tests may be different from
that with common laboratory tests. In other words, there is not enough knowledge concerning price
insensitive expensive tests to predict the effect of cost on electrodiagnostic test requesting.
Furthermore, researchers were uncertain of sustaining the cost reductions in the long run, as previewing
the charges in request form would reduce the costs to some extent but it would be difficult to maintain
constant cost reduction over time (Seguin et al. 2002; Warren et al. 2010). In addition, providing feed-
back and education to physicians is not cheap, because both effective education and feedback require
face-to-face sessions, and producing and communicating the information to physicians is time and re-
source consuming (Eisenberg 2002). Schroeder et al. (1984) calculated the cost of education and feed-
back and concluded that the cost of intervention consumed the savings caused by the intervention. Con-
troversially, Gama et al. (1992) reported that the cost of feedback in their research was £530 while the
cost savings was £3027 calculated in revenue expenditure, showing savings in total costs even after the
investment of feedback production (Gama et al. 1992).
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2.1.3 The outcome of demand management
This chapter discusses the outcomes achieved with demand management approaches. In addition to re-
sults from demand management strategy usage, the challenges of demand management are explored.
The consequences of reducing demand are assumed to be misdiagnosing patients, resulting in more costs
as patients are undertreated and referred more often to secondary care. Interestingly, however, some
studies have found out that reducing unnecessary and inappropriate tests does not affect patient outcome,
which is measured by length of stay, mortality and readmissions to hospitals (Warren et al. 2010;
Winkens et al. 1995; Gama et al. 1992; Seguin et al. 2002). According to Winkens et al. (1995) reducing
the number of unnecessary tests reduced the number of specialized referrals without affecting the patient
outcome. Due to this phenomenon, display of the charges of test on request forms for referring physi-
cians to see, redesign of request forms, and education of referring physicians could actually provide
great savings with similar quality of care.
Demand management helps to match the demand to supply by either cutting inappropriate demand,
increasing preventive demand, or coping better with existing demand through effective care (Figure 5)
(Pencheon 1998). Demand management has various ways to reduce the number of insignificant diag-
nostic tests (Lee et al. 2013; Janssens 2010; Fryer & Smellie 2013; Bernardy et al. 2009), which results
in shorter waiting lists. Then limited resources are used more efficiently, and thus costs are reduced. As
a consequence better patient clinical outcomes are achieved (Winkens et al. 1995), which may be due to
the waiting time reduction which then enables patients with actual need for the service to get the help
they need on time. Both the healthcare professionals and patients form the demand (Pencheon 1998),
thus it is essential to affect both parties in successful demand management.
Figure 5 Framework for the management of the demand for healthcare services, adapted from (Pencheon
1998)
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Demand management has an impact on laboratory, patient and clinical outcome (Fryer & Smellie 2013).
Laboratory impact is measured in number of tests and cost, while patient and clinical impact are more
difficult to measure. Patient impact shows i.e. in the number of false positive and negative results, dis-
comfort and anxiety and in the number of days off work (Janssens 2010). Furthermore, the effectiveness
of demand management is important to measure in the light of clinical and patient outcomes besides
laboratory impact. Demand management outcomes should not be limited to the reduction of test volumes
and costs, only we must see the overall picture, and how reduction of inappropriate test affects patient
outcome.  As over-testing is  reduced and under-testing is  noticed,  the result  will  be fewer referrals  to
secondary care (Winkens et al. 1995). Furthermore, it will result in fewer hospital stays and better quality
of patient life due to fewer false positive test results and less distress of testing. The values and benefits
achieved with more effective healthcare services are discussed in more detail in chapter 2.2.2.
Solomon et al. (1998) divided the demand management strategies into three different categories: predis-
posing factors, enabling factors and reinforcing factors. Predisposing factors include education and train-
ing, which are meant to help physicians notice the need for change. Enabling factors include change of
the test request protocols, agreement on new guidelines and redesign of the request form. These factors
enable physician to act according to new guidelines and to achieve the change in requesting behavior.
Reinforcing factors give feedback and engage physicians to keep track of the costs of diagnostic test,
which encourages physicians to keep the change in their behavior and rewards physicians when they
succeed. Nevertheless, the enabling factors were considered the most powerful in demand management
(Solomon et al. 1998). On the other hand, successful results by using demand management are achieved
with combining these different factors according to other prior studies (Miyakis et al. 2006; Solomon et
al. 1998; Fryer & Smellie 2013; Fryer & Hanna 2009).
Laboratory test volume reductions vary between 7.9% - 79% depending on the demand management
strategy used (Bunting & Van Walraven 2004; Gama et al. 1992; Bailey et al. 2005; Seguin et al. 2002;
Shalev et al. 2009). A study done by Bunting & Van Walraven (2004) reported that a combination of
multifaceted education and feedback reduced their test volumes by 7.9%. Gama et al. (1992) achieved
a test volume reduction of 27% with feedback strategy after the first year intervention. The cost feedback
given to physicians reduced the cost expenditure by 22% within 2 months (Seguin et al. 2002). Bailey
et al. (2005) redesigned a request form for laboratory tests by reducing the preprinted tests on the request
form and achieved a test volume reduction of 27–79% depending on the laboratory test over a two-year
period. Similar results were reported by Shalev et al. (2009) in which the test volume increased by 60–
70% with tests which were added to the request form and reduced the excluded tests by 19.2–27 %. All
in all, demand management approaches reduce test volumes and costs, enabling shorter queues to diag-
nostic tests. However, all of these studies examined the common laboratory tests, which might differ
from more specialized and expensive electrodiagnostic tests in characteristics. Thus the same ap-
proaches, implemented for electrodiagnostic tests, may give different results.
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Yet, many studies observed that only few demand management approaches sustained a long-term change
after the invention (Warren et al. 2010; Seguin et al. 2002; Miyakis et al. 2006; Gama et al. 1992;
Eisenberg 2002; National Coalition of Public Pathology 2012). The combination of education and feed-
back was considered an effective demand management approach, but the change in test volumes did not
last long (Eisenberg 2002; Miyakis et al. 2006). Due to the short-term effect and the expensive costs
caused by providing the feedback and education, education and feedback giving could be considered as
not efficient enough demand management approach. Controversially, Gama et al. (1992) reported that
individual feedback generated a sustained the change. Furthermore, Winkens & Dinant (2002) claim
that feedback is an effective demand management approach, when it is possible to translate the feedback
information to concrete practice and it gives a possibility to physicians to participate in the process.
Nonetheless, the greatest challenge after test volume and cost reduction is to sustain the change (Warren
et al. 2010; Seguin et al. 2002; Miyakis et al. 2006; Gama et al. 1992; Eisenberg 2002). The success and
sustainability of the demand management intervention depends on many actions other than the interven-
tion itself (Solomon et al. 1998; Winkens & Dinant 2002). These additional actions that sustain the
change of an intervention include use of multiple demand management approaches, engagement of the
clinical staff and especially the senior level, ensured support from senior and lead clinicians, and attempt
to keep approaches simple to be easily adopted into practice. (National Coalition of Public Pathology
2012; Solomon et al. 1998).
2.2 The effectiveness of healthcare systems
In this chapter the concept of effective healthcare services and how to measure effectiveness are exam-
ined. As presented in Chapter 2.1 demand management is a tool especially for healthcare professionals
to encourage patients and other professionals to use healthcare services more appropriately. Further-
more, there should be tools for healthcare service consumers. Such a tool would enable them to base
their decision on relevant information, which tells how and what to consume. One type of such infor-
mation is to present the actual effectiveness of services to consumers, patients and political decision
makers, which then could encourage the whole healthcare system to become more effective. However,
in order to show results from effective service, one has to determine and decide how to measure effec-
tiveness. Therefore also the metrics of effective services are explored.
The first effectiveness studies emerged during 1960s and 1970s, and they calculated costs of diseases
(Johannesson & Jönsson 1991). Effectiveness studies compare the input and output of a health care
intervention, which can be either a diagnostic test or treatment. The output consists of health benefit and
possible harm. The input is mostly measured in monetary terms, such as workforce required or the cost
of a new technology. (Kernick 1998.) The need for effectiveness studies originate from increased de-
mand and healthcare costs as well as from limited resources of healthcare (Chalkidou et al. 2009; Kaplan
& Porter 2011). More efficient resource allocation makes cost savings possible (Eichler et al. 2004).
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This trend is nowadays evident in many healthcare sectors in numerous western countries both in diag-
nostic testing and in common physician appointments.
One of the first approaches used to evaluate effectiveness was the human capital approach. Human cap-
ital approach is based on a method of calculating the benefit of a treatment or technology as reduced
costs and reduced working resources. Due to the several limitations of the human capital approach, such
as it lacked the quality of life in the evaluation and did not take into account workers outside permanent
workforce, the cost-effectiveness analysis (CEA) was developed. Furthermore, the human capital ap-
proach calculated disease-specific costs, which did not relate to any treatment or technology, thus the
approach did not provide anything to decide on. The most important advantage of the CEA compared
to the human capital approach is that it takes into account the number of gained life-years. (Johannesson
& Jönsson 1991.) In CEA, the input measured in money is compared to outcome which is commonly
measured in mortality, morbidity and life-years gained (Johannesson & Jönsson 1991; Singer &
Applegate 2001; Kernick 1998). However, CEA also has limitations concerning its comparability, as
the calculations vary in terms of timeframe used, sorts of costs included, and type of life-years gained
(Johannesson & Jönsson 1991; Singer & Applegate 2001; Kernick 1998; Kaplan & Porter 2011;
Neumann et al. 2010). With CEA, decision makers are able to define the absolute benefit gained through
a new health intervention, but it is difficult to compare the results between different interventions be-
cause of the varying calculation methods (Johannesson & Jönsson 1991; Kernick 1998).
Besides cost-effectiveness analysis, also cost-utility and cost-benefit analyses were developed
(Johannesson & Jönsson 1991; Singer & Applegate 2001; Kernick 1998). These methods have emerged
from CEA, and are comparable to CEA. Both compare the output of the intervention to the input, but
cost-utility and cost-benefit differ in term of how the output is measured. In the cost-utility analysis, the
effectiveness is measured usually with quality adjusted life years (QALYs) (Kernick 1998; Singer &
Applegate 2001). The idea in cost-utility analysis is to maximize the number of quality adjusted life
years with the given healthcare budget. Like in CEA, comparability between two studied treatment
methods or diagnostic tools is weak due to varying types of costs and life-years used in the calculations.
(Johannesson & Jönsson 1991.) In cost-benefit analysis, both inputs and outputs are measured in eco-
nomic units, thus the comparison of inputs and outputs is made easier and generally more acceptable.
On the other hand, cost-benefit analysis has a drawback because it values the health benefit in financial
terms, which is not simple to do (Johannesson & Jönsson 1991; Singer & Applegate 2001). Conversely,
Kaplan & Porter (2011) claim, that the difficulty of calculating the health outcome benefit in monetary
units is only a myth, behind which healthcare providers hide in order to ensure high reimbursement pays
from government and insurance companies.
As the cost-benefit and cost-utility analyses did not take into account the opinions of health intervention
participants, the contingent value method (CV) was developed. In the CV method, the willingness to
pay and willingness to accept is studied with a survey from healthcare consumers and decision makers.
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(Johannesson & Jönsson 1991.) The willingness to pay is measured as the maximum amount of money
a person is ready to yield to secure that the proposed treatment or intervention is performed (Johannesson
& Jönsson 1991; Eichler et al. 2004). In contrast, willingness to accept is the minimum amount of money
a person accepts to take if the treatment or intervention is not produced. (Johannesson & Jönsson 1991.)
Comparative effectiveness research (CER) is a broader concept, encompassing the use of the aforemen-
tioned analysis methods (Goehler & Gazelle 2014; Gazelle et al. 2011). The aim of CER is to compare
the current standard of patient care to alternatives, such as new treatments brought about by new tech-
nologies (Chalkidou et al. 2009; Goehler & Gazelle 2014; Gazelle et al. 2011). These comparisons are
then  conducted  with  the  help  of  e.g.  CEA,  cost-benefit  analysis  or  cost-utility  analysis  (Goehler  &
Gazelle 2014; Gazelle et al. 2011).
Although effectiveness research is highly praised and many healthcare decision makers encourage eve-
rybody to use it (Kaplan & Porter 2011; Neumann & Tunis 2010), there are controversial perspectives
to effectiveness evaluations. These limitations of effectiveness research include the varying ways of
calculating both the inputs and the final outputs (Kaplan & Porter 2011). Furthermore, a lot of debate
has been about utility weighting while evaluating the outputs. In fact, the Centers for Medicare and
Medicaid Services (CMS) in the United States have explicitly excluded cost-effectiveness results from
the coverage of decision-making due to the danger of favoring only specific population groups as a
result of a certain way of calculating the cost-effectiveness. (Neumann & Tunis 2010.) There has also
been discussion of whether effectiveness calculations emphasize too much certain diseases and ages and
put patients into unequal positions (Neumann et al. 2010). On the other hand, effectiveness studies
should evaluate the output compared to input, making use of utility functions: e.g. a life-year of a work-
ing-age patient is more expensive than a life-year of 80-year old patient, even though this kind of think-
ing may be politically incorrect. Neumann et al. (2010) found that the worry towards the metric of qual-
ity adjusted life years (QALYs) was about if it emphasizes unequally the importance of younger and
healthier than older generations’ life-years as younger have more high quality life-years to gain Metrics
of effective healthcare service
2.2.1 Measuring effectiveness within healthcare
In order to improve the effectiveness of health care services, metrics are needed to measure and analyze
the development. In this chapter the most common metrics used for effectiveness evaluation within
health care services is explored. In addition, also metrics most suitable for analyzing effectiveness in
diagnostic testing are discussed.
Effectiveness of healthcare services is often measured by patient outcome, such as patient’s functional
status, quality of life, disability, clinical events, mortality or morbidity (Gazelle et al. 2011; Seguin et
al. 2002; Singer & Applegate 2001; Chalkidou et al. 2009). The most common effectiveness metric is
the quality of life-years gained, which is often compared to costs, thus measured by cost per quality-
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adjusted life year (cost per QALY). In QALY, health utility is determined according to preference
weighting. The weighting factor is calculated to each state of health, where the value of zero corresponds
to death and value of one to full health. The QALY is then the product of the health utility score and the
time spent in that state of health (Singer & Applegate 2001; Kernick 1998; Räsänen et al. 2006). Limi-
tations of QALYs include the difficulty in evaluation, and especially, equal evaluation of the quality of
a life-year with a specific disease (Räsänen et al. 2006). As a result, the comparison of QALYs from
different cost-utility analyses is problematic.
QALY, mortality, patient’s functional status and morbidity are difficult to measure as the outcome of a
diagnostic test (Drummond et al. 2009; Lee et al. 2010). One of the effectiveness metrics used to measure
diagnostic testing in terms of health benefit is medical value. Medical value is the value of information
gathered from diagnostic test and the value of correct diagnosing, which affects the final patient outcome
as well. (Lee et al. 2010; Ferrante di Ruffano et al. 2012.) Another effectiveness metric of diagnostic
testing used is the planning value to the patient. This refers to patient’s ability to adjust life according
to the test result. The third effectiveness metric relevant to patient is the psychic value, which refers to
patient’s mood and life changing according to test results. (Lee et al. 2010; Thornbury et al. 1999.) “The
value of knowing” has also been emphasized in the past years as important non-medical value of diag-
nostic testing. It represents the psychic value of diagnostics to patient, as knowledge on own health
condition is important to patient’s psychological well-being. (Lee et al. 2010.) Planning value, psychic
value and the ‘value of knowing’ all refer to the physiological effects of a diagnostic test to a patient. In
addition,  patients  feel  anxiety  and  distress  before  the  test  if  they  are  unaware  of  the  test  procedure
(Thornbury et al. 1999), especially in ENMG testing (Kothari et al. 1995). This also affects their psy-
chological well-being, thus it can be considered as a psychic value to a patient to know about the test
beforehand (Lee et al. 2010). These metrics are assessed in a method called patient utility assessment
presented by Fryback & Thornbury (1991). Usually patients value diagnostic testing highly due to the
importance of “value of knowing”,  which  may  cause  patients  to  demand  certain  tests  in  order  to  get
answers concerning their symptoms.
The value and benefit measured in effectiveness depends on the role of the participant in a diagnosis
situation (Gazelle et al. 2011; Lee et al. 2010). Medical value is the most important value to physician,
who diagnoses and decides about patient management according to the results (Gazelle et al. 2011;
Thornbury et al. 1999; Lee et al. 2010). Furthermore, the payer is usually mostly concerned about med-
ical value in the context of costs and overall patient outcome. At the same time, an important factor for
the patients is the psychological value of a test. (Lee et al. 2010.)
Nonetheless, diagnostic tests are difficult to evaluate from the patient outcome perspective as diagnostic
tests  primarily affect  the physician who sets  the diagnosis  and decides the treatment  plan (Lee et  al.
2010; Ferrante di Ruffano et al. 2012). However, this effect on treatment plan decision-making in turn
affects patient outcome eventually after the decision and treatment is performed (Fryback & Thornbury
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1991; John W. Loop & Lusted 1978; Kaplan & Porter 2011; Ferrante di Ruffano et al. 2009; Bossuyt &
McCaffery 2009). Due to the problematic connection between diagnostic test and final patient outcome,
the concept of diagnostic thinking efficacy was introduced by Fryback & Thornbury (1991). Diagnostic
thinking efficacy evaluates how physicians’ decision-making about diagnosis is affected by a diagnostic
test result. In addition, Fryback & Thornbury (1991) presented the therapeutic efficacy, which evaluates
the effect of a test result on a physician’s treatment plan decision-making. Fryback & Thornbury (1991)
presented a framework for evaluating the efficacy of a diagnostic test. The framework (Figure 6) in-
cludes six levels: technical, diagnostic accuracy, diagnostic thinking, therapeutic, patient outcome and
social efficacy. Of these methods, the technical and diagnostic accuracy efficacy methods are appropri-
ate for measuring new technology and how it effects patient’s treatment. In contrast, the patient outcome
and social efficacy methods are time-consuming to evaluate, and these measure the longer term effects
of diagnostic testing. (Thornbury et al. 1999.) Hence, in this study we focus on evaluating the effective-
ness of ENMG test from the diagnostic thinking and therapeutic efficacy point of view.
Figure 6 Hierarchical model of the efficacy of diagnostic tests, adapted from Fryback & Thornbury (1991)
As the purpose of a diagnostic test is to inform a physician about a patient’s condition, the most valuable
impact of a diagnostic test is how it affects a physician’s decision and treatment plan decision-making
(Janssens 2010). On the other hand, Bossuyt et al. (2012) argued that it is not relevant whether a test
provides information, but rather, whether it provides useful information or whether it is used correctly
and  efficiently,  which  determines  whether  a  diagnostic  test  has  been  effective  from the  clinical  care
perspective. As diagnostic thinking and therapeutic efficacy are important metrics in diagnostic testing,
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many studies have used either surveys done to referring physicians questioning the impact of a diagnos-
tic test on diagnosing or compared the pre and post diagnoses in order to determine whether a test was
useful to physician’s decision-making process (Shepherd 2010; Komur et al. 2014; Rigler & Podnar
2007).
On the other hand, Ferrante di Ruffano et al. (2012) presented that the impact of a diagnostic test should
not be removed from the final patient outcome and especially not from the influence of other tests, thus
the impact of diagnostic test effectiveness should be evaluated from the final patient outcome perspec-
tive. This influence of diagnostic test on patient outcome is shown in Figure 7 (Ferrante di Ruffano et
al. 2012). The effect of test result on diagnosing and treatment plan decision-making is considered as a
short-term patient outcome metric, while mortality, procedure side effects and morbidity are considered
to be long-term patient outcomes (Thornbury et al. 1999). The present study does not remove the impact
of diagnostic testing from patient outcome, but it only evaluates the effectiveness from the short-term
patient outcome perspective, the diagnostic yield and therapeutic yield are shown in Figure 7. The pre-
sent study uses short-term effects as effectiveness metric, similarly as Shepherd (2010) evaluated the
effectiveness of EMG tests by the number of abnormal results, the number of diagnoses an ENMG test
confirmed, whether the EMG test changed the treatment plan, and whether the ENMG test provided new
diagnosis alternatives. In other words, Shepherd (2010) also used diagnostic thinking and therapeutic
efficacies to determine the effectiveness of EMG test.
Figure 7 Attributes of test-treatment pathway that affect patient health, adapted from (Ferrante di Ruffano
et al. 2012)
The concepts of utility and value of a diagnostic test are commonly used to describe the same concept,
although utility and value mean different things (Singer & Applegate 2001). Utility is a subjective meas-
ure depending on the preferences of  the evaluator  and it  is  often used in assessing clinical  or  patient
outcomes such as QALY (Singer & Applegate 2001). Value, on the other hand, is more of an absolute
measure: medical value of  a  diagnostic  test  is  measured  in  the  ability  of  the  test  to  provide  relevant
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information to physician, which enables correct diagnosis and treatment of a patient (Lee et al. 2010).
Although value is considered a more objective metric than utility, the methods used to measure value
are diverse (Johannesson & Jönsson 1991; Singer & Applegate 2001; Kernick 1998) and difficult to
perform with proper comparability (Johannesson & Jönsson 1991; Simonen et al. 2012; Neumann &
Tunis 2010). As utility is considered controversial, so is value due to the aforementioned problems.
Clinical utility and patient utility measure different preferences (Bossuyt et al. 2012; Thornbury et al.
1999). Clinical utility concerns clinical events such as the number of correctly diagnosed patients
(Bossuyt et al. 2012), whereas patient utility is used for measuring patient’s well-being (Thornbury et
al. 1999). Patient utility assessment includes same metrics as Lee et al.'s (2010) psychic value of a di-
agnostic test: patients anxiety, planning value, expectations of future health and quality of life, and
Thornbury et  al.'s  (1999) metric  of  patient’s  willingness to  pay.  All  in  all, patient utility is evaluated
more from the psychological perspective, while the clinical utility takes into account the actual impact
of an intervention. In other words, patient utility measures the impact on individual, while clinical utility
measures the impact on population.
As stated in this chapter, the effectiveness analyses are not as comparable as analysis users would hope
(Johannesson & Jönsson 1991; Singer & Applegate 2001; Kernick 1998). Thus, diagnostic thinking and
therapeutic efficacies are more commonly used in evaluating diagnostic testing, as it does not require
cost effectiveness or cost-benefit analyses and utility preferences (Fryback & Thornbury 1991). Further-
more, final patient outcome is difficult to measure for a diagnostic test (Drummond et al. 2009). How-
ever, there are contradicting perspectives to whether patient outcome should be separated from the eval-
uation of effective diagnostic test and evaluate in isolation (Lijmer et al. 2009). Lastly, the reason for
healthcare managers’ avoidance of effectiveness data is, according to Simonen et al. (2012), the incom-
parability and reliability of effectiveness metrics such as quality adjusted life years (QALY). To con-
clude, the healthcare system would need more reliable and agreed effectiveness metrics to evaluate ef-
fectiveness.
2.2.2 The outcome of effective healthcare services
This chapter discusses the outcomes achieved through more effective healthcare services. Furthermore,
the financial incentives are discussed, in order to explore economically oriented environment a
healthcare system would actually require becoming more effective. Ineffective service production exists
due to the large amount of demand, which is created by patients with both actual need and no need for
the service. Demand is not prioritized with the thought of how much the service actually increases the
medical value. Besides demand management strategies, which help service producers to guide referring
physicians, also incentives are needed to change the requesting behavior and to control and prioritize
the demand.
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The measured outcomes of effectiveness of healthcare service often used are divided into patient out-
come, clinical outcome and economical outcome (Bossuyt et al. 2012; Thornbury et al. 1999; Fryback
& Thornbury 1991; Petrou & Gray 2011; Gazelle et al. 2011; Ferrante di Ruffano et al. 2012). These
well-established outcomes guide the development of a healthcare service as decision makers encourage
improving the selected outcomes. Patient outcome is measured as a psychological effect on patient’s
welfare such as how a patient perceives the health state after an intervention (Lijmer et al. 2009; Lee et
al. 2010). Clinical outcome is the absolute success of a clinical event such as the number of tumors
detected or blood pressure reduced (Chambers et al. n.d.). Economical outcome reflects monetary re-
sults,  such as  the indirect  and direct  costs  of  an intervention vs.  the final  savings.  Often,  economical
outcome is measured where two or several different interventions are compared in terms of their cost-
effectiveness. (Eichler et al. 2004; Chalkidou et al. 2009).
In order to achieve effective healthcare services, the financial asymmetry between healthcare service
producer and orderer has to be improved. The financial incentive should be implemented into the mind-
set of referring physicians, which would then change behavior of healthcare professionals (Flodgren et
al. 2011). The financial asymmetry leads to a situation, where physicians are free to order every service
their patient does or does not need without it affects physician’s economics or performance. Because
the ordering and purchasing of services affects the referring quarter i.e. primary care unit as whole, the
cost of services does not show to the referring physician, who ordered the service and referred the pa-
tient. In addition, Kaplan & Porter (2011) argue that the costs of healthcare services are usually calcu-
lated to match with the agreed reimbursement given by government or insurance companies rather than
to match the actual resource usage, which creates no incentives to service producers to improve their
resource utilization. This also reflects the situation of public sector, where production units order ser-
vices from one another without showing the actual costs of a service to the service-ordering physician,
which would create healthy concern about the resources used. As discussed in Chapter 2.1.2, physicians
usually are unaware of the costs of diagnostic tests, even though they order these tests almost on a daily
basis.
The British national healthcare system’s Quality and Outcomes framework (QOF) is a good example of
recent experiment to improve the effectiveness (Roland 2004). Fleetcroft et al. (2012) argue that the
British national healthcare system (NHS) did not succeed to maximize the health gains of population
with its QOF supported by financial incentives, which incentives depend on certain selected indicators
of health. Conversely, Campbell & Lester (2008) state that NHS succeeded to improve the preventive
healthcare and the behavior of healthcare professionals by setting indicators for disease-specific pro-
cesses, which improved the effectiveness of healthcare system as well.
NHS implemented 146 indicators in 2004 to measure effectiveness of their healthcare system. The Gen-
eral Medical Service (GMS) linked up to 20-25 % of the general physician’s income to these indicators,
which was done in order to change their behavior and improve effectiveness. (Roland 2004; Guthrie et
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al. 2006.) NHS’s idea was to create indicators concerning the health condition of patients with chronic
diseases, encouraging physicians with monetary incentives to improve overall health of the whole pop-
ulation, as chronic disease patients place a burden on the healthcare budgets (Marshall & Smith 2003).
What seems to have happened is that they overlooked the possibility of neglecting non-incentivised
diseases; the monetary bonuses were only paid for curing chronically ill patients with bonus related
indicators (Doran et al. 2011). The scare scenario, where physicians only select optimal patients for
selfish economical gains (Mangin & Toop 2007; Roland 2004), eventually proved to be somewhat true
(Doran et al. 2011). Due to the possibility of gaming for individual gain and reducing the quality of
healthcare, healthcare decision makers should very carefully choose their effectiveness metrics and in-
dicators for physicians. NHS used an effectiveness improvement method of changing physicians’ be-
havior by creating financial incentives. The debate of whether setting financial incentives to physicians
to improve the healthcare system in Finland depends on the metrics and incentive system chosen.
All in all, emphasizing and improving effectiveness of healthcare interventions and services is targeted
to increase the quality of health outcome with continually reducing resources. In other words, with more
effective healthcare we get more benefit with fewer resources. To sum, the idea of effectiveness is to
reallocate current and future resources, so that the maximum health benefit is achieved (Räsänen et al.
2006).
2.3 Insignificant diagnostic tests
In this chapter, the characteristics of insignificant diagnostic tests and inappropriate test requests are
explored and discussed. In addition, the reasons for ordering such tests are shortly presented based on
prior studies. Finally, the outcome of reducing insignificant tests is examined through previous studies.
Prior studies have examined the appropriateness of EMG requests (Cocito et al. 2006; Mondelli et al.
1998; Podnar 2005; Fuglsang-Frederiksen et al. 1995). These studies have shown that 17–25% of the
EMG tests conducted were insignificant due to inappropriate EMG test requests. Furthermore, recent
studies by Di Fabio et al. (2013) and Mondelli et al. (2014) concerning EMG tests’ significance and test
referral appropriateness prove this study topic to be timely, as these two studies were published during
the last few years and revealed that insignificant EMG tests are performed constantly and that it depends
on the quality of test referral and a couple of other factors discussed in next sub-chapter.
2.3.1 Characteristics of an insignificant test
If the effectiveness of a diagnostic test was measured by its effect on physician’s diagnostic and treat-
ment plan decision-making (Lee et al. 2010), then an insignificant test could be considered to be a test
that does not affect physician’s decision-making. However, van Walraven & Naylor (1998) presented
such categorization of inappropriateness too implicit due to the fact that diagnostic decision-making
never depends on one test only, but rather on several tests. Thus the evaluation of whether a diagnostic
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test affects decision-making or not, is not enough to determine the significance of a single test. In addi-
tion, a diagnostic test that does not affect specifically physician’s decision-making may still provide
additional and useful information to both patient and physician (ibid.) Similarly, Lijmer et al. (2009)
presented that diagnostic tests should not be removed from the context and from the influence of other
tests for the evaluation, unlike most of the studies use this method. Furthermore, the setting of evaluating
a single isolated test, does not allow experiments; in other words, it is impossible to exactly measure
how the decision-making process would have proceeded, if the diagnostic test had not been requested.
Moreover, Fuller (2005) states that when considering an ENMG test, the referring physician should
estimate the value it provides combined to other already ordered diagnostic tests’ results. It would be
useful  to  analyze  and  evaluate  a  diagnostic  test  side  by  side  with  other  tests.  However,  since  that  is
difficult, complicated and time-consuming, the impact of a diagnostic test is usually evaluated inde-
pendently.
However, the definition of an insignificant test depends on the field of medicine. Laboratory tests, radi-
ological test and electrodiagnostic tests differ from each other. Laboratory tests usually cost less and are
ordered more commonly, while radiological and electrodiagnostic tests are more expensive, complex
and advanced (Janssens 2010; Shalev et al. 2009; Fuller 2005). The difference between the use of radi-
ological test and electrodiagnostic test is that radiographic imaging is more commonly used than elec-
trodiagnostic tests, and imagining is typically a prior examination, while electrodiagnostic test, espe-
cially ENMG, is often the extension to other examinations (Fuller 2005). Many studies have focused on
reducing the number of laboratory tests, and characteristics used to determine unnecessary tests come
from the field of laboratory (Fryer & Smellie 2013; Janssens 2010; Plebani et al. 2014). In this setting,
inappropriate usage is explored from the too frequent retesting perspective (Janssens 2010; Fryer &
Smellie 2013). Although too frequent control tests are also a problem in the field of electrodiagnostic
testing, it is not the most common reason for insignificant tests. According to prior literature, a greater
problem is that unnecessary ENMG test are those requested too early after the event of injury, while
there are no findings possible to examine yet. In addition, ENMG test not extending clinical examina-
tions or ENMG tests requested without other examinations are considered also insignificant tests. Fur-
thermore, those tests that are not useful in the diagnostics since the symptoms of the patient are not
related to neuromuscular diseases, are considered as inappropriate tests as well. (Di Fabio et al. 2013;
Mondelli et al. 2014; Mondelli et al. 1998; Podnar 2005; Cocito et al. 2006.)
Nonetheless, there are conflicting opinions about whether a normal ENMG test result is insignificant
(Shepherd 2010; Mondelli et al. 1998; Di Fabio et al. 2013; Cocito et al. 2006; Podnar 2005). Shepherd
(2010) claims that a high rate of abnormal tests indicates that the test has been conducted on the right
patient population, as many of them show findings of neuromuscular diseases. Furthermore, Di Fabio et
al. (2013) concluded that normal ENMG tests were considered unnecessary when the patient’s pre-test
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symptoms did not indicate any neuromuscular disease or peripheral nervous system dysfunction. Simi-
larly, Podnar (2005) stated that a low rate of abnormal findings represents low quality of referrals, re-
sulting from inadequate clinical examination before the referral.
On the other  hand,  Loop & Lusted (1978) presented that  effectiveness of  a  diagnostic  test  should be
measured as an optimal ratio of normal and abnormal results produced; a high ratio of normal results
could indicate a high number of inappropriate tests. Yet, normal results can provide necessary and im-
portant information to the referring physician, such as excluding some diagnoses from a set of hypothet-
ical diagnoses. While an abnormal result confirms a disease, a normal result excludes considered diag-
nosis and makes other possibilities worth considering (Cocito et al. 2006). Van Walraven & Naylor
(1998) pointed out that if all normal results were considered as inappropriate tests, the appropriate use
of diagnostic tests would require that a physician ordering a test should know the result in advance in
order to avoid normal test results, making the whole test unnecessary. Due to these reasons, all normal
diagnostic test results cannot be considered insignificant (van Walraven & Naylor 1998). Furthermore,
van Walraven & Naylor (1998) claim that tests which have highly predictable results are unnecessary
and insignificant.
There has also been criticism on the implicit definitions of insignificance of some prior studies on in-
significant tests. Van Walraven & Naylor (1998) studied earlier publications on the subject and listed
inappropriateness criteria used for laboratory tests they deemed implicit. They mainly listed criteria that
were too unspecifically defined or  were not  evaluated from the disease perspective.  On this  list,  van
Walraven & Naylor (1998) included criteria such as “tests which were categorized as inappropriate by
clinical specialists”, “tests that did not contribute to final diagnosis or treatment plan” and “tests which
were normal”. In contrast, they present that proper, explicit inappropriateness criteria include those that
consider the perspective to prior tests, were based on national guidelines or used inappropriateness cri-
teria that was used in prior studies. (van Walraven & Naylor 1998). In other words, van Walraven &
Naylor (1998) claim that diagnostic tests should not be deemed inappropriate in isolation from other
tests, and that inappropriateness criteria should not depend on only one specialist’s opinion about inap-
propriateness.
2.3.2 Characteristics of inappropriate test requests
Like a test can be insignificant, the diagnostic test request done by the referring physician can be inap-
propriate (Janssens 2010). Commonly inappropriate test requests fulfill some of the following criteria;
requests that do not include all relevant information about the patient (Cocito et al. 2006; Di Fabio et al.
2013), only the symptoms of a patient are described but no referral diagnosis is included (Mondelli et
al. 1998; Podnar 2005), the test request is done prematurely or too late concerning patient’s symptoms,
or the test request does not include the appropriate tests that are able to examine the patient’s symptoms
(Janssens 2010; Fryer & Smellie 2013). The greatest challenge with inappropriate test requests is that
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rejecting test referrals by just reviewing them is risky (Fryer & Smellie 2013). The referral may seem to
be inappropriate (formulated incorrectly), however, the test may turn out to be necessary after having
seen  the  patient.  One  may  succeed  to  reduce  the  number  of  inappropriate  referrals  by  educating  the
referring physicians about the appropriateness of test requests, and what to include in it (Fryer & Smellie
2013; Miyakis et al. 2006).
Especially in electroneuromyography testing, the test referral is a crucial factor affecting both success
and significance of an ENMG test (Robinson 2000). Due to the limited possibility of having an dialogue
with referring physician at the moment of performing ENMG test, the referring quarter should include
all relevant information concerning the patient’s disease and symptoms (Fuller 2005). This same pattern
has been noticed in the field of radiology (Lysdahl & Hofmann 2009). An ENMG test should be seen
as an extension after clinical examination, and it should not be performed without a preceding clinical
examination– the ENMG test does not primarily provide the cause for the disease, but rather confirms
precise symptoms (Fuller 2005). In ENMG test requests, question setting seems to the most important
factor that affects the usefulness of ENMG test.
It is essential to include the referral diagnosis and referral query to ENMG test referral. An ENMG test
is generally useful only when it focuses on examining a specific peripheral nervous dysfunction
(Robinson 2000; Podnar 2005). So (2009) argued that an ENMG test request should be based on a
suspected diagnosis; if a referring physician cannot formulate a referral diagnosis he or she should not
request an ENMG test at all (Fuller 2005; So 2009). In practice, referring physicians tend to criticize
ENMG test reports which do not give answer to their questions, although in the referral they might have
asked too general questions, such as ‘neurologic disease?’ or ‘weakness with pain?’ (Smith 2003). Many
prior studies have reported that referring diagnoses are often missing from the ENMG test requests,
providing only symptom description rather than diagnosis suggestion (Di Fabio et al. 2013; Cocito et al.
2006). According to Cocito et al. (2006), making an ENMG test referral without specific suspected
diagnosis is waste of time and resources, as neurophysiologists then have to do the time-consuming
search for proper diagnosis hypothesis before the test. Furthermore, Fuller (2005) reminds that clinical
neurophysiologists are a scarce and expensive resource, and should not be used ineffectively. In addi-
tion, if an ENMG test is requested with too general question, it may lead not only to wasting resources
but also misdiagnosing the patient. An ENMG test with inadequate prior knowledge may either not
focus on the actual problem of the patient, or emphasize findings that are not relevant to patient’s con-
dition (Mondelli et al. 2014; Fuller 2005).
Besides the referral formulation, test ordering behavior affects the quality and significance of ENMG
test (Fuller 2005). Fuller (2005) presents two types of test ordering behavior: pragmatist and completist.
A pragmatist critically considers all test to order and tries to formulate the most efficient diagnostic
strategy as possible. In contrast, a completist is a practitioner who wants to exclude all possible diagno-
ses, and orders every possible test for the patient. (Fuller 2005), which causes ‘over-investigation’
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(Lysdahl & Hofmann 2009). Based on the aforementioned findings, general practitioners would seem
to be more completist in their behavior, while specialists are more pragmatist (Fuller 2005). General
practitioners tend to have lower correlation between the referral diagnosis and post-ENMG diagnosis
than specialists (Di Fabio et al. 2013; Mondelli et al. 1998; Podnar 2005; Cocito et al. 2006; Mondelli
et al. 2014). Prior studies of referral diagnosis and post-ENMG diagnosis correlation (Di Fabio et al.
2013; Mondelli et al. 1998; Podnar 2005; Cocito et al. 2006; Mondelli et al. 2014) are in line with this
typology regarding the behaviors of general practitioners as completists and neurologists as pragmatists.
The pragmatist might be seen as optimal behavior, however, such a way of ordering tests may lead to
problems such as misdiagnosis if too few diagnostic tests are ordered. A completist may also face the
problem of  misdiagnosis,  which  is  due  to  the  excess  number  of  tests  ordered  and  the  possible  false
positive test results (Fuller 2005). To conclude, a physician needs to be critical with test ordering. On
the other hand, a physician should not be too critical and mean with ordering of tests, in order not to
misdiagnose a patient due to limited diagnostic test information.
The most common referral diagnoses differed between general practitioners and specialist. In general
practitioner’s referrals it was usually carpal tunnel syndrome, and in specialists’ referral polyneuropathy,
radiculopathy or other pathology (Di Fabio et al. 2013; Mondelli et al. 1998). Because specialists seemed
to have a better agreement of referral diagnosis and post-test diagnosis, a couple of studies suggested
that if a GP suspects other diagnoses than carpal tunnel syndrome, the patient should be sent to a neu-
rologist or a specialist for further examination (Mondelli et al. 2014; Mondelli et al. 1998). The agree-
ment  of  referral  diagnosis  and  post-test  diagnosis  was  between  3  and  20  percentage  points  better  in
specialists’ referrals than in GPs’ referrals (Table 1) (Podnar 2005; Di Fabio et al. 2013; Mondelli et al.
2014; Mondelli et al. 1998; Cocito et al. 2006). According to Mondelli et al. (1998) the congruence of
referral diagnoses and diagnoses formulated by neurophysiologist was lowest in general practitioners’
referrals (47.7 % of all GPs’ referral diagnoses) and highest in neurosurgeons’ referrals (73%). Special-
ists and especially neurologist and neurosurgeons tend to formulate much more focused referrals to
ENMG tests than general practitioners (Mondelli et al. 1998; Mondelli et al. 2014; Di Fabio et al. 2013;
Podnar 2005). Naturally, a neurological specialization enables better identification of different nervous
system dysfunctions, which is reflected in the referrals made by neurologist or neurosurgeons.
2.3.3 The outcomes of reducing insignificant tests
Reducing insignificant ENMG tests and referrals will improve the quality of ENMG testing and reduce
waiting times (Podnar  2005;  Cocito et  al.  2006).  As shown in Figure 7 the timing of  test,  test  result,
diagnosis and treatment all affect the patient outcome. Therefore shortening of the waiting list improves
patient outcome due to better timing of test and faster treatment. When ENMG test requests are formu-
lated in sufficient detail and appropriately, then neurophysiologist is able to perform a focused and cor-
rect ENMG test (Cocito et al. 2006). Then time and resources are saved, and more efficient reallocation
Chapter 2 Literature
N. Välimaa 32
of scarce resources is possible (Eichler et al. 2004). However, perhaps the greatest advantages of reduc-
ing inappropriate ENMG test arise when patients with actual need will have the test within shorter period
of time (Podnar 2005), and patients who do not need the test will not experience discomfort due to
unnecessary invasive EMG needle test (Kothari et al. 1995) or get false positive test results (Fuller
2005).
According to prior studies, the share of insignificant ENMG tests and inappropriate test requests is 17–
28% of all ENMG tests performed (Table 1). The number of insignificant ENMG tests presents approx-
imately fifth of all ENMG test performed annually (Di Fabio et al. 2013; Mondelli et al. 1998; Mondelli
et al. 2014; Cocito et al. 2006). Even though the criteria to define inappropriate tests varied between the
studies, the percentages were comparable, and this data might be used as reference across different CN
laboratories. In addition, healthcare policies, regulations and funding affect physician’s test ordering
behavior, which affects the number of inappropriate tests requested (Eisenberg 2002). Therefore the
number of inappropriate tests may vary between different countries. Also, the different research methods
explain the variation in the percentage of inappropriate tests. Most of the prior studies used general data
analysis, which refers to gathering information about e.g. patient’s personal data, specialty of physician
requesting the ENMG test, clinical information included in test referral, referral diagnosis and the find-
ing from ENMG test (Di Fabio et al. 2013; Mondelli et al. 2014; Cocito et al. 2006; Shepherd 2010).
Mondelli et. al. (1998) conducted a short survey to neurophysiologists concerning the referral diagnosis
and its appropriateness.
However, insignificant ENMG tests are often linked to inappropriate ENMG test requests (Di Fabio et
al. 2013; Cocito et al. 2006; Mondelli et al. 1998). Inappropriate test requests refer to ENMG test request
without referral diagnosis or with too general query (Robinson 2000; Smith 2003), resulting in extensive
ENMG examinations. As a result, reducing the number of inappropriate test requests will release much
more resources than expected. Still, the number of requests without referral diagnosis or specific query
varies  between 21 % and 40 % of  all  referrals  (Table 1)  (Di  Fabio et  al.  2013;  Mondelli  et  al.  1998;
Mondelli et al. 2014; Cocito et al. 2006; Podnar 2005).
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Table 1 Summary of prior studies of EMG and NCS tests' and test referrals' appropriateness
Study Coun-try
Type
of test
Research
method
no. of
pa-
tients
exam-
ined
Normal
results
(%) of
all tests
% of
tests or-
dered by
GP
% of
tests or-
dered by
special-
ist
% of re-
ferrals
with re-
ferral
diagno-
sis
% of re-
ferral
diagno-
ses con-
firmed
% of
GP's re-
ferral
diagno-
ses con-
firmed
%of
special-
ist’s re-
ferral
diagno-
ses con-
firmed
Crite-
ria for
inap-
pro-
priate
tests
% of in-
appro-
priate
tests
Di Fa-
bio et al.
(2013)
Italy EMG
Data
analysis
a 1220 25 % 57 % 37 % 32 % 58 % 54 % 64 %
(1),
(2),
(3)
17 %
Mondell
i et al.
(1998)
Italy EMG
Survey
and data
analysis
a
2709 22 % 49.9 % 50.1 % 76.6 % 45.4 % 41.1 % 51.3 % (1) 22.8 %
Mondell
i et al.
(2014)
Italy EDX
Data
analysis
a 1586 37.5 % 66.2 % 33.8 % 65.1 % 71.9 % 70.9 % 73.4 % (5),(4)
21%
(could
have
avoided
with
careful
clinical
exami-
nation)
Cocito
et al.
(2005)
Italy EDX
Data
analysis
a 3900 37.5 % 25 % 75 % 79 % 40.5 % 36.5 % 41.8 % (8) 28 %
Podnar
(2005)
Slo-
venia EMG
Data
analysis
a 300 55 % 65 % 35.3 % 59.7 % 44 % 47.4 % 67 %
(2),
(3),
(5)
> 56 %
Shep-
herd
(2010)
US EDX
Data
analysis
b
100 12 % 100 % 0 % 100 % - - -
(6),
(7),
(8)
(40 %
did not
confirm
diagno-
sis, 70
% did
not
change
clinical
manage-
ment
Karadag
et al
(2014)
Tur-
key EDX
Data
analysis
a 2701 37.9 % 0.7 % 99.3 % 100 % - - - - -
a Retrospective research method
b Before-after-study method
(1) did not confirm neurophysiologist's working diagnosis
(2) did not explain patient's symptoms
(3) test gave normal result and patient did not have symptoms of peripheral nervous dysfunction
(4) test referral was inaccurate without referral diagnosis
(5) test referral was not in relation to clinical findings
(6) test result was normal
(7) test did not change treatment plan
(8) test did not affect pre-diagnosis or treatment plan
To conclude, inappropriate testing has been presented as a major reason for increased diagnostic test
utilization. Reducing these inappropriate tests would result in great savings. Minimizing the number of
insignificant diagnostic tests can be reflected into other healthcare sectors as well, while ineffective-
ness is most probably present also in other healthcare services from where insignificant procedures
could be removed (van Walraven & Naylor 1998). In addition, inappropriate diagnostic test utilization
generates unnecessary discomfort among patients (Thornbury et al. 1999; Kothari et al. 1995) and in-
creases the number of false positives (Fuller 2005), which generate a burden to other healthcare sec-
tors as well (van Walraven & Naylor 1998).
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3 Research methodology
This chapter describes the empirical setting of this study, namely a case study research approach.
Furthermore, the research design and the data collection and analysis methods are presented in
more detail.
This study is a document-based, non-experimental research, in which data is gathered retrospectively
from HUS patient information systems and from referring physicians and neurophysiologists via survey
and from three selected HUS specialists via interviews. The gathered information and the results of this
study did not affect the patients already examined. The present study uses a case study method (Creswell
2014). This study includes both qualitative and quantitative research methods. However, the emphasis
is on the quantitative survey research method.
Statistical analysis methods are used to explore survey data, performance data and data gathered with
closed-ended interview questions. The survey data gathered from neurophysiologists is analyzed with
ordinal logistic regression model and chi-square tests. In addition, the differences between HUS CN
laboratories, based on performance data, are statistically tested with Student’s t-test (Taanila 2012). The
present study uses both cross-sectional and longitudinal surveys (Creswell 2014) to gather data. Quali-
tative data analysis includes categorizing open-ended interview answers, which then are explicated and
summarized. However, the semi-structured interviews of this study include mainly closed-ended ques-
tions that are gathered to support the results from surveys, additionally these closed-ended interview
answers are analyzed with quantitative methods.
3.1 Research task
The aim of this study is to help Meilahti CN laboratory to understand the reasons behind insignificant
test requests, and how and which ENMG tests to prioritize in order to reduce the number of insignificant
tests. For the first, this study identifies the characteristics of insignificant ENMG test and inappropriate
ENMG test referral. After the identification, possible demand management strategies searched from
literature are proposed to reduce and control the number of these specific insignificant ENMG tests and
test referrals. Lastly, the number of insignificant ENMG tests are calculated for Meilahti CN laboratory
based on the answers gathered from two surveys. Albeit diagnostic tests would be good to analyze and
evaluate side by side with other diagnostic tests, within the limits of this study, this was not feasible. It
is both difficult, complicated and time-consuming, thus diagnostic tests are often evaluated in isolation
(e.g. Mondelli et al. 1998; Lijmer et al. 2009; Cocito et al. 2006).
Based on these objectives of this study, following research questions are answered; “What strategies
could be used to reduce the number of insignificant diagnostic tests in healthcare?”, “What are the char-
acteristics of insignificant ENMG test in CN laboratory in Meilahti hospital?” and “What number of
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ENMG test requests and ENMG tests are insignificant in Meilahti CN laboratory and do different refer-
ring units differ in this?”. The main research question is explanatory while the other two supportive
questions are more descriptive in nature.
To conclude, in order to answer these questions and to achieve the aim of this study, a literature review,
two surveys, three interviews and performance data collection are conducted. The main data is gathered
via surveys done to both referring physicians and neurophysiologists. The three interviews are made in
order to gather information about two specific patient diagnosis groups and to get support for the results
from statistical analysis of survey answers. Performance data is gathered from Meilahti CN laboratory’s
patient information system in order to gain understanding of the current situation and the problem at
hand. Furthermore, a summary of prior studies is constructed in order to review a solution to the in-
creased ENMG test demand through various demand management strategies.
3.2 Research design and approach
3.2.1 Quantitative and qualitative research
According to Creswell (2014), a determination of proper research design for the study depends on the
nature of research problem. Since this study aims to answer two descriptive research questions of “what
are the characteristics” and “how many” (Pinsonneault & Kraemer 1993) and one explanatory question,
the present research mixes qualitative and quantitative research methods. However, this research uses
mainly statistical analysis methods and gathers numeric data (Creswell 2014), therefore the emphasis is
on the quantitative research method, even though this study uses the most common qualitative research
method – the case study approach (ibid.). With qualitative research method, the present study explores
phenomenon from the individuals’ perspective within a natural setting (Malterud 2001).
3.2.2 A case study research approach
The case study method is suitable for this study, because this study focuses only on one case: Meilahti
CN laboratory, and especially, to the significance of ENMG tests. Furthermore, this research explores
the research problem through different lenses by gathering data from different sources, which is a
strength of case study approach (Baxter & Jack 2008). In addition, according to Yin (2009), a case study
method is the preferable method if the focus of the research is on a present phenomenon within a current
and actual process and that the researcher is not able to control the studied event, if the research answers
to exploratory or explanatory research questions and if the studied phenomenon is highly dependent on
the context. Although not all of requirements of a case study research are met in the current study, it still
fits the best with the aim of this study. Within this study the behavior of physicians cannot be controlled
by the researcher and this study explores the actual behavior of physicians when requesting tests. Fur-
thermore, the studied phenomenon, the significance of ENMG test and the reasons for ordering insig-
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nificant test, is highly dependent on the medical and clinical context. However, this study has a descrip-
tive focus instead of exploratory as it tries to answer questions of “what are the characteristics” and
“how many”. Nonetheless, the findings of this study are generalized to answer to the first research ques-
tion concerning whole healthcare sector, hence this research provides answer to explanatory question as
well.
The reasons for case selection were the following; Meilahti CN laboratory was selected to be the focus
of this study, because this laboratory has the highest volume of electro diagnostic tests within the HUS
area that require actions to minimize these volumes in the future. In addition, ENMG test waiting times
are long within the laboratory and needs to be shortened. Furthermore, ENMG test requires a lot of
neurophysiologist’s time to perform, therefore minimizing the number of inappropriate ENMG tests will
save a lot of resources and labor time and provide cost savings to test referring quarter.
According to Yin (2009) a case study method uses multiple methods for data collection. The main data
collection method used in the present study is survey, because it fits well with the characteristics of this
study. According to Pinsonneault & Kraemer (1993) the survey research method is preferred method
when the research fulfills the following requirements. First, the researched phenomenon is being studied
in its natural setting. Second, the focus of the research has occurred in recent past or is currently hap-
pening. Third, the independent and dependent variables cannot be controlled or the research wants to
keep the variables  uncontrolled.  Lastly,  survey research approach is  preferred if  the research aims to
answer research questions of “what” and “how many”. (Pinsonneault & Kraemer 1993.) All of these
requirements are fulfilled in this study.
One of the surveys used in this research is cross-sectional as it collects data in one point in time and the
other survey is longitudinal survey, which collects data in two points in time (Pinsonneault & Kraemer
1993). Survey done to referring physicians is cross-sectional as it collects their opinion only once and
in one point in time, namely while reviewing the final report of ENMG test results. However, the survey
done to neurophysiologists is a longitudinal survey, as it is divided into two parts, first part is answered
before and the second after preforming the ENMG test to patient.
3.3 Data collection
Three different data collection methods were used. First, the performance data from patient information
systems of all CN laboratories within HUS area was collected and analyzed in order to formulate a
whole picture of the problem at hand. Furthermore, the differences between these CN laboratories were
explored in order to plan and focus future actions. One of the goals was to determine which ENMG tests
are increased, how much compared to previous years and why. The analysis of performance data is used
to answer the first research question concerning valid demand management strategies. In order to select
and propose demand management strategies, one has to understand the main problems in CN laborato-
ries’ performances. Besides the demand management strategies, performance data was used to extend
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the information gathered with surveys, such as adding the information of the referring quarter to evalu-
ated patient case.
Second, in order to answer the second research question about the characteristics of an insignificant
ENMG test, a survey was conducted to the referring physicians and neurophysiologists concerning the
significance of the requested ENMG test. A survey (Appendix B: Survey made for referring physicians)
was carried to the referring primary and secondary care physicians in the area of Helsinki. Survey was
conducted in Finnish (Appendix E: Kysely tilaajataholle). First, an electric survey was sent to referring
physicians attached to the ENMG test report, but unfortunately it became clear that electric survey for-
mula did not reach enough audience due to the lack of usage of electric and digital patient information
reporting systems. Hence, top 10 ENMG test requester units were selected, which account approx. 50
% of the total ENMG test requested annually, and to these units a paper version of the same survey was
sent. The survey was conducted during November to December 2014. A total 70 patient cases were
evaluated by referring physicians from 10 different referring units.
In order to answer to the last research question about the number of insignificant ENMG tests, survey
made to neurophysiologists was conducted. The survey (Appendix A: Survey made for neurophysiolo-
gists) was carried to neurophysiologists in Meilahti and Laakso CN laboratories. The survey to neuro-
physiologists was conducted in Finnish (Appendix D: Kysely KNF-lääkäreille) A printed survey was
attached  to  ENMG test  referral  and  neurophysiologist  was  compelled  to  answer  the  first  half  of  the
survey before examining or interviewing the patient before the actual test and the second part after per-
forming the test. With this method it was possible to gather information about neurophysiologist’s ability
to evaluate the significance of ENMG test based only on test referral. The survey was conducted during
November to December 2014. A total 282 patient cases were evaluated by 11 neurophysiologists.
The potential sampling bias in finding representative physicians was dealt with recruiting all neurophys-
iologists working in Meilahti CN unit to answer the survey within the selected time period. Selecting
ten the most requesting referring units, gives good representative sample of referring physicians. Physi-
cians were asked to answer the survey every time they requested or performed an ENMG test within the
selected time period, an therefore this study has a good representative sample of patient cases.
These surveys gave the advantage to compare the opinions of referring physicians and neurophysiolo-
gists on similar patient cases, and therefore provided the answer to the second research question con-
cerning the differences in opinions. Altogether 33 patient cases were evaluated by both sides. The test
identification codes that made the opinion comparison possible was gathered from patient information
systems.
The third data collection method was interviewing three clinical specialists, which helped to answer to
the second research question. The first interviewee is a head of orthopedic and traumatology department
in HUS Töölö hospital. Second interviewee is a chief physician of orthopedic and traumatology clinic
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in HUS Töölö hospital. Third interviewee is a head of orthopedic surgery department in Peijas hospital.
These three interviewees have experience of requesting diagnostic tests and therefore they were able to
provide viewpoints to which affects the significance of diagnostic test. The three specialists were spe-
cialized in spinal, musculoskeletal or foot surgery. For the interviews we selected approx. 20 ENMG
patient cases to each interview. The patient cases were first selected by reviewing ENMG test reports
and then ensured the representativeness of cases by reviewing the selected cases by neurophysiologist.
In total 20 spinal cases were selected for spinal surgery specialists, 17 meralgia paresthetica cases were
selected for musculoskeletal surgery specialists and 19 morton neuroma cases were selected for  foot
surgery specialist. Spinal cases were mostly requested by the interviewee himself. However, there were
both cases of meralgia paresthetica and morton neuroma;  some  of  the  cases  were  requested  by  the
interviewee himself and some by other physicians. Nonetheless, interviewees were encouraged not to
focus on the fact that who had ordered the ENMG test, rather to whether the test provided any additional
value to the referring physician while making decisions concerning the patient case. The meaning was
to get the third general opinion about the ENMG tests’ significance in addition to neurophysiologists’
and referring physicians’ opinions. In addition, the aim of these interviews was to gather information
about the selected specific patient diagnosis groups, and whether performing a difficult ENMG test to
these patients really provides new information or helps with diagnosing or treatment plan decision-mak-
ing. The interviews performed had closed-ended questions (Appendix C: Interview questions to special-
ists), which were categorized and analyzed with quantitative content analysis methods. The interviews
were made in Finnish (Appendix F: Haastattelukysymykset kliinikoille).
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Figure 8 Data collection process of this study
3.3.1 Survey material
Both surveys were first formulated by the author of this study and then evaluated by two physicians, of
whom the other one was the instructor of this study, in order to avoid questions that would have been
either difficult or irrelevant to answer. In addition, both surveys included multiple-choice questions,
therefore the answer alternatives were extremely carefully selected and then reviewed by experienced
researcher in order to avoid answer alternatives that are either easy or tempting to select. The only open-
ended questions were in survey done to neurophysiologists concerning the referral diagnosis and work-
ing diagnosis, which were limited to short answers i.e. a couple of words.
Survey material was collected from both neurophysiologists and referring physicians. Both surveys were
conducted during November – December 2014. During that time all neurophysiologists working in Mei-
lahti CN laboratory were required to fill up the survey every time they performed ENMG-1, ENMG-2
or ENMG-3 test. Altogether 11 neurophysiologists answered to the questions, four of whom were in-
terns. However, not all referring quarters were involved in the survey done to referring physicians, as
the first version of the survey was done electronically via HUS electronic reporting systems to all refer-
ring quarters, which ordered ENMG tests during that time, but failed to reach enough audience due to
the minimal usage of such electronic reporting systems. Therefore a paper version of this similar survey
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was made to top 10 referring quarters, which accounted for 50 % of all ENMG tests requested annually.
A paper survey was delivered to these units and at the same time a short introduction of this research
was given to these quarters in order to ensure that referring physicians understood the aim of this study
and to increase the answering rate.
The survey done to neurophysiologists was a paper attached to the ENMG test referral and it was divided
into two sections, which were answered before the test and after the test. The aim of the survey was to
gather information about neurophysiologists’ opinion which ENMG test are insignificant and what fac-
tors affect the significance of a test. The survey included question of neurophysiologists’ prior evalua-
tion of the significance of ENMG tests, which was purely based on the evaluation of ENMG test referral,
as neurophysiologists were asked not to interview the patient before answering the first part of the sur-
vey. The first part of the survey also included questions concerning the working diagnosis and referral
diagnosis proposed, and whether neurophysiologist was certain about the working diagnosis. In addition,
the survey had a question of whether the referral diagnosis was meant to either exclude or confirm the
diagnosis proposed, and neurophysiologist was asked to evaluate the quality of ENMG test referral
query. After performing ENMG test to patient, neurophysiologist answered to the second part of the
survey. In the second part neurophysiologists provided the final evaluation of the significance of the
preformed test and whether it provided new information. In addition, the neurophysiologist evaluated
the extent of the test and the reasons for the significance of ENMG test. In order to analyze the survey
answers, performance data was collected from patient information systems to fill up the missing infor-
mation concerning the patient cases evaluated. The additional information included referring quarter,
findings of ENMG test and extent of performed ENMG test. After this a comprehensive data table was
built including both survey answers and performance data.
This study used the framework presented by Thornbury et al. (1999) to identify insignificant tests from
referring physician perspective. According to Thornbury et al. (1999) a diagnostic test, that is not eval-
uated to be helpful with either diagnosing or treatment plan decision-making, is considered as less sig-
nificant. Moreover, several other ENMG studies have supported Thornbury’s framework (Fuller 2005;
Di Fabio et al. 2013; Cocito et al. 2006; Podnar 2005; Rigler & Podnar 2007; Mondelli et al. 1998;
Mondelli et al. 2014).
The survey done to referring physicians was meant to be answered when a physician received the report
of ENMG test results and informed patient concerning the results. During or after the appointment where
the results of ENMG tests were discussed with the patient, the referring physician answered to the survey
questions. Survey included questions concerning the significance of ENMG test to patient diagnosis and
treatment plan decision-making. In addition, in a survey referring physician was asked to evaluate the
referral query they had included to referral and possible reasons for the significance of ENMG test. The
final questions concerned referring physician’s specialty and working experience. A database was build
from the survey answers. Referring physicians were asked to write the ENMG test code, which identified
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the test from patient information system. This made the comparison of the opinions of referring physi-
cians and neurophysiologists possible concerning the same patient cases.
3.3.2 Interview material
This study included three interviews made to three specialists in HUS with long working experience in
the field of medicine. The meaning of these interviews was to gather information concerning two dif-
ferent patient diagnosis groups, to whom ENMG test is difficult to conduct and the outcome of such test
is debatable. These patient diagnosis groups were meralgia parestetica and morton metatarsalgia. In
addition, a spine surgeon evaluated patient cases concerning back problems in order to gather opinion
in general about the significance of ENMG tests.
Interviews were held between November and December 2014 at  the same times as  surveys with the
other instructor of this study, who has a medical education, which ensured that interview answers were
understood by the author of this study. All of these interviews included approx. 20 patient cases, that
had already been examined with ENMG test and the final reports had been written and diagnoses and
treatments had already been decided. Interviewees were asked three questions concerning the patient
cases and the significance of ENMG test in the specific case. In addition, these interviewees were asked
a couple of general questions about the significance and meaning of ENMG test in general in diagnosing
and treatment plan decision-making. The questions concerning specifically patient cases were closed-
ended questions with multiple-choice questions, while the more general questions were open-ended. To
each interview, information about the selected 20 patient cases were printed including the ENMG test
referral, final report of ENMG test result and the final decision made by the referring physician based
on the ENMG test result. This information was reviewed to interviewee and based on that information
he evaluated whether ENMG test was significant of not, and what was the reason for the significance.
Interviews were approximately one hour long and the answers were both written and recorded for the
analysis.
3.3.3 Performance data
The secondary data of CN laboratory’s performance was gathered from HUS medical imaging center’s
patient information system QPati. The information was collected from years 2011-2014, in order to see
the trend of ENMG test volumes during the past years and also to analyze the differences between the
CN laboratories within HUS area. Information gathered included identification code of test, typology of
test, date of test referral received, date of test performed, referring quarter, CN laboratory where test
was performed, test result and name of neurophysiologist. The numeric data was collected from the
information system with different filters and exported to Excel file.
Chapter 3 Research methodology
N. Välimaa 42
3.4 Data analysis
The data analysis of this research includes analysis of both qualitative data and quantitative data. The
qualitative data was analyzed with qualitative content analysis method and quantitative data was ana-
lyzed with three different statistical methods: Ordinal logistic regression model, chi-square test and Stu-
dent’s t-test.
Figure 9 Data analysis process of this study and linkage to research questions
3.4.1 Qualitative data analysis
Qualitative data analysis is used for exploring the interview material of this study, as according to
Creswell (2014) open-ended questions in interviews needs to be considered as qualitative data. This
method includes gathering the qualitative data through interviews with notes and recordings. The anal-
ysis itself includes transcribing the audio recording, finding repetitive answers to the open-ended inter-
view questions and then coding the answers from interview into numeric terms and then analyzing it
with quantitative data methods. This analysis method is called content analysis approach (Krippendorff
2003). Content analysis approach is mainly used to making interferences from newspapers or other texts
to context of their use (Krippendorff 2003) and to actually count the number of i.e. repetitive words
within the text to analyze it with more quantitative method (Lacey & Luff 2007).
The qualitative data of interviews within this research was meant to support the findings of survey ma-
terial analysis and provide additional information concerning the selected patient diagnosis groups. The
interview was semi-structured having mainly closed-ended multiple-choice questions, which were
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coded numerically. However, the interview included a couple of open-ended questions, which needed
transcribing and additional interpretation and coding of repetitive answers. The first open-ended ques-
tion was “For what reason ENMG test is evaluated as insignificant or very insignificant?”. This question
was presented to all three interviewees and the answers to this question were coded, categorized and
used as support for findings of the survey data analysis. The other open-ended questions were presented
to only one interviewee who was expert in the field. Due to the fact that there was only one answer to
the questions concerning the patient diagnosis groups of meralgia paresthetica and one answer concern-
ing morton neuroma, the answers were not coded numerically, but presented as such to support and
reason the final result of statistically analyzed closed-ended multiple choice questions concerning the
significance of ENMG test when performed on a patient with morton neuroma or meralgia paresthetica.
3.4.2 Statistical methods
The main data was gathered through surveys from neurophysiologists and referring physicians. The
survey included mainly multiple-choice questions, which were coded into data table and the answers to
open-ended questions were first categorized and then coded to the same data table. The data table was
constructed into Excel work sheet having the questions in columns and each individual patient case in
each row. The patient cases evaluated by neurophysiologists were categorized according to referring
quarters. Referring units were divided into the following five groups; “hand surgery and surgery and
orthopedic outpatient clinics”, “physiatry outpatient clinic and rehabilitation center”, “neurology and
neurosurgery outpatient clinic”, ”other outpatient clinics” and “primary care”. “Other outpatient clinics”
included e.g. rheumatology outpatient clinic, emergency rooms and wards. Finally, from the patient
information system the test findings of ENMG were gathered and added into the data sheet with neuro-
physiologists answers in order to compare the proposed referral diagnosis, working diagnosis with the
final finding of ENMG test.
To identify the main factors affecting the significance of an ENMG tests, an ordinal logistic regression
model was built within a standard computer program (SPSS; IBM, Armonk, NY, United States) from
the survey data gathered from neurophysiologists. Logistic regression model is used to explore and an-
alyze the interaction and effects of selected variables (Sykes 2007). A regression model tries to model
the effect of independent variable on dependent variable. An ordinal logistic regression model is a type
of logistic regression model, in which the dependent variable is ordinal (Mccullagh 1980). Ordinal var-
iable means that the variable it is not continuous scalable metric only it has stepwise values of i.e. 1 to
5, which represent “strongly disagrees” (1) to “strongly agrees” (5). Ordinal logistic regression models
are usually used for modeling the findings of surveys especially variables, which are representing opin-
ions. (Bender & Grouven 1997.) In addition to ordinal logistic regression model, Pearson and Spear-
man’s correlations were calculated for  the variables  with a  standard computer  program (SPSS; IBM,
Armonk, NY, United States). Spearman’s correlation was used, as the majority of variables were non-
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parametric ordinal or nominal variables (Taanila 2012). With the Spearman’s correlation it was explored
whether there is a strong correlation between selected independent variables (correlation >0.5 or <-0.5),
because then these correlating independent variables could not have been selected to the same model to
explain the dependent variable due to multicollinearity.
Figure 10 presents the linkages between variables of ordinal logistic regression model, where the unit
of analysis was a patient to whom an ENMG test was performed. The dependent variable was set to be
the evaluation of final significance of ENMG test. Independent variables were selected from the differ-
ent questions presented in neurophysiologists’ survey. These independent variables included the quality
of referral query, prior evaluation of significance, normal or abnormal ENMG test result, surprising or
unsurprising ENMG test result, intern or specialist who performed the test, specialty of referring quarter,
evaluation of the extent of a test, neurophysiologist’s certainty of working diagnosis, extent of performed
test and the agreement between referral diagnosis and final ENMG finding.
Figure 10 Ordinal logistic regression model variables
In addition to ordinal logistic regression model a separate statistical analysis of neurophysiologists’ an-
swers was calculated using chi-square test. The goal was to identify in more detail, which variables
affect the significance of an ENMG test and especially how the referring quarter affects the significance.
With  chi-square  test  the  differences  of  groups  can  be  measured  with  categorical  variables  (Taanila
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2012). Chi-square test is also used to measure the dependency between two variables (ibid.). Further-
more, the reliability of the data was tested with chi-square tests, in which were distribution of signifi-
cance evaluations was compared between neurophysiologists.
The answers to survey done to referring quarter were not statistically analyzed due to the small number
of patient cases evaluated. The total number of 70 patient cases was not large enough sample size to
measure statistically. Furthermore, the comparison of opinions of neurophysiologists and referring phy-
sicians resulted in 33 patient cases, therefore no statistical analysis was done either as the sample size
was too small. These answers were evaluated only by calculating the percentages of answers.
Lastly, performance data of CN laboratories was gathered in order to explore changes in ENMG test
volumes and to have an understanding of performance of CN laboratories within HUS area, such as
waiting  time,  test  volumes,  percentages  of  referring  quarters.  A  Student’s  t-test  was  used  to  identify
whether CN units statistically differentiated from each other.
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4 Results
This chapter presents the results of qualitative and quantitative data analysis. Firstly, this chapter
will present the current state of Meilahti CN laboratory. Secondly, the results of the input from
neurophysiologists and referring physicians are presented in order to determine which kind of
ENMG test  are  being considered as  insignificant.  Finally,  this  chapter  presents  the input  from
three interviews and the findings concerning the controversial diagnosis groups; morton neuroma
and meralgia paresthetica. The sub-chapter 4.1 concentrates on describing the phenomena of in-
creasing ENMG test volumes, while the last two sub-chapters will present the results of analysis
of where to focus efforts of demand management.
This chapter is divided in terms of which are the main reasons for ordering an insignificant ENMG tests.
Research material was gathered from patient information systems, from neurophysiologists and refer-
ring physicians with two different surveys presented in chapter 3.3.1 and from three interviews per-
formed to specialists presented in chapter 3.3.2.
4.1 Current situation in Meilahti CN laboratory
During the years 2011-2014 the volume of ENMG test has increased by 26 % (Figure 11) in Meilahti
CN laboratory. ENMG test volumes have increased annually by approx. 8.0 %. At the same time waiting
time for ENMG test has become approx. 12 days longer 2014 vs. 2013 (Figure 12) in Meilahti. Further-
more, Meilahti CN laboratory has not achieved its strategic goal concerning the optimal length of wait-
ing time except for two months in year 2014. The objective for waiting time of ENMG examination is
to have at least 65 % of all ENMG tests to be done within 50 days or less, which days are calculated
from when test referral is received to when test result report is send to referring physician. Also the other
units have noticed the same problem of long queues.
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Figure 11 the development of ENMG test volume during years 2011-2014 in HUS area
Figure 12 the development of non-emergency waiting time to ENMG test during years 2011-2014 in HUS
area
CN laboratories within HUS area all differ from each other concerning ENMG test volumes, waiting
time and specialty of test requestors. The greatest difference is in the profile of referring quarters (Figure
13). The percentage of ENMG tests ordered by primary care and physiatry outpatient clinic varies be-
tween CN laboratories. Due to these differences, CN laboratories may need to acquire different demand
management strategies. Furthermore, the length of waiting time varies between Meilahti CN laboratory
and all HUS CN units (t-test p-value 0.04) and especially between Meilahti CN unit and Hyvinkää CN
laboratory and Lohja CN laboratory (t-test p-value 0.02). Waiting time is the longest in Meilahti, Jorvi
and Peijas CN laboratories and shortest in Lohja and Hyvinkää (Figure 12).
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Figure 13 Referring quarters requesting ENMG tests in 2014 in HUS area
During the data gathering process of this study a great challenge in the communication with referring
quarters was noticed. Normally, the only communication occurs when neurophysiologist reads an
ENMG test referral, the referring physician reads ENMG test result report or when neurophysiologists
call to referring physician directly about the test result in a case of emergency. In Meilahti CN laboratory
they also arrange meetings with referring quarters. Specialists from different fields give lectures to each
other about requesting and utilizing electrodiagnostic tests, in order to understand each other’s view-
points. However, this might not be enough: when a referring physician makes an inappropriate test re-
ferral, he or she might get feedback 3-4 months later and not personally but in a summarized form, if at
all – not every CN laboratory arrange these educational meetings with referring quarters.
In addition, there were no digital communication channels, through which these referring physicians
would have found the survey used in this study or through which such a survey could have been sent to
referring quarters. Therefore a paper version of the same survey was made and personally taken to these
different quarters. This drawback during this research process represents well the current situation of
challenging communication and the lack of effective communication channels in the healthcare sector,
which can be considered as one of the findings of this study.
Hence, better and more agile communication channels are needed in order to improve the quality of
referrals and selection of patients who benefit from ENMG testing. A better communication would help
both service provider and orderer to manage their costs. Especially, the communication between CN
laboratory and primary care is minimal. One would assume that sending emails is effective way to com-
municate, but due to the constantly changing personnel in primary care, sending emails is not efficient.
Due to this more effective real-time communication should be encouraged. Using phones is difficult,
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because physicians are extremely difficult to reach with phones as they are busy with their daily work,
and they do not work at one place only.
4.1.1 Increasing volume of ENMG tests and the main referring quarters
The percentage of ENMG tests of all electrodiagnostic tests performed during year 2014 was ~45 % in
Meilahti CN laboratory. The percentage has increased during last years being 38 % of all electrodiag-
nostic tests in 2011 (Figure 15). The overall volume of electrodiagnostic tests in Meilahti CN laboratory
has increased by ~6.4 % between years 2011-2014 (Figure 14). Total increase of ENMG tests’ volumes
within whole HUS area was 8.3 % between years 2011-2014.
Figure 14 the development of electrodiagnostic test volume in Meilahti CN laboratory during years 2011-
2014
Figure 15 the development of the percentage of ENMG tests of all electrodiagnostic tests in Meilahti CN
laboratory during years 2011-2014
Furthermore, the volume of ENMG-3 test in Meilahti CN laboratory has increased by ~160 % between
years 2011-2014 (Figure 16). At the same time the volume of ENMG-1 test has decreased, while volume
of ENMG-2 has slightly increased (Figure 16). In Meilahti, a majority of ENMG-3 tests are ordered by
outpatient clinics. About 15 % of ENMG-3 tests are ordered by primary care physicians and ~11 % by
8400
8600
8800
9000
9200
9400
2011 2012 2013 2014
Electrodiagnostic test volume in Meilahti CN unit 2011-2014
38%
40%
42%
45%
34%
36%
38%
40%
42%
44%
46%
2011 2012 2013 2014
Percentage of ENMG tests of all electro diagnosic tests in Meilahti and Laakso
CN units, 2011-2014
Chapter 4 Results
N. Välimaa 50
physiatrists. In contrast, in Hyvinkää CN laboratory ~46 % and in Lohja CN laboratory 40 % of ENMG-
3 tests are ordered by primary care physicians. (Figure 17.) In Jorvi CN laboratory and Peijas CN labor-
atory physiatrists order a quarter of ENMG-3 tests. The greatest difference between CN laboratories is
the percentage of  ENMG tests  ordered by primary care physicians and physiatrists.  In  Meilahti  they
account 26 % of all ENMG-3 tests ordered annually, while in Hyvinkää and Lohja CN laboratories these
referring quarters account for approx. 47 – 63 % of all ENMG-3 tests ordered (Figure 18).
Figure 16 the development of ENMG-1, ENMG-2 and ENMG-3 test volumes in Meilahti CN laboratories
during years 2011-2014
Figure 17 The percentage of ENMG-3 tests ordered by different referring quarters in HUS area in 2014
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Figure 18 The percentage of ENMG-3 tests ordered by primary care physicians and physiatrist in HUS
area, in 2014
4.1.2 Current actions used for shortening the waiting times
Meilahti CN laboratory has implemented actions to shorten waiting time for ENMG test and to reduce
the costs. HUS Medical Imaging Center has aimed at decreasing the number of outsourced physicians,
thus Meilahti CN laboratory reduced it by 75 % between years 2011-2014 (Figure 19). In 2011 the cost
of outsourced neurophysiologists in Meilahti CN laboratory was 114 150 € and in 2014 the cost was
only 28 250 € (Figure 19). Meilahti CN laboratory replaced outsourced physicians with more permanent
personnel – neurophysiology interns. Because reducing outsourced neurophysiologists did not shorten
the waiting time for ENMG tests, Meilahti used other methods. These methods included increasing the
number of ENMG tests done outside office hours by permanent neurophysiologists, increasing the re-
source utilization by 4.5 % and implementing Lean methods (Womack et al. 1992). ENMG tests per-
formed after office hours increased by 655 % between years 2011-2014 (Figure 20). However, the num-
ber of ENMG tests performed during office hours has not increased (Figure 21). This is a result of adding
time-consuming new electrodiagnostic tests to the test repertoire, which new tests have taken time from
ENMG tests. In addition to this, Meilahti CN laboratory has increased the capacity utilization rate by
4.5 % between years 2013-2014 measured in examination hours performed per employee’s yearly work-
ing days.
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Figure 19 the development of cost of outsourced neurophysiologists during years 2011-2014 in Meilahti CN
laboratory
Figure 20 the development of ENMG test performed outside office hours in Meilahti CN laboratory during
years 2011-2014
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Figure 21 the development of ENMG tests performed during office hours in Meilahti CN laboratory during
years 2011-2014
4.2 The main findings from surveys
The ENMG tests evaluated by neurophysiologists were requested by primary care in 28 % (n=78) of
cases, and the rest 72 % (n=204) by secondary care physicians. The ENMG tests requested by secondary
care physicians were ordered by hand surgeons and orthopedists (33 %, n=67), neurologists and neuro-
surgeons (28 %, n=58), physiatrists (18%, n=36) and other specialties e.g. rheumatologists, cardiolo-
gists, from emergency rooms and wards (22 %, n=45).
An ordinal logistic regression model was built in order to determine the main factors influencing signif-
icance  of  ENMG test.  According  to  Pearson  correlations  (Appendix  H:  Pearson  correlation  between
ordinal logistic regression model variables) none of the independent variables correlate strongly with
each other, therefore these selected variables can be used in this regression model without any singular-
ities and multicollinearity. The strongest correlation between independent variable and dependent vari-
able is between prior significance and final significance (Pearson correlation 0.535, sig. 0.00). The sec-
ond strongest is how surprising the ENMG finding is (Pearson correlation 0.380, sig. 0.00) and the third
is whether ENMG was performed by intern or specialist (Pearson correlation 0.259 sig. 0.00). The def-
initions of variables used in the ordinal logistic regression model are shown in Table 3. The output from
the best describing ordinal logistic regression model is presented in Table 2.
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Table 2 Associations between independent variables and test significance evaluated by neurophysiologists.
Ordinal logistic regression model – parameter estimates for independent variables, SPSS (N=263)
Parameter Estimates
Estimate Std. Error Wald df Sig.
95% Confidence Interval
Lower Bound Upper Bound
Thresh-
old
[Final significance = 1] -7.489 .909 67.926 1 .000 -9.270 -5.708
[Final significance = 2] -7.187 .899 63.851 1 .000 -8.950 -5.425
[Final significance = 3] -2.899 .782 13.736 1 .000 -4.432 -1.366
[Final significance = 4] -2.473 .775 10.173 1 .001 -3.993 -.953
Location [Prior significance=1] -3.934 .576 46.589 1 .000 -5.064 -2.804
[Prior significance=2] -1.977 .450 19.331 1 .000 -2.859 -1.096
[Prior significance=3] 0a . . 0 . . .
[Referral query=1] -.817 .612 1.782 1 .182 -2.016 .383
[Referral query=2] -.445 .351 1.606 1 .205 -1.133 .243
[Referral query=3] 0a . . 0 . . .
[Certainty of working diagnosis=1] 1.852 .962 3.708 1 .054 -.033 3.737
[Certainty of working diagnosis=2] .811 .530 2.341 1 .126 -.228 1.851
[Certainty of working diagnosis=3] .906 .509 3.160 1 .075 -.093 1.904
[Certainty of working diagnosis=4] 0a . . 0 . . .
[Evaluation of extent=1] .126 .534 .056 1 .813 -.920 1.172
[Evaluation of extent=2] 0a . . 0 . . .
[Surprising findings=1] -1.516 .416 13.258 1 .000 -2.332 -.700
[Surprising findings=2] -1.715 .602 8.104 1 .004 -2.895 -.534
[Surprising findings=3] 0a . . 0 . . .
[Extent of test=1] -.179 .863 .043 1 .836 -1.869 1.512
[Extent of test=2] -.113 .345 .107 1 .744 -.789 .563
[Extent of test=3] 0a . . 0 . . .
[Specialist intern=1] -1.197 .306 15.271 1 .000 -1.797 -.596
[Specialist intern=2] 0a . . 0 . . .
[Abnormal normal=1] -.841 .357 5.529 1 .019 -1.541 -.140
[Abnormal normal=2] 0a . . 0 . . .
[Final vs referral diagnosis=1] .239 .369 .421 1 .517 -.483 .962
[Final vs referral diagnosis=2] 0a . . 0 . . .
[Referring quarter=1] -.138 .431 .103 1 .748 -.982 .706
[Referring quarter=2] .004 .478 .000 1 .992 -.931 .940
[Referring quarter=3] -1.374 .529 6.750 1 .009 -2.410 -.337
[Referring quarter=4] -.329 .441 .555 1 .456 -1.193 .536
[Referring quarter=5] 0a . . 0 . . .
Link function: Logit. a. Parameter is set to zero because it is redundant.
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Table 3 Ordinal logistic regression model variable definitions
The number and definition of variable
Threshold and lo-
cations
1 2 3 4 5
1 Final signifi-
cance
Insignificant Slightly significant Somewhat sig-
nificant
Significant
(needed for doc-
umentation)
Very signifi-
cant
2 Prior signifi-
cance
Slightly signifi-
cant
Somewhat signifi-
cant
Very signifi-
cant
3 Referral query Referral query
missing or unclear
and poorly de-
fined
Somewhat defined,
but unclear or well-
defined, but irrele-
vant
Well-defined,
relevant and
clear
4 Certainty of
working diagno-
sis
No working diag-
nosis
Not certain Almost certain Very certain
5 Evaluation of
extent
Too narrow or too
broad
Appropriate
6 Surprising find-
ing
Unsurprising find-
ing
Something surpris-
ing, but it did not
affect patient diag-
nosis nor treatment
plan decision-mak-
ing
Surprising
finding
7 Extent of test ENMG-1 ENMG-2 ENMG-3
8 Specialist in-
tern
Intern Specialist
9 Abnormal nor-
mal
Normal Abnormal
10 Final vs refer-
ral diagnosis
Different Same
11 Referring
quarter
Primary care Other outpatient
clinics
Physiatry out-
patient clinic
and rehabilita-
tion center
Hand surgery
and general sur-
gery and ortho-
pedic outpatient
clinics
Neurology and
neurosurgery
outpatient
clinics
The results of Model Fitting Information and Goodness-Of-Fit showed the selected regression model to
fit well and to describe the dependent variable. Pseudo R-square is high in the selected regression model
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(Nagelkerke 0.485), which shows that the selected independent variables describe well the dependent
variable (Pearson sig. 0.000, Deviance sig. 1.000). The test of parallel lines shows that null hypothesis
can be rejected as p-value is >0.05, thus the model fits well and independent variables describe the
dependent variable well. These results from analysis of goodness-of-fit and Pseudo R-square are shown
in Appendix G: Model fitting information of ordinal logistic regression model.
The findings of ordinal logistic regression model showed that the main factors affecting the final sig-
nificance of ENMG tests were as follows (put in order according to the size of estimate), see Table 3:
1. Prior evaluated insignificance was associated with lower final significance (-3.934, p-value 0.000)
2. Neurophysiologist was uncertain or did not have working diagnosis increased the significance
(1.852, p-value 0.054)
3. ENMG finding being unsurprising lowered the final significance (-1.516, p-value 0.000)
4. Referring quarter was physiatry outpatient clinic or rehabilitation center it lowered the final sig-
nificance (-1.374, p-value 0.009)
5. Neurophysiology intern performing the test lowered the final significance (-1.197, p-value 0.000)
6. ENMG finding being normal was associated with lower final significance (-.841, p-value 0.019)
The effects of independent variables are analyzed in more detail in next sub-chapters with chi-square
test.
4.2.1 Prior evaluation of ENMG test’s significance
According to ordinal logistic regression model prior evaluation of low significance was strongly asso-
ciated with low final significance (estimate for low prior significance -3.934, p-value 0.000). This means
that if neurophysiologists evaluated ENMG to be less significant based on a test referral, the test per-
formed showed to be less significant according to final evaluation as well. This indicates that neuro-
physiologists seem to be able to evaluate significance of ENMG tests by reviewing ENMG test referrals.
Even analysis of separate survey answers showed that 73.7 % (n=14) of insignificant ENMG tests were
evaluated beforehand to be only slightly significant according to test referral. In addition, 48.8 % (n=42)
of very significant ENMG tests were evaluated in advance to be very significant based on test referrals.
Chi-square statistics test how the distributions of categorical, non-parametric variables differ from one
another between the selected groups. The difference between groups of different significance levels is
statistically significant (߯ଶ 118.02, p-value 0.000) (Table 4 below), which supports the finding from
ordinal logistic regression model that prior evaluated significance is strongly associated with final sig-
nificance.
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Table 4 Effect of prior significance on final significance, chi-square test
Final significance
Prior signifi-
cance
Insignif-
icant
Slightly
signifi-
cant
Some-
what
signifi-
cant
Signifi-
cant
(needed
for docu-
mentation)
Very
signifi-
cant
Chi
square
-test
value
p-
value
sig.
Slightly signifi-
cant
73.7%
(n=14)
80%
(n=4)
25.3%
(n=38)
6.3%
(n=1)
5.8%
(n=5)
118.0 0.000 <0.05
Somewhat sig-
nificant
15.8%
(n=3)
20%
(n=1)
70%
(n=105)
87.5%
 (n=14)
45.3%
(n=39)
Very significant 10.5%
(n=2)
0%
(n=0)
4.7%
(n=7)
6.3%
 (n=1)
48.8%
(n=42)
Furthermore, the prior evaluation of ENMG tests’ significance shows to have strong positive correlation
with final evaluation of ENMG tests’ significance (Spearman correlation 0.540, p-value 0.000) (Table
5 below). All these findings confirm the phenomenon that neurophysiologists were able to evaluate
ENMG test’s overall significance based on test referral.
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Table 5 Spearman's rho between selected variables. (**. Correlation is significant at the 0.01 level (2-tailed).)
Correlations
Final signifi-
cance
Prior signifi-
cance
Referral
query
Certainty of work-
ing diagnosis
Evaluation
of extent
Surprising
findings Extent of test
Spearman's rho Final significance Correlation Coefficient 1.000 .540** .210** -.006 .002 .363** .050
Sig. (2-tailed) . .000 .001 .921 .977 .000 .422
N 263 263 263 263 263 263 263
Prior significance Correlation Coefficient .540** 1.000 .308** .011 .001 .279** .047
Sig. (2-tailed) .000 . .000 .855 .984 .000 .443
N 263 263 263 263 263 263 263
Referral query Correlation Coefficient .210** .308** 1.000 .224** .398** .091 -.048
Sig. (2-tailed) .001 .000 . .000 .000 .142 .437
N 263 263 263 263 263 263 263
Certainty of working di-
agnosis
Correlation Coefficient -.006 .011 .224** 1.000 .093 -.112 -.035
Sig. (2-tailed) .921 .855 .000 . .133 .069 .575
N 263 263 263 263 263 263 263
Evaluation of extent Correlation Coefficient .002 .001 .398** .093 1.000 -.048 -.191**
Sig. (2-tailed) .977 .984 .000 .133 . .439 .002
N 263 263 263 263 263 263 263
Surprising findings Correlation Coefficient .363** .279** .091 -.112 -.048 1.000 .188**
Sig. (2-tailed) .000 .000 .142 .069 .439 . .002
N 263 263 263 263 263 263 263
Extent of test Correlation Coefficient .050 .047 -.048 -.035 -.191** .188** 1.000
Sig. (2-tailed) .422 .443 .437 .575 .002 .002 .
N 263 263 263 263 263 263 263
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4.2.2 Neurophysiologists’ certainty of working diagnosis
Regression model showed if neurophysiologist did not have any working diagnosis, it increased the final
significance of ENMG test (estimate for no working diagnosis is 1.852, p-value 0.05). This phenomenon
could be related to the effect that a surprising ENMG test finding is evaluated to be more significant. If
neurophysiologist do not have any suggestions for working diagnosis, ENMG test most likely provides
new information and the ENMG finding can be considered to be surprising. However, Spearman corre-
lation shows that there is no correlation between certainty of working diagnosis and surprising finding
(Spearman correlation -0.112, p-value 0.069).
Furthermore, chi-square test analysis of neurophysiologists’ answers supported the finding from regres-
sion model that low certainty of working diagnosis increased ENMG test’s final significance (߯ଶ 42.38,
p-value 0.001) (Table 6 below). The more certain neurophysiologist was about the working diagnosis,
the less  significant  ENMG test  was performed.  Since,  50 % (n=33) of  ENMG tests  with no working
diagnoses were evaluated as very significant, while only 22.2 % (n=6) of ENMG tests with very certain
working diagnoses resulted in very significant ENMG test, it seems that low certainty of proposed work-
ing diagnosis results in more significant ENMG test.
Table 6 Effect of certainty of working diagnosis on final significance, chi-square test
Certainty of
working di-
agnosis
Insig-
nifi-
cant
Slightly
signifi-
cant
Some-
what sig-
nificant
Significant
(needed
for docu-
mentation)
Very
signifi-
cant
Chi
square -
test
value
p-
value
sig.
No working
diagnosis
10%
(n=1)
0%
(n=0)
40%
(n=4)
0%
(n=0)
50%
(n=5)
42.38 0.001 <0.05
Uncertain 2.7%
(n=3)
3.6%
(n=4)
63.6%
(n=70)
0%
(n=0)
30%
(n=33)
Almost cer-
tain
7%
(n=9)
0.8%
(n=1)
51.9%
(n=67)
7.8%
(n=10)
32.6%
(n=42)
Very certain 22.2%
(n=6)
0%
(n=)
33.3%
(n=9)
22.2%
(n=6)
22.2%
(n=6)
However, the quality of referral query affected neurophysiologist’s certainty of working diagnosis
(Spearman correlation 0.224, p-value 0.000). The poorer referral query, the more uncertain neurophys-
iologist was about the working diagnosis. Furthermore, 82 % (n=23) of ENMG tests with very certain
working diagnoses had a well-defined and relevant referral query, while 30 % (n=33) of ENMG tests
Chapter 4 Results
N. Välimaa 60
with uncertain working diagnoses had only somewhat defined and unclear referral query (߯ଶ 28.99, p-
value 0.012) (Table 7 below).
Table 7 Effect of quality of referral query on the certainty of working diagnosis, chi-square test
The quality of
referral query
/ Certainty of
working diag-
nosis
Refer-
ral
query
missing
Un-
clear
and
poorly
de-
fined
Some-
what de-
fined, but
unclear
Well de-
fined and
clear, but
irrelevant
Well de-
fined, clear
and rele-
vant
Chi
square
-test
value
p-
value
sig.
No working
diagnosis
9 %
(n=1)
9%
(n=1)
45%
(n=5)
0%
(n=0)
36%
(n=4)
28.99 0.012 <0.05
Uncertain 0%
(n=0)
10%
(n=11)
30%
(n=33)
6%
(n=7)
54%
(n=60)
Almost cer-
tain
1%
(n=1)
5%
(n=6)
18%
(n=24)
7%
(n=9)
70%
(n=92)
Very certain 4%
(n=1)
7%
(n=2)
7%
(n=2)
0%
(n=0)
82%
(n=23)
4.2.3 Surprising ENMG finding and the significance of normal finding
Surprising ENMG finding was evaluated as significant ENMG test, whilst unsurprising finding as less
significant. This effect was noticed in ordinal regression model as well; unsurprising ENMG test finding
resulted in less significant ENMG test (estimate for unsurprising ENMG test result -1.516, p-value
0.000). Surprising ENMG finding correlated positively with both prior and final evaluation of ENMG
tests’ significance. Surprising finding correlated more positively with final evaluation of ENMG tests’
significance (Spearman correlation 0.36, p-value 0.000) than with prior evaluation (Spearman correla-
tion 0.28, p-value 0.000). These indicated that the more surprising ENMG test result, the more signifi-
cant ENMG test was.
In addition, chi-square test of neurophysiologists’ answers supported the finding, while 2.6 % (n=2) of
insignificant ENMG tests gave surprising finding, compared to very significant ENMG tests of which
62.8 % (n=49) gave surprising finding (߯ଶ 31.87, p-value 0.000) (Table 8 below).
Table 8 Effect of surprising finding on final significance, chi-square test
Final significance
/ Surprising find-
ing
Insignifi-
cant and
slightly
significant
Somewhat
significant
Significant
and very
significant
Chi
square -
test
value
p-value sig.
Not surprising
finding
11.2%
(n=22)
61.9%
(n=122)
26.9%
(n=53)
31.87 0.000 <0.05
Surprising finding 2.6%
(n=2)
34.6%
(n=27)
62.8%
 (n=49)
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In addition to unsurprising finding, ENMG test giving a zero result, referring to normal finding, was
evaluated less significant than test providing an abnormal finding. Since, 37.6 % (n=71) of abnormal
ENMG tests were evaluated as very significant compared to 17.2 % (n=15) of normal findings evaluated
as very significant (߯ଶ 12.00, p-value 0.02) (Table 9). Regression model supported this finding, as nor-
mal  finding decreased the significance of  ENMG test  (estimate for  normal  test  result  -0.841,  p-value
0.019).
Table 9 Effect of normal finding on final significance, chi-square test
Final sig-
nificance /
Normal or
abnormal
finding
Insignifi-
cant
Slightly
signifi-
cant
Some-
what sig-
nificant
Significant
(needed for
documenta-
tion)
Very
signifi-
cant
Chi
squar
e test
value
p-
value
sig.
Abnormal 5.8%
 (n=11)
1.6%
(n=3)
50.3%
(n=95)
4.8%
(n=9)
37.6%
(n=71)
12 0.017 <0.05
Normal 9.2%
(n=8)
2.3%
(n=2)
63.2%
(n=55)
8%
(n=7)
17.2%
(n=15)
4.2.4 Difference between neurophysiology specialist and intern
According to survey answers from neurophysiologists, final evaluation of ENMG test correlates with
neurophysiologist’s degree of specialty; the lower the degree of specialty of neurophysiologist, the less
significant ENMG test was (Pearson correlation 0.259, p-value 0.000) (Appendix H: Pearson correlation
between ordinal logistic regression model variables). Furthermore, a more detailed analysis of survey
answers showed that greater percentage of ENMG tests performed by neurophysiology specialists were
evaluated to be very significant while ENMG tests performed by neurophysiology intern were evaluated
to be less  significant;  40.5 % (n=66) of  ENMG tests  performed by specialist  were evaluated as  very
significant, while 16.8 % (n=20) of interns’ ENMG tests were evaluated as very significant (߯ଶ 42.30,
p-value 0.000) (Table 10). A majority of ENMG tests conducted by interns was evaluated by themselves
to be only somewhat significant (73.9 % n=88). The same effect was noticed in ordinal logistic regres-
sion model, where it showed that interns conducted less significant ENMG tests than specialists (esti-
mate -1.197, p-value 0.000).
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Table 10 Effect of the level of specialty of neurophysiologist on final significance
Neurophysiologist
who performed
ENMG test / Final
significance
Specialist Intern Chi-
square
test -
value
p-value sig.
Insignificant 5.5%
(n=9)
8.4%
(n=10)
42.30 0.000 <0.05
Slightly signifi-
cant
3.1%
(n=5)
0%
(n=0)
Somewhat signifi-
cant
38%
(n=62)
73.9%
(n=88)
Significant
(needed for docu-
mentation)
9.2%
(n=15)
0.8%
(n=1)
Very significant 40.5%
(n=66)
16.8%
(n=20)
A reason for such difference between specialists and interns is not described by the different patient
mix,  because  the  distribution  of  ENMG tests  requested  by  different  referring  quarters  was  the  same
between the two groups (߯ଶ 4.33, p-value 0.362) (Table 11 below). However, the difference may be due
to the different opinions about what test should be considered as significant or insignificant, because
these answers were based on their own evaluation.
Table 11 Distribution of different referring quarters between interns and specialists
Neurophysiologist
who performed
ENMG test / Re-
ferring quarter
Specialist Intern Chi-
square
test -value
p-value sig.
Hand surgery and
surgery outpa-
tient clinic and
orthopedic outpa-
tient clinic
26.4%
(n=43)
20.2%
(n=24)
4.33 0.362 >0.05
Physiatry outpa-
tient clinic and
rehabilitation
center
14.7%
(n=24)
10.1%
(n=12)
Other outpatient
clinics
16%
(n=26)
16%
(n=19)
Neurology outpa-
tient clinic and
neurosurgery out-
patient clinic
19.6%
(n=32)
21.8%
(n=26)
Primary care 23.3%
(n=38)
31.9%
(n=38)
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4.2.5 Other factors affecting the significance of ENMG test
In addition to ordinal regression model’s statistically significant independent variables, through chi-
square test analysis also other factors were identified to affect ENMG tests’ significance. Especially, the
quality of referral query seemed to affect ENMG tests’ final significance. Although, according to re-
gression model referral query was not statistically significant to affect final significance of an ENMG.
Nonetheless, according to separate analysis of survey answers the poorer the referral query, the less
significant ENMG was performed. Only 37.5 % (n=9) of ENMG tests with poorly defined, missing or
unclear referral query resulted in very significant ENMG test. In contrast, 74.4 % (n=64) of ENMG tests
with a well-defined, relevant and clear referral query resulted in very significant ENMG test. In other
words, the significance of ENMG tests varied according to the quality of referral query (߯ଶ 16.96, p-
value 0.031) (Table 12 below). Furthermore, there seemed to be a positive statistically significant cor-
relation between the quality of referral query and the final significance of ENMG test (Spearman corre-
lation 0.210, p-value 0.001). Similar and stronger correlation seemed to be between the quality of refer-
ral query and prior significance (Spearman correlation 0.308, p-value 0.000).
Table 12 Effect of the quality of referral query on final significance, chi-square test
Final signifi-
cance / Quality of
referral query
Insig-
nifi-
cant
Slightly
signifi-
cant
Some-
what sig-
nificant
Significant
(needed
for docu-
mentation)
Very
signifi-
cant
Chi
squar
e -test
value
p-
value
sig.
Referral query
missing or un-
clear and poorly
defined
4.2%
(n=1)
16.7%
(n=4)
29.2%
(n=7)
12.5%
(n=3)
37.5%
(n=9)
16.95 0.031 <0.05
Somewhat de-
fined, but un-
clear or well-de-
fined, but irrele-
vant
1.2%
(n=2)
8.4%
(n=14)
23.5%
(n=39)
5.4%
(n=9)
61.4%
(n=102)
Well defined,
clear and rele-
vant
0%
(n=0)
2.3%
(n=2)
18.6%
(n=16)
4.7%
(n=4)
74.4%
(n=64)
The extent of performed ENMG test was not affected by the quality of test referral query. The assump-
tion was that the poorer the test referral query was, the more extensive ENMG test was performed. This
assumption was based on the fact that if a test referral query was unfocused and poorly defied it would
result in more extensive ENMG test, because a neurophysiologist would need to do screening and search
for the reason for patient’s symptoms. Therefore, the extent did not affect the final significance of
ENMG test and the poorly defined test referral did not result in ENMG test to be more extensive (߯ଶ
4.15, p-value 0.386) (Table 13 and Table 14 below).
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Table 13 The effect of the quality of test referral on the extent of ENMG test, chi-square test
The quality
of referral
query / Ex-
tent of
ENMG test
Referral
query
missing or
unclear
and poorly
defined
Somewhat de-
fined, but un-
clear or well-
defined, but
irrelevant
Well
de-
fined
and
rele-
vant
All Chi
square -
test value
p-value sig.
ENMG-1 0%
(n=0)
3.8%
(n=3)
2.3%
(n=4)
2.5%
(n=7)
4.15
2.99
(between
ENMG-2
and
ENMG-3)
0.386
0.22
(between
ENMG-2
and
ENMG-
3)
>0.05
ENMG-2 52.2%
(n=12)
68.8%
(n=55)
65%
(n=115
)
65%
(n=182)
ENMG-3 47.8%
(n=11)
27.5%
(n=22)
32.8%
(n=58)
32.5%
(n=91)
Table 14 The effect of the extent of ENMG test on the final significance of ENMG test, chi-square test
Final signifi-
cance / The ex-
tent of ENMG
test
Insignifi-
cant or
slightly sig-
nificant
Somewhat
significant
Significant
or very sig-
nificant
Chi
square -
test value
p-value sig.
ENMG-1 14.3%
(n=1)
28.6%
(n=2)
57.1%
(n=4)
3.84 0.428 >0.05
ENMG-2 8.5%
(n=15)
58%
(n=102)
33.5%
(n=59)
ENMG-3 8.8%
(n=8)
49.5%
(n=45)
41.8%
(n=38)
In survey neurophysiologists were asked to list the main reasons for ENMG test’s insignificance. The
major reason was self-evident diagnosis, which accounted 42 % (n=10) of all insignificant or slightly
significant tests. The other two specific reasons were unnecessary control test 20.8% (n=5), and too
extensive and unspecific referral query 20.8 % (n=5). Other reasons included reasons such as normal
finding, patient’s symptoms had disappeared, same ENMG finding found previously which had not
reached referring physician, and the fact that patient’s symptoms did not relate to nervous system dys-
function (Table 15 below).
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Table 15 Reasons presented for insignificant and slightly significant ENMG test
Final significance / reasons for ENMG
tests' insignificance
Insignificant or slightly
significant
Other reason 16.7% (n=4)
Unnecessary control test 20.8% (n=5)
Self-evident diagnosis 41.7% (n=10)
Too broad and unspecific referral query,
which caused ENMG finding to be irrele-
vant for patient's symptoms
20.8% (n=5)
Other reasons included:
normal finding
symptoms had disappeared
same ENMG test done previously but information had not reached refer-
ring doctor
patient's symptoms did not relate to nervous system dysfunction plus nor-
mal ENMG test result
To summarize the findings of chi-square test analysis of neurophysiologists’ answers, the main factors
contributing to insignificant ENMG test were prior evaluation of low significance, normal finding, un-
surprising finding, poor quality of referral query, if neurophysiologist intern performed the test, and if
neurophysiologist was certain about the working diagnosis.
In addition to aforementioned characteristics of insignificant ENMG test, the findings of ordinal logistic
regression model  showed that  the referring quarter  affected ENMG tests’  significance.  Due to this  a
more detailed analysis was made to identify the differences between referring quarters. The results from
these analyses are presented separately in the next chapter.
4.3 The differences between referring quarters
This chapter  explores  the differences between primary care and secondary care from the ENMG test
requestor perspective. Secondary care is analyzed in more detail in order to explore the differences be-
tween different outpatient clinics. Lastly, this chapter reveals the findings of where to focus demand
management in future in order to decrease the number of inappropriate ENMG test requests. The anal-
ysis in this chapter is based on surveys performed to neurophysiologists.
According to ordinal logistic regression model physiatry outpatient clinics and rehabilitation center re-
quested less significant ENMG tests compared to other referring quarters including primary care (esti-
mate for physiatry outpatient clinic and rehabilitation center -1.374, p-value 0.009) (Table 2 above).
However, a more detailed analysis of neurophysiologists’ answers to survey showed a great difference
between  primary  care  and  secondary  care  requests.  Primary  care  orders  less  significant  ENMG tests
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compared to secondary care according to neurophysiologists’ final evaluation of ENMG tests’ signifi-
cance. The overall percentage of insignificant tests was 6.7 % and only slightly significant ENMG tests
was 1.8 %, while the percentage of very significant ENMG tests was 30.5 % (n=86). According to final
evaluation, 19.2 % (n=15) of ENMG tests ordered by primary care physicians were evaluated as very
significant while similarly significant ENMG tests accounted 34.8% (n=71) of ENMG tests requested
by secondary care. There was statistically significant difference between primary care and secondary
care at the significance level of 90 % (߯ଶ 9.37, p-value 0.09) (Table 16 below).
 Primary care ordering less significant ENMG tests is explained with various differences compared to
secondary care concerning ENMG test requesting.
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Table 16 Differences between primary and secondary care ENMG test request, chi-square test
All phy-
sicians
Pri-
mary
care
Second-
ary care
Chi
square
-test
p-
value
sig.
Neurophysiologist final evaluation of
ENMG tests' significance
100 %
(n=282)
100%
(n=78)
100%
(n=204)
Insignificant 6.7%
(n=19)
7.7%
(n=6)
6.4%
(n=13)
9.37 0.090 >0.05,
<0.1
Slightly significant 1.8%
(n=5)
0.0% (n
=0)
2.5%
(n=5)
Somewhat significant 53.2%
(n=150)
59.0%
(n=46)
51%
(n=104)
Significant (needed for documenta-
tion)
5.7%
(n=16)
9.0%
(n=7)
4.4%
(n=9)
Very significant 30.5%
(n=86)
19.2%
(n=15)
34.8%
(n=71)
No evaluation 2.1%
(n=6)
5.1%
(n=4)
1%
(n=2)
Prior significance of ENMG test 100 %
(n=282)
100 %
(n=78)
100 %
(n=204)
Insignificant 0%
(n=0)
0%
(n=0)
0%
(n=0)
10.43 0.000 <0.05
Slightly significant 22%
(n=62)
24.4%
(n=19)
21.1%
(n=43)
Somewhat significant 59.6%
(n=168)
69.2%
(n=54)
55.9%
(n=114)
Very significant 18.4%
(n=52)
6.4%
(n=5)
23%
(n=47)
ENMG test results 100 %
(n=282)
100 %
(n=78)
100 %
(n=204)
Abnormal results 67%
(n=189)
55.1%
(n=43)
71.6%
(n=146)
6.90 0.009 <0.05
Normal results 33%
(n=93)
44.9%
(n=35)
28.4%
(n=58)
Surprising ENMG test findings 100%
(n=275)
100%
(n=73)
100%
(n=202)
Unsurprising abnormal results 45.8%
(n=126)
42.5%
(n=31)
47%
(n=95)
11.64 0.003 <0.05
Unsurprising normal results 25.8%
(n=71)
38.4%
(n=28)
21.3%
(n=43)
Surprising abnormal results 21.5%
(n=59)
11%
(n=8)
25.2%
(n=51)
surprising normal results 6.9%
(n=19)
8.2%
(n=6)
6.4%
(n=13)
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Table 17 Differences between primary and secondary care’s ENMG test requesting, chi-square test
All phy-
sicians
Primary
care
Second-
ary care
Chi
square
-test
p-
value
sig.
Referral diagnosis 100 %
(n=282)
100 %
(n=78)
100 %
(n=204)
No referral diagnosis 13.8%
(n=39)
10.5%
(n=8)
15%
(n=31)
17.08 0.003 <0.05
Radiculopathy (unspecific) 12.8%
(n=36)
10.5%
(n=8)
13.6%
(n=28)
Polyneuropathy 14.9%
(n=42)
21.1%
(n=16)
12.6%
(n=26)
Lower limb radiculopathy 11.7%
(n=33)
13.2%
(n=10)
11.2%
(n=23)
CTS 9.6%
(n=27)
14.5%
(n=11)
7.8%
(n=16)
Too general diagnosis 6%
(n=17)
11.8%
(n=9)
3.9%
(n=8)
Ulnar nerve neuropathy 5%
(n=14)
1.3%
(n=1)
6.3%
(n=13)
Other upper limb neuropathy 2.5%
(n=7)
0% (n=) 3.4%
(n=7)
Other pathologies 18.8%
(n=53)
13.2%
(n=10)
20.9%
(n=43)
% of times referral physician was right
about referral diagnosis
100 %
(n=var-
ies)
100 %
(n=var-
ies)
100 %
(n=var-
ies)
Radiculopathy (unspecific) 52.8%
(n=19)
50%
(n=4)
53.6%
(n=15)
Lower limb radiculopathy 55.6%
(n=15)
16.7%
(n=1)
66.7%
(n=14)
CTS 63%
(n=17)
63.6%
(n=7)
62.5%
(n=10)
Polyneuropathy 33.3%
(n=14)
23.5%
(n=4)
40%
(n=10)
Ulnar nerve neuropathy 71.4%
(n=10)
100%
(n=1)
69.2%
(n=9)
Upper limb radiculopathy 50%
(n=5)
50%
(n=1)
50%
(n=4)
Agreement of referral diagnosis with
ENMG finding
100 %
(n=242)
100 %
(n=69)
100 %
(n=173)
No 61.7%
(n=150)
72.5%
(n=50)
57.5%
(n=100)
4.70 0.02 <0.05
Yes 38.3%
(n=93)
27.5%
(n=19)
42.5%
(n=74)
Agreement of working diagnosis with
ENMG finding
100 %
(n=264)
100 %
(n=76)
100 %
(n=188)
No 56.4%
(n=149)
68.4%
(n=52)
51.6%
(n=97)
6.23 0.01 <0.05
Yes 43.6%
(n=115)
31.6%
(n=24)
48.4%
(n=91)
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Table 18 Differences between primary and secondary care’s ENMG test requesting, chi-square test
All phy-
sicians
Pri-
mary
care
Second-
ary care
Chi
square
-test
p-
value
sig.
Agreement of referral diagnosis with
working diagnosis
100%
(n=235)
100%
(n=69)
100%
(n=166)
No 34%
(n=80)
42%
(n=29)
30.7%
(n=51)
2.77 0.10 >0.05
Yes 66%
(n=155)
58%
(n=40)
69.3%
(n=115)
Certainty of working diagnosis 100 %
(n=282)
100%
(n=78)
100%
(n=204)
Not certain 39.4%
(n=111)
37.2%
(n=29)
40.2%
(n=82)
1.18 0.72 >0.05
Almost certain 46.8%
(n=132)
51.3%
(n=40)
45.1%
(n=92)
Very certain 9.9%
(n=28)
9%
(n=7)
10.3%
(n=21)
Don't have clinical diagnosis 3.9%
(n=11)
2.6%
(n=2)
4.4%
(n=9)
The quality of referral query 100 %
(n=282)
100 %
(n=78)
100 %
(n=204)
Referral query missing
or unclear vs. referral
query well-defined
Referral query missing 1.1%
(n=3)
1.3%
(n=1)
1%
(n=2)
2.93 0.25 >0.05
Unclear and poorly defined referral
query
7.1%
(n=20)
9%
(n=7)
6.4%
(n=13)
Somewhat defined query, but still
unclear
22.7%
(n=64)
28.2%
(n=22)
20.6%
(n=42)
Well defined and clear query, but
still irrelevant
5.7%
(n=16)
5.1%
(n=4)
5.9%
(n=12)
Well defined, clear and relevant
query
63.5%
(n=179)
56.4%
(n=44)
66.2%
(n=135)
Evaluation of ordered extent of ENMG
test
100 %
(n=282)
100 %
(n=78)
100 %
(n=204)
Appropriate 85.8%
(n=242)
89.7%
(n=70)
84.3%
(n=172)
0.29 0.59 >0.05
Too broad 8.5%
(n=24)
9%
(n=7)
8.3%
(n=17)
Too narrow 1.8%
(n=5)
0% (n=) 2.5%
(n=5)
ENMG is wrong test for examining
patient
0.4%
(n=1)
0% (n=) 0.5%
(n=1)
Not evaluated 3.5%
(n=10)
1.3%
(n=1)
4.4%
(n=9)
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First, according to neurophysiologists’ prior evaluation, primary care requests less significant ENMG
test than secondary care. Since, 23 % (n=47) of secondary care requested ENMG tests were considered
to be very significant by evaluating the referrals while only 6.4 % (n=5) of primary care ENMG test
referrals were considered to provide very significant ENMG test (߯ଶ 10.43, p-value 0.000) (Table 16
above).
Secondly, primary care physicians order more normal result tests than secondary care physicians. Of
ENMG tests ordered by primary care, 44.9 % (n=35) gave normal finding compared to 28.4 % (n=58)
of ENMG tests requested by secondary care physicians (߯ଶ 6.90, p-value 0.010 (Table 16 above).
This difference is not due to primary care physicians’ greater number of exclusion diagnoses, because
only 3.9 % (n=3) of primary care physicians ordered ENMG tests were meant to exclude a diagnosis
compared to 10.2 % (n=21) of secondary care physicians ordered ENMG tests to exclude a diagnosis.
Thirdly, secondary care physicians requested ENMG tests that provided more surprising findings than
primary care physicians. Especially, when comparing the number of unsurprising normal findings, pri-
mary care physicians order more of such tests. Since, 21.3 % (n=43) of secondary care physicians re-
quested ENMG tests provided unsurprising normal finding compared to 38.4 % (n=28) of primary care
physicians respectively. Neurophysiologists’ opinion about self-evident zero results is that these kind of
tests should be reduced, because examining patients who assumedly have no nervous system dysfunc-
tion, is waste of resources and causes unnecessary discomfort to a patient.
In contrast, the number of surprising abnormal findings was much greater among ENMG tests ordered
by secondary care physicians. The number of ENMG tests gave surprising abnormal result was 11%
(n=8) in primary care physicians compared to 25% (n=51) in secondary care physicians ordered tests.
There is a statistically significant difference between secondary care and primary care in ordering of
surprising normal and abnormal result ENMG tests (߯ଶ 11.64, p-value 0.000) (Table 16 above).
Lastly, the referral diagnoses suggested by referring physician differs between secondary care and pri-
mary care. The two most common referral diagnoses suggested by primary care was polyneuropathy
(21.1%, 16/78) and carpal tunnel syndrome (CTS) (14.5 %, 11/78). However, primary care physicians
included unfocused referral queries in 11.8% (9/78) of referrals, which was the third most common
category of referral queries. In secondary care referrals the most common referral diagnoses were much
more varied; other pathologies such as amyotrophic lateral sclerosis (ALS) and spinal stenosis (20.9 %,
43/204), no referral diagnosis (15%, 31/204), radiculopathy (unspecific) (13.6%, 28/204) and polyneu-
ropathy (12.6 %, 26/204). There was a statistically significant difference between primary care and sec-
ondary care considering the referral diagnoses (߯ଶ 17.08, p-value 0.000) (Table 17 above).
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Generally, secondary care physicians were more often correct with their referral diagnosis than primary
care physicians. Agreement between referral diagnosis and ENMG finding was higher with secondary
care physicians than with primary care physicians; 42.5 % (n=74) of secondary care physicians’ and
27.5 % (n=19) of primary care physicians’ referral diagnoses agreed with the final ENMG finding, There
was a statistically significant difference between secondary care and primary care concerning the agree-
ment of referral diagnosis and ENMG finding (߯ଶ 4.70, p-value 0.020) (Table 17 above).
Furthermore, these two referring quarters differ in referral diagnoses which they manage to confirm with
ENMG test. Primary care physicians were most commonly correct with CTS diagnosis, namely in 63.6%
(n=7) of times when CTS was suggested as referral diagnosis. Secondary care physicians had a correct
referral diagnosis with multiple diagnoses such as ulnar nerve neuropathy (69.2 % of times when ulnar
nerve was suggested, n=9), lower limb radiculopathy (66.7 % n=14), CTS (62.5 % n=10) and radicu-
lopathy (53.6 % n=15) (Table 17 above).
The agreement between working diagnosis and final ENMG finding was slightly higher in secondary
care patients than primary care patients. Altogether 48.4 % (n=91) of working diagnoses in secondary
care patients compared to 31.6 % (n=24) of working diagnoses in primary care patients agreed with the
final ENMG (߯ଶ 6.23, p-value 0.010) (Table 17 above). However, the percentage of agreement between
referral diagnosis and working diagnosis did not differ between secondary and primary care (߯ଶ 2.77,
p-value 0.100) (Table 18 above).
Although there are a lot of differences between secondary and primary care as referring quarters, they
showed similar results in a couple of areas of requesting ENMG tests. First, neurophysiologist’s cer-
tainty of used working diagnoses were similar between secondary care and primary care patients (߯ଶ
1.18, p-value 0.720) (Table 18 above). Second, both primary and secondary care physicians requested
the same number of i) too extensive, ii) too narrow and iii) appropriate extent ENMG tests (߯ଶ 0.29, p-
value 0.590) (Table 18 above). Lastly, the quality of referral query was similar between these two refer-
ring quarters (߯ଶ 2.93, p-value 0.25) (Table 18 above). 66.2 % (n=135) of secondary care referrals and
56.4 % (n=44) of primary care referrals included a well-defined, relevant and clear referral query. The
overall percentage of inappropriate ENMG test referrals was 30.9 % (87/282) of all ENMG test referrals
(Table 18 above). The percentage varied depending on the referring quarter, being 38.5 % among pri-
mary care physicians and 28 % among secondary care physicians.
In ordinal logistic regression model, physiatry outpatient clinic and rehabilitation center showed to re-
quest less significant ENMG tests than other referring quarters. In a separate analysis of neurophysiol-
ogists’ answers, physiatry outpatient clinic and rehabilitation center seemed to have similar test request-
ing characteristics as primary care. The final significance of ENMG tests requested by physiatry outpa-
tient clinic and rehabilitation center differed slightly although not significantly from other referring pol-
yclinics; 19.4 % (n=7) of ENMG tests ordered by physiatry outpatient clinic and rehabilitation center
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were evaluated as very significant, while the percentage of very significant ENMG tests requested by
all  other  outpatient  clinics  was  28.4  % –  44.4  % of  all  ENMG tests  ordered  (Table  19  below).  This
difference is not statistically significant when comparing all secondary care referring quarters with each
other (߯ଶ 16.15, p-value 0.33), but comparing physiatry outpatient clinic and rehabilitation center alone
to all other outpatient clinics the difference is statistically significant. Especially, neurology and neuro-
surgery outpatient clinics requested more very significant ENMG tests than physiatry outpatient clinic
and rehabilitation center.
Table 19 Differences within secondary care referring units, chi-square test
All re-
ferring
quar-
ters
Hand
surgery
and gen-
eral sur-
gery and
orthope-
dic out-
patient
clinic
Physi-
atry
outpa-
tient
clinic
and re-
habili-
tation
center
Other
outpa-
tient
clinics
Neurol-
ogy and
neuro-
surgery
outpa-
tient
clinics
Pri-
mary
care
Chi
squar
e -test
p-
valu
e
sig.
Neurophysi-
ologist final
evaluation
of ENMG
tests' signifi-
cance
100%
(n=282)
100%
(n=67)
100%
(n=36)
100%
(n=45)
100%
(n=58)
100%
(n=76)
Insignifi-
cant
6.7%
(n=19)
7.5%
(n=5)
8.3%
(n=3)
6.7%
(n=3)
3.4%
(n=2)
7.9%
(n=6)
28.48 0.06
5
>0.0
5
Slightly
signifi-
cant
1.8%
(n=5)
3%
(n=2)
8.3%
(n=3)
0%
(n=0)
0%
(n=0)
0%
(n=0)
Some-
what sig-
nificant
53.2%
(n=150)
52.2%
(n=35)
58.3%
(n=21)
44.4%
(n=20)
48.3%
(n=28)
60.5%
(n=46)
Signifi-
cant
(needed
for docu-
menta-
tion)
5.7%
(n=16)
6% (n=4) 5.6%
(n=2)
4.4%
(n=2)
3.4%
(n=2)
7.9%
(n=6)
Very sig-
nificant
30.5%
(n=86)
28.4%
(n=19)
19.4%
(n=7)
44.4%
(n=20)
44.8%
(n=26)
18.4%
(n=14)
No evalu-
ation
2.1%
(n=6)
3%
(n=2)
0%
(n=0)
0%
(n=0)
0%
(n=0)
5.3%
(n=4)
The second difference between physiatry outpatient clinic and rehabilitation center and all other outpa-
tient  clinics  is  the  number  of  too  extensive  ENMG  tests  requested  and  performed.  19.4  %  (n=7)  of
ENMG tests requested by physiatry outpatient clinic and rehabilitation center were evaluated to be too
extensive compared to 3 % - 10.3 % of ENMG tests ordered by all other outpatient clinics (߯ଶ 6.96, p-
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value 0.073). This difference between referring quarters can be considered as statistically significant at
the significance level of 90 % (Table 20 below). The greatest difference was between physiatry outpa-
tient clinic and rehabilitation center and surgery and orthopedic outpatient clinics.
Table 20 Differences within secondary care referring units, chi-square test
All re-
ferring
quar-
ters
Hand
surgery
and gen-
eral sur-
gery and
orthope-
dic out-
patient
clinic
Physiat-
ric out-
patient
clinic
and re-
habili-
tation
center
Other
outpa-
tient clin-
ics
Neurol-
ogy and
neuro-
surgery
outpa-
tient
clinics
Pri-
mar
y
care
Chi
squa
re -
test
p-
valu
e
sig.
Extent of
ENMG test
100%
(n=282)
100%
(n=67)
100%
(n=36)
100%
(n=45)
100%
(n=58)
Appropri-
ate
85.8%
(n=242)
88.1%
(n=59)
77.8%
(n=28)
91.1%
(n=41)
79.3%
(n=46)
6.96 0.07
3
>0.0
5,
<0.1
0
Too broad 8.5%
(n=24)
3%
(n=2)
19.4%
(n=7)
4.4%
(n=2)
10.3%
(n=6)
Too nar-
row
1.8%
(n=5)
4.5%
(n=3)
2.8%
(n=1)
0%
(n=0)
1.7%
(n=1)
ENMG is
wrong test
for exam-
ining pa-
tient
0.4%
(n=1)
0%
(n=0)
0%
(n=0)
2.2%
(n=1)
0%
(n=0)
Not evalu-
ated
3.5%
(n=10)
4.5%
(n=3)
0%
(n=0)
2.2%
(n=1)
8.6%
(n=5)
Agreement of
referral diag-
nosis with
ENMG find-
ing
100%
(n=226)
100%
(n=51)
100%
(n=32)
100%
(n=36)
100%
(n=48)
No 58.8%
(n=133)
41.2%
(n=21)
68.8%
(n=22)
50%
(n=18)
64.6%
(n=31)
8.53 0.03
6
<0.0
5
Yes 41.2%
(n=93)
58.8%
(n=30)
31.3%
(n=10)
50%
(n=18)
35.4%
(n=17)
% of exclu-
sion diagnoses
of 'no agree-
ment' be-
tween referral
diagnosis and
ENMG find-
ing
10.1%
(n=19)
13.5%
(n=5)
7.7%
(n=2)
18.5%
(n=5)
12.2%
(n=5)
7.49 0.28 >0.0
5
Lastly, the agreement of referral diagnosis and final ENMG finding was lower in physiatry outpatient
clinic than in all other outpatient clinics. Physiatry outpatient clinic’s and rehabilitation center’s referral
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diagnoses agreed with final ENMG finding in 31.3 % (n=10) of all referral diagnoses suggested com-
pared to 35.4 % - 58.8 % of referral diagnoses suggested by all other outpatient clinics. The difference
between these referring quarters concerning the diagnosis agreement is statistically significant (߯ଶ 8.53,
p-value 0.04) (Table 20 above). Physiatry outpatient clinic and rehabilitation center did have only 7.7
% (n=2) of their referral diagnoses suggested for exclusion diagnosis purpose, while the same percentage
varied between 12.2 – 18.5 % in all other outpatient clinics (Table 20). Therefore the low agreement
between referral diagnosis and ENMG finding was not due to great number of exclusion diagnoses
suggested by physiatry outpatient clinic and rehabilitation center. The greatest difference concerning the
agreement of referral diagnosis and ENMG finding was between physiatry outpatient clinic and reha-
bilitation center and surgery and orthopedic outpatient clinics.
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Table 21 Differences within secondary care referring units, chi-square test
All re-
ferring
quar-
ters
Hand
surgery
and gen-
eral sur-
gery and
orthope-
dic out-
patient
clinic
Physiat-
ric out-
patient
clinic
and re-
habili-
tation
center
Other
outpa-
tient
clinics
Neurol-
ogy and
neuro-
surgery
outpa-
tient
clinics
Pri-
mary
care
Chi
squa
re -
test
p-
valu
e
sig.
The quality of
referral query
100%
(n=282)
100%
(n=67)
100%
(n=36)
100%
(n=45)
100%
(n=58)
100%
(n=76)
Referral
query
missing
1.1%
(n=3)
3% (n=2) 0%
(n=0)
0%
(n=0)
0%
(n=0)
1.3%
(n=1)
10.26 0.24
7
>0.0
5
Unclear
and poorly
defined
7.1%
(n=20)
6% (n=4) 8.3%
(n=3)
8.9%
(n=4)
3.4%
(n=2)
9.2%
(n=7)
Somewhat
defined,
but still un-
clear
22.7%
(n=64)
23.9%
(n=16)
30.6%
(n=11)
6.7%
(n=3)
20.7%
(n=12)
28.9%
(n=22)
Well de-
fined and
clear, but
still irrele-
vant
5.7%
(n=16)
3% (n=2) 8.3%
(n=3)
8.9%
(n=4)
5.2%
(n=3)
5.3%
(n=4)
Well de-
fined, clear
and rele-
vant
63.5%
(n=179)
64.2%
(n=43)
52.8%
(n=19)
75.6%
(n=34)
70.7%
(n=41)
55.3%
(n=42)
ENMG test
results
100%
(n=282)
100%
(n=67)
100%
(n=36)
100%
(n=45)
100%
(n=58)
Abnormal
results
68.4%
(n=193)
71.6%
(n=48)
66.7%
(n=24)
73.3%
(n=33)
75.9%
(n=44)
0.98 0.80
7
>0.0
5
Normal re-
sults
31.6%
(n=89)
28.4%
(n=19)
33.3%
(n=12)
26.7%
(n=12)
24.1%
(n=14)
Unsurpris-
ing abnor-
mal results
52.8%
(n=149)
61.2%
(n=41)
52.8%
(n=19)
51.1%
(n=23)
51.7%
(n=30)
8.69 0.46
6
>0.0
5
Unsurpris-
ing normal
results
25.9%
(n=73)
23.9%
(n=16)
27.8%
(n=10)
20%
(n=9)
17.2%
(n=10)
Surprising
abnormal
results
13.8%
(n=39)
10.4%
(n=7)
13.9%
(n=5)
22.2%
(n=10)
24.1%
(n=14)
Surprising
normal re-
sults
5%
(n=14)
1.5%
(n=1)
5.6%
(n=2)
6.7%
(n=3)
6.9%
(n=4)
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Table 22 Differences within secondary care referring units, chi-square test
All re-
ferring
quar-
ters
Hand
surgery
and
general
surgery
and or-
thope-
dic out-
patient
clinic
Physiat-
ric out-
patient
clinic
and re-
habili-
tation
center
Other
outpa-
tient
clinics
Neurol-
ogy and
neuro-
surgery
outpa-
tient
clinics
Pri-
mar
y
care
Chi
squa
re -
test
p-
valu
e
sig.
Certainty of
working diag-
nosis
100%
(n=282)
100%
(n=67)
100%
(n=36)
100%
(n=45)
100%
(n=58)
Not certain 39.4%
(n=111)
32.8%
(n=22)
44.4%
(n=16)
48.9%
(n=22)
37.9%
(n=22)
10.85 0.28
6
>0.0
5
Almost
certain
46.8%
(n=132)
50.7%
(n=34)
41.7%
(n=15)
35.6%
(n=16)
48.3%
(n=28)
Very cer-
tain
9.9%
(n=28)
13.4%
(n=9)
2.8%
(n=1)
13.3%
(n=6)
8.6%
(n=5)
Don't have
clinical di-
agnosis
3.9%
(n=11)
3%
(n=2)
11.1%
(n=4)
2.2%
(n=1)
5.2%
(n=3)
Referral di-
agnosis
100%
(n=282)
100%
(n=67)
100%
(n=36)
100%
(n=45)
100%
(n=58)
No referral
diagnosis
19.9%
(n=56)
23.9%
(n=16)
11.1%
(n=4)
20%
(n=9)
17.2%
(n=10)
2.14 0.54
3
>0.0
5
Agreement of
referral diag-
nosis with
working diag-
nosis
100%
(n=217)
100%
(n=51)
100%
(n=27)
100%
(n=36)
100%
(n=45)
No 28.6%
(n=62)
23.5%
(n=12)
33.3%
(n=9)
30.6%
(n=11)
24.4%
(n=11)
1.24 0.74
3
>0.0
5
Yes 71.4%
(n=155)
76.5%
(n=39)
66.7%
(n=18)
69.4%
(n=25)
75.6%
(n=34)
Physiatry outpatient clinic and rehabilitation center did not differ in other areas of test requesting from
other referring quarters than above mentioned (Table 21, Table 22). Physiatry outpatient clinic and re-
habilitation center referrals were evaluated to be similar quality as all other referring quarters’ referrals.
Same phenomenon was noticed with primary care referrals.
4.4 Comparison of referring physician’s and neurophysiologist’s opinions
In this chapter the opinion about ENMG tests’ significance is explored and compared between referring
physicians and neurophysiologists. In addition, this chapter presents the percentages of insignificant
ENMG tests evaluated by both referring physicians and neurophysiologists.
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Survey was conducted to all referring quarters electronically, however, after the first week of introduc-
ing the survey to the quarters, we noticed that it did not reach the referring units. Therefore a paper
version of the same survey was formulated. However, this survey was performed only to the top 10 most
ENMG test requesting referring units. We gathered 70 answers from the referring quarters. The majority
of answers came from physiatrists (21.4 %), hand surgeons (30 %) and neurologists (28.6 %), while we
got only few answers from primary care physicians (2.9 %). The work expertise of referring physicians
who answered to the survey was high; 50 % had 5-10 years of working experience as doctor and 42.9
% had over 10 years of working experience (Table 23 below).
Table 23 the profile of answerers of a survey made to referring physicians
Physician typology
Physiatrist 21.4% (n=15)
Hand surgeon 30% (n=21)
Orthopedist 1.4% (n=1)
Neurologist 28.6% (n=20)
Intern 14.3% (n=10)
General practitioner 2.9% (n=2)
Anesthesiologist 1.4% (n=1)
Experience
1-5 years 7.1% (n=5)
5-10 years 50% (n=35)
over 10 years 42.9% (n=30)
Findings of this survey were interesting. According to referring physicians, 42.9 % (n=30) of all ENMG
tests requested, did not change patients’ treatment plan. 17.1 % (n=12) of ENMG tests changed already
decided treatment plan, and 40 % (n=28) of ENMG tests changed treatment plan as the decision was
meant to be made according to ENMG test results (Table 24 below). Of ENMG tests ordered, 35.7 %
(n=25) excluded a diagnosis, while 44.3 % (n=31) confirmed a diagnosis suspicion. Only 10 % of
ENMGs (n=7) provided new diagnosis alternative. 7.1 % (n=5) were ordered for control and the remain-
ing 2.9 % (n=2) did not affect patient treatment plan because ENMG test result was in contrast to other
diagnostic test results. (Table 24 below).
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Table 24 Results of how ENMG test affected referring physicians’ decision-making.
ENMG test result changed patient's treatment plan
No 42.9% (n=30)
Yes 17.1% (n=12)
Treatment plan was meant to do according to
ENMG test result
40% (n=28)
ENMG test affected patient diagnosis by:
Excluded diagnosis 35.7% (n=25)
Confirmed diagnosis 44.3% (n=31)
Provided new diagnosis 10% (n=7)
Control test 7.1% (n=5)
Something else: 2.9% (n=2)
Clinical examination tells different than ENMG test results
MRI test result tells different than ENMG test result
There were only 33 patient cases of which the opinions of ENMG test significance was gathered both
referring physicians and neurophysiologists. Because the sample size was small, no statistical signifi-
cance analysis could be performed. However, opinions seemed to be mostly in line, and especially when
comparing neurophysiologists’ prior evaluation of significance and referring physicians’ final evalua-
tion of significance for patient diagnosing and treatment plan decision-making. The majority of the tests,
namely 71.8 % (24/33) of all ENMG tests, were evaluated similarly by both parties, although there were
a couple of cases which were dissimilarly evaluated. Altogether 63.7 % (n=21) of all ENMG tests, eval-
uated by both parties, was evaluated somewhat significant or very significant by both referring physi-
cians and neurophysiologists (Table 25 below). Furthermore, 9.1 % (n=3) of these ENMG tests were
evaluated insignificant or slightly significant by both parties (Table 25). However, the remaining 27.3
% (n=9) was evaluated dissimilarly. Nonetheless, neurophysiologist evaluated 67 % (n=6) of these dis-
similarly evaluated ENMG tests to be either somewhat significant or very significant, thus neurophysi-
ologist would have conducted these tests anyway.
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Table 25 Comparison of referring physician's and neurophysiologist's opinion about ENMG test's signifi-
cance, N=33. Referring physician’s evaluation of ENMG test’s significance for treatment plan decision-
making.
Neurophysiologist’s prior evaluation of the significance of ENMG test
Insignifi-
cant
Slightly signif-
icant
Somewhat signifi-
cant
Very signifi-
cant
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Insignifi-
cant
0% (n=0) 6.1% (n=2) 0% (n=0) 0% (n=0)
Slightly
significant
0% (n=0) 3% (n=1) 12.1% (n=4) 6.1% (n=2)
Somewhat
significant
0% (n=0) 0% (n=0) 36.4% (n=12) 6.1% (n=2)
Very sig-
nificant
0% (n=0) 9.1% (n=3) 18.2% (n=6) 3% (n=1)
Referring physicians evaluated the significance from the diagnosing point of view and it was compared
to neurophysiologists’ prior evaluation of significance. 66.7 % (n=22) of these were evaluated either
somewhat significant or very significant by both parties (Table 26 below). 6.1 % (n=2) of ENMG tests
were evaluated slightly significant by both parties (Table 26). 21.1 % (n=7) were evaluated dissimilarly,
however 57 % (n=4) of dissimilarly evaluated ENMG tests were evaluated somewhat significant or very
significant by neurophysiologist, thus these tests would have been performed.
Table 26 Comparison of referring physician's and neurophysiologist's opinion about ENMG test's signifi-
cance, N=33. Referring physician’s evaluation of ENMG test’s significance for diagnosis decision-making.
Neurophysiologist's prior evaluation of the significance of ENMG test
Insignificant Slightly signifi-
cant
Somewhat signifi-
cant
Very significant
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Insignificant 0 % (n=0) 0 % (n=0) 0 % (n=0) 0 % (n=0)
Slightly sig-
nificant
0% (n=0) 6.1% (n=2) 9.1% (n=3) 3% (n=1)
Somewhat
significant
0% (n=0) 0% (n=) 27.3% (n=9) 9.1% (n=3)
Very signifi-
cant
0% (n=0) 9.1% (n=3) 27.3% (n=9) 3% (n=1)
Control test 0% (n=0) 3% (n=1) 0% (n=) 0% (n=)
Don't know 0% (n=0) 0% (n=) 3% (n=1) 0% (n=)
Even though, referring physician’s opinion about ENMG test’s significance was in accordance with
neurophysiologist’s opinion, the evaluation of quality of referral queries differed between the two
groups. 50 % (n=16) of ENMG tests were evaluated by both parties as well-defined and clear. However,
the remaining 50 % (n=16) of these referral queries were evaluated dissimilarly (Table 27 below); 9.4
% (n=3) of referral queries were evaluated as well-defined by referring physicians while neurophysiol-
ogists evaluated those to be poorly defined and unclear.
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Table 27 Comparison of referring physician's and neurophysiologist's opinion about the quality of referral
query
Neurophysiologist's evaluation of referral query
Referral query
missing
Poorly de-
fined and
unclear
Somewhat de-
fined, but unclear
and irrelevant
Relevant and
well defined
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Referral query
missing
0% (n=0) 0% (n=0) 0% (n=0) 0% (n=0)
Poorly defined
and unclear
0% (n=0) 0% (n=0) 3.1% (n=1) 0% (n=0)
Well defined
and clear
0% (n=0) 9.4% (n=3) 18.8% (n=6) 50% (n=16)
Don't know 3.1% (n=1) 0% (n=0) 6.3% (n=2) 9.4% (n=3)
Referring physicians evaluated that for patient diagnosing 0 % of ENMG tests requested were insignif-
icant and 14.3 % (n=10) were only slightly significant (Table 28 below). For treatment plan decision-
making 2.9 % (n=2) were evaluated to be insignificant and 14.3 % (n=10) only slightly significant (Table
28). Altogether 11.4 % (8/70) were evaluated as insignificant or only slightly significant for both patient
diagnosing and treatment plan decision-making. Referring physicians evaluated that very significant
ENMG tests accounted for 45.7 % (n=32) for patient diagnosing and 32.9 % (n=23) for treatment plan
decision-making (Table 28).
Table 28 Results of how referring physicians evaluated the significance of requested ENMG test
ENMG test result was significant for final diagnosis
Insignificant 0% (n=0)
Slightly significant 14.3% (n=10)
Somewhat significant 37.1% (n=26)
Very significant 45.7% (n=32)
Control test 1.4% (n=1)
Don't know 1.4% (n=1)
ENMG test result was significant for treatment plan decision-making
Insignificant 2.9% (n=2)
Slightly significant 14.3% (n=10)
Somewhat significant 50% (n=35)
Very significant 32.9% (n=23)
Don't know 0% (n=0)
Evaluation of referral query
Referral query missing 2.9% (n=2)
Poorly defined and unclear 4.3% (n=3)
Well defined and clear 78.6% (n=55)
Don't know 14.3% (n=10)
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To summarize the findings, referring physician’s and neurophysiologist’s opinion about the significance
seemed to be mainly in line, but that the opinion about appropriate referral query differed. Referring
physicians seemed to evaluate referral queries to be more appropriate than what neurophysiologists
evaluated them to be. The number of inappropriate ENMG test referrals was according to neurophysi-
ologists’ evaluation 30.9 % (87/282) of all ENMG test referrals, while referring physicians evaluated
that only 7.2 % (5/70) of their referrals to be poorly defined and unclear or missed referral query.
4.5 Controversial diagnosis groups
In this chapter the findings of interviews with experts are presented. There were three interviews made
to  specialists  who  were  superior  experts  in  their  own  field.  Interviews  included  two  selected  patient
diagnosis groups morton neuroma and meralgia paresthetica. These diagnosis groups were selected due
to neurophysiologists’ observation that ENMG tests in these patient groups are often difficult and un-
successful to perform and the test result often remains equivocal. Furthermore, one interview was con-
ducted to spine surgeon specialist in the attempt to find out how and when ENMG tests generally affect
diagnosing and treatment plan decision-making in the field of spine orthopedics.
4.5.1 Morton neuroma
Interviews concerning morton neuroma patient diagnosis group revealed the following; The interviewee
had the opinion that it is extremely important to have an ENMG test for decision-making before opera-
tion in a suspicion for morton neuroma. Practically, in the studied clinic, lesion release operation is not
performed without ENMG test’s proof of nerve lesion. Therefore, ENMG tests are not ordered if these
test are not needed. For morton neuroma suspects,  a  clinical  examination or  a  MRI is  not  enough to
confirm the diagnosis or to decide on operation. Furthermore, ENMG tests are never requested without
having seen the patient first, thus unnecessary and too general and unspecific ENMG requests are never
made.
Of the 19 patient cases discussed, the interviewee evaluated that 100 % were either significant or very
significant.  The main reason why these ENMG tests  were significant  was that  it  either  confirmed an
operation or excluded an unnecessary morton neuroma operation.
4.5.2 Meralgia paresthetica
Unlike in morton neuroma, ENMG test conducted to meralgia paresthetica suspects were not always
evaluated as significant or very significant. The interviewee stated that meralgia paresthetica diagnosis
usually can be set by clinical examination. However, according to him, iatrogenic (nerve injury caused
in operation) meralgia paresthetica suspects should always be examined with ENMG test.
Of the 17 meralgia paresthetica patient cases evaluated, 35 % were considered to be either significant
or very significant and 47.1 % were evaluated as insignificant. The main reasons why ENMG test was
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not considered significant was that either ENMG test result was controversial to other diagnostic test
results, pure clinical examination would have been enough to decide on diagnosis of meralgia pares-
thetica, or ENMG test report did not answer to the referral query. In addition to these reasons, an ENMG
was considered unnecessary if patient’s symptoms did not correlate with the finding or with anamnesis.
The major reasons why ENMG test was significant for meralgia paresthetica suspects was that the test
either specified diagnosis (33.3% of cases) or confirmed operation decision (33.3 % of cases). The two
other reasons were that ENMG test excluded diagnosis (22.2 % of cases) or it provided new diagnosis
alternative (11.1 % of cases).
4.5.3 ENMG tests’ significance in spine patients candidates for spine surgery
According to the interview, occasionally diagnostic tests can be ordered inappropriately due to patient
demands, meaning that patients often require a diagnostic test to explain their pain and symptoms. Often
patients do not trust their physicians and the clinical examination, and they demand for more evidence
through diagnostic tests.
In spine diagnostics, ENMG is not the primary diagnostic test and ENMG alone does not provide enough
information. Therefore it is essential to relate ENMG test to other diagnostic tests such as x-ray test or
MRI test. If ENMG was not available, the best alternative would be to do better clinical examination.
According to the interviewee, ENMG tests are not requested without a proper indication, and only oc-
casionally these tests are ordered without clinically investigating the patient before the ENMG request.
According to interviewee, specialists often consider zero result to be as important as other results from
ENMG, and especially when zero result is helping with differential diagnosing. Specialists deem ENMG
statements very important and they have to rely on these and to the terminology used in test result re-
ports. Due to this if neurophysiologist do not answer clearly to the referral question, ENMG test may
become  useless.  This  leads  to  the  fact  that  presenting  a  clear  and  well-defined  referral  query  is  also
essential for referring physicians in order for them to get the most out of ENMG test.
The interviewee had the opinion that the primary care requests ENMG tests with less justifiable indica-
tions than the secondary care, which may be due to the poor understanding of the characteristics of
ENMG test in the primary care. According to the interviewee, primary care may even request ENMG
tests as primary diagnostic tests, although ENMG does not serve as such. It is crucial to first determine
whether patient has peripheral or distal injury with MRI, and only after that send patient to ENMG test.
Of the discussed 20 patient cases, 20 % (n=5) were evaluated as significant or very significant. The main
reason for ENMG test to be significant or very significant is when ENMG test confirms, specifies or
excludes a diagnosis, and especially when ENMG test either confirms an operation-decision or helps to
avoid unnecessary operation. Instead of requesting the 35 % (n=7) of patient cases discussed, which
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were evaluated insignificant ENMG tests, interviewee proposed an alternative to ENMG test. The alter-
native action compared to ENMG test was to do nothing. In most of these occasions ENMG did not
provide new information or the result did not fit well to the information gathered from other diagnostic
tests. Furthermore, a couple of these insignificant ENMG tests were considered useless, because the
report did not answer to the referral question presented.
All interviewees stated similar characteristic of insignificant ENMG test which were:
1. ENMG test result is controversial to other diagnostic test results
2. ENMG test gave zero result, when it was not used for differential diagnostics
3. Test report does not answer to referral query
4. ENMG test is requested in order to win time either due to long queues to diagnostic tests and
outpatient clinics or to put a patient to a test which has long waiting time giving the physician
a time period to observe patient’s symptoms whether they spontaneously disappear
5. ENMG test result does not correlate with clinical findings and symptoms
6. ENMG test is requested in order to find out what causes patient’s symptoms or pain without
any specific referral query
7. If thorough clinical examination would have confirmed diagnosis, then ENMG test could be
considered as unnecessary.
Furthermore, the interviewed experts stated that the optimal referral query, that provides the most value
to referring physician, is a question which can be answered with either ‘yes’ or ‘no’. Neurophysiologists’
own opinion about the patient case is valuable to referring physician. In addition, the referring physician
usually appreciates possible suggestions given by the neurophysiologist concerning additional diagnos-
tic tests.
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5 Discussion
5.1 Summary of findings and conclusions
This chapter will present the conclusions based on the main findings of this research and relate
them to findings of previous studies and literature. Managerial implications within the focal or-
ganization are presented. Related to managerial implications, the key challenges of behavioral
change within healthcare are discussed. These key challenges present barriers, which have to be
taken into account when implementing the selected approaches of demand management strategy.
Lastly, this chapter will explore the limitations of this study with validity and reliability aspects.
To reiterate, this study has focused on exploring the factors affecting ENMG tests’ significance and then
on the strategies to reduce the number of insignificant ENMG tests. The topic was approached by con-
ducting surveys to both neurophysiologists and referring physicians in order to clarify their opinion
about significance of a ENMG test. These survey results were studied with statistical methods, supported
by individual comments from interviews of three experts within the field. Furthermore, a literature re-
view was conducted to gather information about the strategies used for reducing insignificant tests, to
explore what causes the problem of increased demand, and how financial incentives have affected the
behavior of requesting tests. Similarly, measures of effectiveness were explored, and selected to be used
in this study. This research underlines propositions of how to reduce the number of insignificant ENMG
tests. Statistical analysis and literature review all contributed to accomplish the objective of this study,
which was to understand the factors affecting the significance of ENMG test and then describe the de-
mand management strategies, which would be able to reduce the number of insignificant ENMG tests.
Firstly,  characteristics  of  referral  queries  were  found  to  be  one  of  the  main  factors  affecting  ENMG
tests’ significance. The poorer the referral query, the less significant was the ENMG test result. Inter-
estingly, the assumption that a poor referral query leads to a more extensive ENMG test could not be
proved statistically. The effect of poor referral queries was identified in interviews as well, suggesting
that ENMG test was insignificant to referring physicians too if the referral query was either missing,
unfocused, or otherwise poorly defined. Interestingly, neurophysiologists and referring physicians eval-
uated referral queries differently, as even a half of the of cross-evaluated ENMG test referral queries
were evaluated dissimilarly, and often so that the evaluation given by the neurophysiologist was poorer
than that of the referring physician. In addition, neurophysiologist evaluated that poorly defined referral
queries accounted 31 % of all ENMG test referrals, while the number was only 8 % for referring physi-
cians. This finding suggests that increasing referring physicians’ knowledge of well-defined referral
query would be beneficial.
According to literature, demand management approaches to improve the quality of referral queries in-
clude redesigning the referral form, education, and constant feedback on referral query formulation to
referring physicians (Fryer & Smellie 2013; Janssens 2010; Lang 2013; Lee et al. 2013). Furthermore,
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Spyridonis et al. (2013) presented that ‘pain drawings’ enable patients to describe their symptoms more
objectively and precisely. This might make referral queries and a referral diagnoses more focused and
clear. Currently, at HUS, ‘pain drawings’ are drawn at the CN laboratory, and doing that already for the
referral could be beneficial.
Secondly, neurophysiologists were found to be able to evaluate the significance of ENMG test based on
test referral already. The analysis showed that the prior and final evaluations of significance of ENMG
test were in line, meaning that the prior evaluation based on only test referral described the overall
significance well enough. Besides, neurophysiologists’ prior evaluation was rather similar to referring
physicians’ final evaluation of significance of ENMG tests. Hence, it would improve effectiveness of
tests if neurophysiologists evaluated a greater number of ENMG test referrals and relied on their exper-
tise while accepting and rejecting referrals. This suggest that neurophysiologists should continue their
referral evaluation, and the practice of pre-approving referrals from certain referring quarters should be
broadened.
In literature, evaluation and blocking of referrals is argued to be risky due to the possibility of blocking
essential diagnostic tests (Janssens 2010), because laboratory personnel does not have enough infor-
mation about the patient case. Nonetheless, Fryer & Smellie (2013) showed that assessing test requests
decreased the share and cost of inappropriate tests. This method of reviewing test referrals should be
adopted more widely within the field of ENMG testing, thanks to knowledgeable and capable neuro-
physiologists who are experts in their extremely specialized and advanced field of medicine.
Thirdly, other factors found lowering the significance of an ENMG test were test result’s expectedness
and normality. The more surprising an ENMG test result, the more significant the test. A test did not
have to provide surprising result in order it to be significant, but less significant tests more often provided
unsurprising test results. Related to surprising ENMG findings, zero result ENMG tests were evaluated
to be less significant than ENMG test that provided abnormal findings. However, interviews with ex-
perts revealed that zero results are essential for diagnosing a patient and deciding on treatment plan for
a patient. That is to say, that a zero result is significant only if referring physician has requested the test
for deciding between a couple of different diagnosis alternatives, called differential diagnosing, or if a
zero result informed the referring physician to not operate on the patient.
In literature, opinions on normal test results and its significance vary (Shepherd 2010; Mondelli et al.
1998; Di Fabio et al. 2013; Cocito et al. 2006; Podnar 2005). Nonetheless, if diagnostic tests are re-
quested too often, without clinical examination or interviewing a patient and ordered too many tests at
a time, the probability of having normal findings increases, which may indicate inefficient resource
utilization (Fuller 2005; Shepherd 2010; Podnar 2005). Furthermore, such an unsurprising zero result
ENMG test could be avoided by doing a proper clinical examination to a patient before requesting
ENMG. This phenomenon reflects to the formulation of a well-defined and relevant referral query, and
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according to Fuller (2005), a referring physician should not request an ENMG test, if he or she is not
able to formulate a focused referral query. These findings are in line with our results.
Fourthly, the specialty of the referring quarter was found to affect the significance of an ENMG test.
Especially primary care and physiatry outpatient clinics and rehabilitation centers requested less signif-
icant ENMG tests than other referring units. The possible reason to this is that primary care and physiatry
outpatient clinics have different patient mix than other more specialized referring units. Patients in pri-
mary care and physiatry outpatient clinics have various health problems, and therefore physicians have
a hard time identifying the cause of patients’ symptoms. Our results support this assumption in that the
referral diagnoses of physiatrists and primary care physicians more seldom agreed with the final finding.
In this setting, formulating a perfectly focused referral diagnosis is more difficult than in other more
specialized referring quarters. Possibly due to this, ENMG test referral queries from primary care and
physiatry outpatient clinics are often unfocused, forcing neurophysiologist to conduct an extensive in-
terview and clinical examination on a patient before even performing ENMG test. As a result, they also
requested more ENMG tests with unsurprising, normal results.
Furthermore, unfocused ENMG tests may not provide valuable information, or at least not from neuro-
physiologist’s perspective. It could be assumed, however, that such ENMG tests provide value to pri-
mary care or physiatry outpatient clinic physicians by still narrowing down diagnosis alternatives. Nev-
ertheless, neurophysiologists are experts in conducting electrodiagnostic tests rather than taking a role
as a referring physician. To optimize resource utilization, interviewing and clinically examining patients,
as well as treatment pathway decisions, should be performed by the referring physician.
Besides, according to the survey for referring physicians, only 10 % of ENMG tests requested provided
new diagnosis alternatives. This shows how few ENMG test actually help referring physician to diag-
nose a patient, if the physician has no referral diagnosis or idea of what might be the reason for patient’s
symptoms. In other words, ENMG test should not be requested if referring physician does not know
how to focus and formulate referral query. It should not be used as a screening tool (Fuller 2005). Ac-
cording to our interviews, experts stated that especially primary care physicians are not all aware of the
characteristics of ENMG testing, and they see it as primary diagnostic test. Our findings are in line with
Fuller's (2005) argument that an ENMG test should be an extension to other diagnostic tests, not an
independent primary test.
The greatest challenge with primary care is that the physicians there change constantly, because physi-
cians are required to work a period of time in primary care as a part of their training in order to graduate.
Due to this, educating them individually would be inefficient. However, education of primary care chief
physicians might be a useful approach, because then the chief physician could educate the other primary
care physicians. Furthermore, building an efficient and ongoing communication channel with primary
care physicians would be valid approach to affect test requesting.
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In addition to education and feedback, literature suggests financial incentives such as increased pricing
for poorly defined referrals as a demand management strategy (Tierney et al. 1990; Seguin et al. 2002;
Miyakis et al. 2006; Gama et al. 1992; Sood et al. 2007;Cummings et al. 1982). Overall, the results
suggest that demand management efforts should be focused especially on physiatry outpatient clinics
and primary care centers.
Although primary care physicians’ referral diagnoses had lower agreement with the ENMG finding than
secondary care referral diagnoses, primary care physicians were most often correct with the diagnoses
of CTS and polyneuropathy. Mondelli et al. (2014) suggest that requests from primary care are approved
only for the diagnosed CTS cases, and Mondelli et al. (1998) suggest that referrals from certain referring
quarters should first be evaluated by a neurologist before the ENMG test. According to the results of the
present study, CTS and polyneuropathy cases could be automatically approved from these referring
quarters, while others should still be subject to neurophysiologists’ approval. On the other hand, trans-
ferring and casting patients into other units’ responsibility, i.e. in this case to neurology outpatient clinic,
would only support the existence of current healthcare’s ‘silos’. Therefore, the approach suggested by
Mondelli et al. (1998) would require further research.
Scholars argue that the value of ENMG test is highly related to neurophysiologists’ skills, expertise and
experience (Hellmann et al. 2005; Daube & Rubin 2009; Smith 2003; Chémali & Tsao 2005; So 2009).
The results of the ordinal logistic regression model seemed to support this argument, as it indicates that
the ENMG tests performed by interns were less significant than ENMG tests performed by specialists.
However, the patient group examined by interns did not differ from patients examined by specialists.
The underlying reason for this finding may not be the lower expertise of interns, but the different attitude
of interns towards the evaluation of significance of ENMG test. In other words, interns seemed to be
more willing to adopt the perspective that there in fact are insignificant ENMG tests, while specialists
were very much against that thought. This same phenomenon of criticism towards research about quality
was addressed by Mondelli et al. (1998), who presented that studies which judge competences of phy-
sician colleagues and concern quality assurance are often criticized by physicians. Similarly, this study
invoked same kind of criticism both from neurophysiologists’ and referring physicians’ side. Therefore,
the difference of significance of ENMG tests between interns and specialists is probably not solely de-
pending on the expertise they have, but also the difference in attitudes towards evaluating one’s own
performance and work, and ability to question the current practices.
Finally, the percentage of insignificant ENMG tests performed was 6.7 % according to neurophysiolo-
gists’ evaluation and 2.9 % according to referring physicians’ evaluation. However, the number of
slightly significant ENMG test was only 1.8 % according to neurophysiologists, and 14.3 % according
to referring physicians. Altogether, the number of insignificant and only slightly significant ENMG tests
were 10.3 %, 33 out of 319 all patient cases evaluated by either referring physicians (n = 70) or neuro-
physiologists (n = 249).
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It is debatable which group is more capable of evaluating the actual significance and effectiveness of an
ENMG test; referring physicians, who make treatment decisions and service the customer, or neuro-
physiologists, who are experts in the specific field of medicine. In the business world, firms tend to rely
on the customer satisfaction and believe that ‘the customer is always right’ (Danneels 2003). Therefore
one might consider referring physician’s opinion concerning the significance of an ENMG test more
representative. In addition, referring physicians are actually the ones that make the decisions to which
the ENMG test is meant to provide supportive information. Therefore if referring physician has evalu-
ated that ENMG did not provide effective information for the decision-making process, then it should
be considered as the truth. On the other hand, one can argue that neurophysiologists are better at identi-
fying the factors contributing to a successful and significant ENMG test. Neurophysiologists are experts
in  their  field  of  medicine  and  they  have  performed  numerous  ENMG tests,  thus  they  are  capable  of
seeing when an ENMG test did not provide needed information and why.
Previous studies have found the percentage of insignificant ENMG tests to be between 17 - 28 % (Di
Fabio et al. 2013; Mondelli et al. 1998; Mondelli et al. 2014; Cocito et al. 2006). However, the numbers
are not quite comparable, since the criteria for insignificant ENMG test varies between studies and are
not the same as those used in this research. In prior studies, the authors had defined tests to be insignif-
icant if these gave normal result, test referral was poorly defined, test result did not affect treatment plan
or diagnosis, or there was no correlation between working diagnosis, referral diagnosis and final ENMG
finding. Furthermore, in their studies, ENMG tests’ significance were not evaluated by neurophysiolo-
gist  like  in  our  study.  However,  our  percentage  of  insignificant  tests  is  within  the  same  scale  as  the
percentages from previous studies.
Agreement between referral diagnosis and final ENMG test finding varied between 40.5 – 71.9 % in
previous studies (Di Fabio et al. 2013; Mondelli et al. 1998; Mondelli et al. 2014; Cocito et al. 2006;
Podnar 2005), while in this study the agreement was only 38.5 %. This difference indicates that ENMG
test referrals sent to Meilahti CN laboratory really need reviewing and improvement, in order to increase
the agreement percentage, which is one of the spin offs of this study. Nonetheless, our results are in line
with previous studies, as the agreement was lower in primary care physicians’ referral diagnoses than
in secondary care physicians’ referral diagnoses.
5.2 Practical managerial implications of this study
Based on the findings of this research, Meilahti CN laboratory has implemented a set of actions to reduce
the number of insignificant ENMG tests and improve effectiveness of ENMG testing. These managerial
implications are presented in this chapter.
First, the finding that a poor referral queries result in less significant ENMG tests, was noticed in Mei-
lahti CN laboratory already before conducting this research. Therefore Meilahti CN laboratory rede-
signed their test referral form by adding a compulsory question concerning the referral query and the
Chapter 5 Discussion
N. Välimaa 89
level of lesion. However, this improvement has not yet seemed to increase the number of appropriate
ENMG test referrals.
Second, the correlation between prior and final evaluation of ENMG test significance encouraged neu-
rophysiologists to rely on their expertise while reviewing and accepting ENMG test referrals. Meilahti
CN laboratory has been evaluating and accepting every test referral made by primary care physician
during the past years. Nonetheless, as a spin off from this study, Meilahti CN laboratory has now en-
couraged neurophysiologists to evaluate referrals more critically and reject test referrals when needed.
Furthermore, ENMG test referrals from neurology outpatient clinic has been taken for further evaluation
for experimental reasons.
Because primary care physicians and physiatrists were found to order less significant ENMG tests, three
different demand management strategies were adopted by Meilahti CN laboratory to reduce these insig-
nificant tests. First, new, stricter instructions and limitations concerning ENMG test ordering were for-
mulated and sent to primary care centers. For example, an approach of prohibiting ENMG test referrals
by primary care physicians in other occasions than suspected carpal tunnel syndrome (CTS), has been
proven effective in HUS Jorvi CN laboratory. Although strict instructions and limitations are being
created for primary care, the strategy of HUS is to place itself closer to primary care, so that not too
many patient end up in secondary care. Therefore, primary care physicians are instructed to seek help
specialist help in form of consultations, instead of referring patients to secondary care. Furthermore,
neurophysiologists in Meilahti established a helping phone line to advise primary care physicians in
ordering of electrodiagnostic tests. Second, an educational meeting was set with primary care chief phy-
sicians. Third, new instructions for physiatrists concerning the ordering of ENMG tests are in progress
and also an educational meeting with physiatrists has been decided.
Interestingly, Meilahti CN laboratory offered a test package for carpal tunnel syndrome (CTS) diagnosis
for primary care physicians already before conducting this research. However, primary care physicians
were reluctant to accept the package: they were afraid of underdiagnosing the patient by only ordering
the carpal tunnel syndrome package. This may show that referring physicians want to avoid responsi-
bility and prefer rely on neurophysiologists’ professionalism. Especially in situations where a primary
care physician is not sure of the diagnosis, they could certainly benefit from a helping phone line, which
will probably prevent an insignificant ENMG tests to be requested.
Diagnosis groups of meralgia paresthetica and morton neuroma were explored in more detail to deter-
mine whether ENMG tests are useful in these patients. According to literature, diagnosis of meralgia
paresthetica is commonly a result of clinical examination, although tumor and lumbar disc herniations
must be excluded with diagnostic tests (Patijn et al. 2011). Our interviewee, an expert within this field,
supported this proposition, and, save for the iatrogenic nerve injury leading to meralgia paresthetica,
HUS could stop performing these ENMG tests.
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Diagnosing morton neuroma with  ENMG tests  is  difficult,  as  the  test  is  difficult  to  perform to  such
patients. Thus, we explored the possibility of shifting towards the Swedish model, where morton neu-
roma is first tested with MRI test and then operated without performing ENMG test. However, according
to our expert interviewee, the operation of morton neuroma without ENMG test is risky and may lead
to unnecessary operations, which should be avoided. As a result, ENMG test was evaluated appropriate
for morton neuroma patients, and that HUS does not operate patients without first having the ENMG
test.
In the light of results that showed ENMG tests to be less significant when ordered by primary care
physician or physiatrist, the differences between HUS CN laboratories become interesting. The percent-
age of ENMG tests requested by primary care physicians and physiatrists was much higher in Hyvinkää
and Lohja CN laboratories than in Meilahti, Peijas or Jorvi CN laboratories. Furthermore, the ratio of
ENMG test referrals from primary care physicians and physiatrists per population is higher in Hyvinkää
and Lohja than in Meilahti. In addition, waiting time was also shorter in Hyvinkää and Lohja compared
to Meilahti, Peijas and Jorvi CN laboratories. Due to the fact that in Hyvinkää and Lohja, a greater share
of ENMG test referrals are made by physiatrists and primary care physicians, the potential of reducing
less significant ENMG tests could be relatively larger than in Meilahti, Peijas or Jorvi CN laboratory.
Besides, after the reduction of insignificant ENMG tests in Hyvinkää and Lohja, some patients could be
even transferred from Meilahti to Hyvinkää and Lohja CN laboratories to shorten queues in Meilahti
CN laboratory.
All in all, this study lead to numerous managerial implications within Meilahti CN laboratory, which
are summarized in Table 29.
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Table 29 Summary of research findings linked to managerial implications of Meilahti CN laboratory
Finding Actions taken by HUS, further implications
Neurophysiologist can rely on his/her ex-
pertise on evaluating the significance of
ENMG test based on test referral
· Neurophysiologists are encouraged to evaluate
test referrals and reject them if needed
· Test referrals from neurology outpatient clinic are
being reviewed by neurophysiologist for experi-
mental reason
Primary care and physiatry outpatient clinic
order less significant ENMG test than other
outpatient clinics
· New instructions with new limitations is written
and sent to primary care centers
· Neurophysiologists established a helping phone
line for primary care physicians
· An education session is set up with primary care
chief physicians
· New instructions are being written to physiatrists
and given an presentation of instructions to them
Poor quality of referral query results in less
significant ENMG test (usually to unsur-
prising zero results due to poor clinical ex-
amination and patient interview)
· New instructions are sent to both primary care
and physiatry outpatient clinics
· Education session with referring quarters are ar-
ranged constantly
· The findings of this study are being communi-
cated to neurophysiologists and emphasized the
importance of answering to the referral query
· Pain drawings should be attached to referrals to
improve referral quality and help neurophysiolo-
gist evaluate referrals
At the moment, communication with refer-
ral physicians is minimal with no agile
communication channels
· Neurophysiologists established a helping phone
line for primary care physicians
· Education session with referring quarters are ar-
ranged constantly
· Communicating referring units about the regional
distribution of demand
Meralgia paresthetica patients could be di-
agnosed in some situations with clinical ex-
aminations without ENMG
· New instructions are being written in HUS-level
concerning the examination of meralgia pares-
thetica patients
According to literature, displaying test
prices could reduce the number of inappro-
priate tests
· If a neurophysiologists needs to perform an ex-
tensive clinical examination before the ENMG
test due to a poor referral query, this could be
charged separately from the referring quarter
Primary care physicians are often correct
concerning CTS and polyneuropathy refer-
ral diagnoses, but otherwise less often cor-
rect with referral diagnoses
· CTS and polyneuropathy referrals could be auto-
matically accepted, while subjecting other refer-
rals from primary care physicians to prior evalu-
ation
Primary care physicians and physiatrists
make up a larger share of ENMG test refer-
rals in Hyvinkää and Lohja than in Peijas,
Meilahti and Jorvi
· There is a greater potential to omit insignificant
tests in Hyvinkää and Lohja, possibly enabling
transfer of tests to shorten queues in Meilahti
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5.3 Savings potential
Assuming that customer, here the referring physician, is the right person to evaluate which test provided
value into decision-making process, the cost savings potential is calculated according to referring phy-
sician’s opinion. Therefore, while ENMG tests that were evaluated insignificant or only slightly signif-
icant from both diagnosing and decision-making perspectives make up to 11.4 % of all ENMG tests
performed, it results in roughly 460 insignificant or only slightly significant ENMG test per year in
Meilahti CN laboratory, where approx. 4000 ENMG tests are performed annually.
One ENMG test takes about 30-60 minutes of neurophysiologist’s time. Further, an insignificant test
may take even longer time due to poorly defined and unfocused test referral. In addition, writing the
ENMG test report takes additional 15-20 min. We can safely calculate that 460 tests account for 460
hours of neurophysiologist time plus the time for writing out the test result report to referring physicians
being roughly 150 hours. In total, 610 hours of neurophysiologists’ time is allocated to perform insig-
nificant and only slightly significant ENMG tests annually in Meilahti CN laboratory. This amount of
neurophysiologist time could be reallocated to perform very significant ENMG tests instead of insignif-
icant. 610 hours of neurophysiologists’ time account for 0.37 person-years (1 person-year is 220 work-
ing days). Of course, one has to deduct the time that it would take to evaluate ENMG test referrals and
decide, which should be prioritized in order to perform fewer insignificant ENMG tests. The total num-
ber of ENMG tests performed a year in the HUS area was 8550 in year 2014, which means 980 (11.4
%) insignificant or only slightly significant tests, accounting to approximately 980 hours only to perform
the tests, plus the time to write the report accounting to 330 hours. In total, roughly 1300 hours of neu-
rophysiologist time is allocated annually in HUS CN laboratories to insignificant ENMG tests, transfer-
ring to 0.79 person-years, which could be reallocated more effectively.
In monetary terms, insignificant and only slightly significant ENMG tests account for roughly 154 000
€ per year in Meilahti CN laboratory, while one ENMG test costs 337 €, and assuming that the pricing
of an ENMG test presents all costs caused by performing one ENMG test. Cost savings in total for all
CN laboratories within HUS area altogether it would be roughly 329 000 € per year, if the 11.4 % of all
ENMG tests accurately presents the share of insignificant ENMG test in other CN laboratories as well.
However, even though the aim of this research is to reduce the number of insignificant tests, the greater
goal is to reallocate CN laboratory resources so that they are able to provide more value to customers
i.e. referring physicians and patients; allocating neurophysiologists time to very significant ENMG tests
rather than insignificant and only slightly significant tests. According to the results of this research, a
better clinical examination done by referring physician and then formulating a more focused, relevant
and well-defined referral query would save a lot of resources. Above all, a good clinical examination
might even hinder the need for an ENMG or some other test. On the other hand, this raises the question,
what to do with the patient instead of the ENMG test?
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5.4 Challenges in deploying changes within current healthcare system
The managerial implications presented in previous chapter embody actions that are meant to change the
behavior of referring physicians and replace ENMG tests with other actions. However, replacing actions
must be explored and achieving a change within current healthcare system is challenging, which are
discussed in this chapter based on the literature review and findings of this study.
As stated in previous chapter, omitting assumedly insignificant ENMG tests only creates savings if they
are replaced with more cost-effective alternatives. If a referring physician does not know what causes
patient’s symptoms even after careful clinical examination and he is not able to formulate a good referral
query, then he or she might have to refer patient to a specialist of neurology i.e. neurologist. This of
course would increase queues for neurology outpatient clinic, but it might also improve patient outcome.
This is improved as patients get correct treatment within shorter period of time than what they would
have gotten out of having first an insignificant ENMG test and only then referred to neurology outpatient
clinic. However, according to interviews, a valid alternative to requesting an insignificant ENMG test
was doing nothing to the patient. Therefore, although suggested by Mondelli et al. (1998), the referral
to neurology outpatient clinic in such situations might not be recommended either.
Generally, referring patients into other ‘silos’ of the healthcare system is not the answer to long queues.
However, currently the Finnish healthcare system functions so that patients are constantly circulating
between different healthcare units. This is especially true in patients with multiple difficult-to-treat and
difficult-to-diagnose health problems. However, the demand stays the same or even increases if we con-
tinue to ‘cast patients’ to other silo’s responsibility. A better solution would be to have functioning
communication channels between healthcare sectors and ‘silos’, and to have more integrated healthcare
system, which would pursue towards common goal.
Generally, having long waiting times to diagnostic tests creates a vicious cycle. According to interviews,
referring physicians refer patients to multiple diagnostic tests at the same time in order to save time in
waiting and to begin patient’s treatment as early as possible. The referring physician first evaluates the
reports of all these tests only before the next patient visit. This obviously results in unnecessary tests,
when one of the tests ordered already confirms the diagnosis, making the other tests redundant. This not
only delays the actual treatment, but also increases waiting times for other patients. Shorter waiting
times would enable referring physicians to rely on requesting only the most appropriate test, one at a
time, evaluating the results before ordering more tests.
However, making behavioral changes in physicians could prove challenging, because these changes
should optimally be orderer centric, not producer centric. Part of the culture in Finnish healthcare indus-
try, most physicians are inherently inclined to always think what’s best for the patient at hand, regardless
of the costs. Furthermore, the new trend of consumers extensively measuring and tracking their health
and bodily functions, called quantified self (Swan 2012), has increased demand for diagnostic tests and
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shifted attitudes towards demanding knowledge, instead of relying on the professionalism of a physician.
A good example of this is the rising market for specialized diagnostic tests provided by private firms,
such as Cityterveys Oy operating in 5 locations in Finland, advertising tests to anyone willing to pay.
These kinds of intrinsic motivators for physicians’ behavior need actions that create orderer centric mo-
tivation, such as financial motives, instead of producer centric changes.
From the  business  strategy  perspective,  it  is  unusual  that  demand  is  sought  to  be  decreased,  not  in-
creased. Although perceptions are dissimilar in demand management literature, the business value of
information is still important also in this situation. Value of information could be evaluated by stating a
question of: “How much money would a referring physician be willing to pay for the test, if he will be
rewarded a greater sum for a test that turned out significant?” In other words, referring physicians would
need to have their own individual budgets instead of budgets for the whole referring unit or municipality.
Referring units, e.g. a primary care unit would have internal budget allocation between their physicians
and physician’s budget would be affected if they order tests or buy healthcare services for their patients.
In that way they would become well aware of the costs and not have financial information asymmetry
between the diagnostic test performing unit. However, personal budgeting would increase administrative
costs and could create dilemmas when e.g. the budget runs out (Janssens 2010). Furthermore, there are
other unwanted outcomes of this kind of financial incentive creation such as seen in NHS’s QOF-system,
where physicians began to select patients according to their monetary benefits (Doran et al. 2011; Roland
2004; Mangin & Toop 2007). However, some state that if incentives are not changed, nothing will
change (Bernardy et al. 2009).
The increased demand is difficult to control due to strong incentive asymmetry, where different parties
have different goals. Referring physicians want to solve patient’s case as soon as possible, with as many
diagnostic tests as it requires and with high quality not depending on the cost of care. On the other hand,
the diagnostic test provider wants to conduct tests to only patients with actual need for the test and to
whom it brings the most value, and they want to avoid unnecessary costs and long waiting times.
Reducing the number of inappropriate tests would create cost savings, allocate resources more effec-
tively, shorten waiting times, improve referring physicians diagnosing and treatment plan decision-mak-
ing, and thus increase quality of care. If patients were diagnosed and treated earlier, it would improve
the overall patient outcome. Therefore, reducing insignificant diagnostic tests would improve healthcare
system in many sectors rather than only in diagnostic testing. These demand management approaches
and factors affecting insignificant ENMG testing can be replicated to other fields of diagnostic testing,
e.g. radiology and other medical imaging. In addition, some of the findings could apply in other fields
of medicine outside diagnostic testing, for example regarding financial incentives and alternative poli-
cies in referring patients from primary care to secondary care.
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5.5 Reliability, validity and limitations of the study
This chapter presents the reliability and validity of this study and discusses the possible limitations.
Reliability is measured through whether a research is possible to be replicated and that this replicated
study provides similar results (Flick 2009). Research methods used in this study are presented in detail,
and justified reasons for the selection of the specific methods used are presented. This makes the present
study possible to replicate in other settings. In terms of data accuracy, the reliability of this study is
slightly limited due to the rather limited samples used. While all findings presented were shown to be
statistically significant with high confidence levels, the strengths of those effects are subject to meas-
urement errors. This research should be replicated with larger samples before making decisions based
on exact numeric results of this study, especially in other settings outside HUS and Meilahti CN labor-
atory.
Construct validity describes whether the study measures the studied phenomenon with logical and rea-
sonable metrics and methods (Flick 2009). This study conducted a wide literature review from which
suitable metric to measure the significance and effectiveness of a diagnostic test was selected. The se-
lection was further confirmed through expert interviews. While choosing the right construction for meas-
uring significance and effectiveness healthcare is largely a value based problem, we have considered the
problem from multiple perspectives, using multiple methods, and chosen ones that suit the focal organ-
ization. Thus, we argue that construct validity is high in this study.
External validity measures the extent to which a research’s findings can be generalized (Flick 2009).
Because this study focused on exploring the effectiveness electrodiagnostic tests and especially ENMG
tests, the findings of this study can at widest to be generalized to radiological tests and with some care-
fulness to other diagnostic testing. However, the findings of the literature review partly apply for a wider
context, and our findings provide sound suggestions for testing in other contexts. In order to increase
the external validity and to generalize the findings of this study to a wider context, additional similar
studies are needed in other sectors of healthcare.
The ability of our methods to measure the concept of significance of ENMG testing can be debated. The
surveys conducted to both neurophysiologists and referring physicians may have resulted in biased an-
swers, because healthcare professionals have been found to act in a protective manner when their work
performance is observed (Mondelli et al. 1998). Hence, when introducing these surveys, some criticism
was presented toward this study setup, because the aim of the study was to ask the physicians to evaluate
the significance of tests they have either requested or performed. One improvement would have been to
get a second opinion from another physician concerning the same patient cases. However, this study
now presents physicians’ opinions, who are locally involved in the process of requesting and performing
these ENMG tests. Because the opinions are gathered from these physicians, the number of insignificant
cases found is likely based on conservative evaluations, and thus the results are more likely to be also
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accepted by the physicians involved in the process, making the results of this study more useful. Besides,
decision-making concerning patient’s diagnosis or treatment plan is done according to physician’s own
opinions about the results of diagnostic tests. Therefore, our results present this decision-making process
and effectiveness of these tests very well.
A second limitation was the small number of data from referring quarter survey made to primary care
physicians. Therefore, the results from that survey may not be very representative. This was a challenge
not easily overcome, since referring physician turnover is high within a primary care unit, making them
hard to reach. The survey made to neurophysiologist included ENMG tests requested by primary care
physicians, however, thus this subproject managed to gather at least some opinion about primary care
requests. The survey was made to primary care physicians too, but unfortunately they request ENMG
tests only occasionally during one month and such a primary care unit has many physicians, thus gath-
ering their answers was not possible. Furthermore, we gathered few patient cases which were evaluated
by both neurophysiologists and referring physicians, therefore no statistical tests could be employed to
verify the observations.
Thirdly, the lack of purely quantitative data analysis of ENMG test usage and patients’ treatment path-
ways could be considered one limitation of this study. However, such data was unfortunately not avail-
able since it is not recorded in the first place. This issue is at present under development, and treatment
pathway data recording will be implemented in a future patient information system in HUS. This re-
search only gathered data concerning physicians’ opinions, which are subjective. The answers of neu-
rophysiologists’ survey were checked with chi-square test not to differ between neurophysiologists, thus
the opinion about the significance of ENMG test can be considered as consistent and reliable.
Lastly, the final coding of survey answers is partly dependent on the coder, thus categorization of an-
swers within this study is one perspective to examine the findings. However, the used coding was veri-
fied many times before calculating the final results, and findings gathered from quantitative and quali-
tative content analysis can be considered as reliable. Nonetheless, due to fact that significance was meas-
ured in this study and was the focus of analysis, one has to take into account that the interpretation of
the word ‘significant’ may vary between physicians who answered to the survey, even though the survey
included a definition of significance.
Overall, despite some limitations of this study, our findings are mainly analogous to the results of similar
previous studies, giving support to our results.
Chapter 6 Summary
N. Välimaa 97
6 Summary
6.1 Answers to research questions
This chapter summarizes the findings of this study and provides the answers to research questions
presented in chapter 1.2. Furthermore, the future research areas and topics evoked by this study
are discussed.
The main aim of this study was to identify strategies to reduce the number of insignificant diagnostic
tests in healthcare. First, we identified characteristic of an insignificant diagnostic test, and then explored
demand management strategies through a literature review to reduce the number of insignificant ENMG
tests. Lastly, the application of those methods were explored in the case of HUS and its Meilahti CN
laboratory. Next, each of the questions and the answers to them are presented individually.
What strategies could be used to reduce the number of insignificant diagnostic tests in
healthcare?
To answer this question, first, a literature review was conducted in order to explore the demand man-
agement strategies used in previous studies to reduce the usage of insignificant diagnostic tests. Second,
the characteristics of an insignificant diagnostic test were researched from prior studies and a survey
conducted to neurophysiologists, to find the most valid demand management strategies appropriate for
this setting. Lastly, the reasons for increased demand of diagnostic tests were searched from literature
and the performance data of Meilahti CN unit was analyzed.
The main demand management strategies presented in literature were meant for diagnostic test service
providers to be implemented into their operations. These approaches included educating test requesting
physicians, giving feedback, referral evaluation, redesigning the test request form and establishing con-
stant communication with test orderers (Janssens 2010; Fryer & Smellie 2013; Mondelli et al. 1998).
Demand management strategies requiring political decision-making and a mutual agreement with ser-
vice requestor were blocking diagnostic tests from selected referring quarters (Mondelli et al. 1998;
Fuller 2005) and creating financial incentives for referring physicians (Fryer & Smellie 2013; Mannion
2014; Doran et al. 2011; Bernardy et al. 2009; Marshall & Smith 2003).
However, studies have shown that education and feedback giving is expensive (Schroeder et al. 1984)
requiring a lot of resources to produce feedback and have educational sessions (Janssens 2010), and the
savings achieved have been marginal and consumed by the costs of education and giving feedback
(Eisenberg 2002; Schroeder et al. 1984). Nonetheless, providing information, feedback and communi-
cation channels is not as expensive nowadays as it has been in the past, due to advanced IT-systems.
Two of  the  main  factors  found  to  predict  the  significance  of  an  ENMG test  were  the  quality  of  test
referrals and the referring quarter. Poorly defined referrals lead into less significant tests, and primary
care physicians and physiatrists request less significant ENMG tests than other categories of specialists.
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Therefore, more critical prior evaluation of test referrals, attaching ‘pain drawings’ to referrals already,
and educating referring physicians about the characteristics of good ENMG test referrals are suggested
in order reduce the number of insignificant ENMG tests. These measures should be focused on primary
care physicians and physiatrists. Mondelli et al. (1998) suggested that ENMG test referrals from primary
care should not be accepted in any other than CTS suspect case, which has been tested successfully in
HUS Jorvi CN unit. Thus, the significance of ENMG tests requested by primary care physicians could
be improved by education, reducing requesting possibilities (e.g. limiting primary care physicians to
only requesting ENMG tests for CTS patients), or even charging an extra price for additional clinical
examinations resulting from poor referral queries.
According to literature, while changes can be achieved with aforementioned demand management strat-
egies, the most effective strategy is to create incentives for diagnostic test requestors (Bernardy et al.
2009; Kaplan & Porter 2011). Creating motivation is more effective in creating behavioral changes than
forcing them with policies. For example, financial incentives would create motivation already at the
requestor side. However, creating such monetary incentives is risky and might affect overall quality of
care. For example, a UK study showed that creating economic incentives for physicians encouraged
them to select patients who would ensure them greater income (Fleetcroft et al. 2012). Furthermore,
creation of such incentives would require political impact and a lot of planning before implementation.
In the end, these financial incentives have to be considered, because no significant change is likely to
occur if the change depends only on the actions implemented by service provider (Bernardy et al. 2009).
What are the characteristics of an insignificant ENMG test?
o What are the main factors contributing ENMG tests’ insignificance?
o Does the opinion about the ENMG tests’ significance or the quality of test referral
query vary between referring physicians and neurophysiologists?
To answer this question, a survey was conducted to neurophysiologists and perspectives of various
stakeholders on the characteristic of an insignificant ENMG test were gathered through a literature re-
view. First, the prior evaluation of ENMG test significance, made based on only ENMG test referral,
showed to predict the final significance of an ENMG test well. This indicates that neurophysiologists
are capable of evaluating the significance of an ENMG test according to a test referral.
Second, according to analysis, the poorer the referral query, the less significant the test was performed.
The survey for referring physicians showed that only 10 % of ENMG tests requested provided new
diagnosis alternative, indicating that requests made in hope of receiving new suggestions were rarely
significant. An ENMG test should not be explorative, but instead, sufficient information should be gath-
ered before the ENMG test (Di Fabio et al. 2013). Moreover, an answer to a focused and well-defined
referral query provides more usable, practical information and thus more significant tests, a finding in
line with prior studies (e.g. Fuller 2005; Di Fabio et al. 2013).
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Third, according to neurophysiologists, normal and expected ENMG findings were less significant in
average. Requesting an ENMG without a well-informed referral query more likely results in expected
and normal ENMG findings. Literature presented varying opinions about the significance of normal or
zero results (Shepherd 2010; Mondelli et al. 1998; Di Fabio et al. 2013; Cocito et al. 2006; Podnar 2005),
but according to our interviews, a normal test result can be significant while used for excluding a diag-
nosis or for differential diagnosing. Furthermore, expected test results are significant when these tests
provide information about post-operative symptoms. In conclusion, normal results are not an indication
of insignificance.
Fourthly, primary care physicians and physiatrists requested less significant tests compared to other
physicians. Referral diagnoses of primary care physicians and physiatrists agreed with ENMG finding
less frequently than those of other physicians. They also requested more normal and unsurprising ENMG
tests. This may be due to the challenging patient mix these quarters have, patients who have a wde scale
of health problems and thus are difficult to treat, or excessive use of ENMG tests as explorative diag-
nosing (Di Fabio et al. 2013).
To answer to the second sub-question, the answers from neurophysiologists and referring physicians
were cross-checked. The opinions of neurophysiologists and referring physicians about the significance
of an ENMG test were mostly similar. Especially neurophysiologists’ prior evaluation and referring
physicians’ final evaluation of significance were mainly in line. This indicates that neurophysiologists
could rely on their expertise while evaluating the significance of ENMG tests according to test referrals.
However, due to the small sample size, this finding could not be proved statistically.
Interestingly, test requestor and provider evaluated the quality of ENMG test referrals differently.
Around 30 % of all ENMG test referrals were considered poor by neurophysiologists, while referring
physicians evaluated them to account for only 7 %. Neurophysiologists were more critical of the referral
queries that referrers rated as good, indicating the need of education for referring physicians.
What number of ENMG test requests and ENMG tests are insignificant in Meilahti CN labora-
tory and do referring units differ in this?
As mentioned above, according to neurophysiologists, 30% of referral queries were poor. This means
that the Meilahti CN laboratory receives approx. 1 200 poorly and inappropriately formulated ENMG
test referrals annually.
About 11 % of all ENMG tests were evaluated to be either insignificant or only slightly significant by
referring physicians, which accounts for 460 insignificant or slightly significant ENMG tests performed
yearly in Meilahti CN laboratory. It was calculated that 460 tests account for in total 610 hours or 0.37
person-years of neurophysiologists’ time that could be reallocated to perform more significant ENMG
tests, reducing waiting times. For the HUS area in total, assuming similar share of insignificant tests, 11
% would translate into 980 tests, or 0.79 person-years that could be reallocated more effectively.
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In monetary terms, calculated through the full costs of an ENMG study, insignificant and only slightly
significant ENMG tests account for 154 000 € per year in Meilahti CN laboratory. For the whole HUS
area, assuming a similar share of insignificant tests, the figure would be 329 000 € annually.
6.2 Future research
Although some previous studies about insignificant diagnostic tests exist, research concerning the utili-
zation of such findings is minimal. The issue of effectiveness in healthcare becomes more and more
important in future, and it is likely that various players within healthcare will begin to use the results of
these kind of studies. In order to deepen the knowledge of insignificant tests and to clarify how to reduce
these tests, this study found interesting future research possibilities.
Prior studies on effectiveness in healthcare services have focused on the characteristics of ineffective
services. However, there are only a few studies which have evaluated the effect of remedies on service
effectiveness and success of the adopted demand management strategies. Therefore, more ‘before-and-
after’ studies of effectiveness are needed to find the most effective demand management strategies for
healthcare. For the current topic, this would mean implementing the managerial implications suggested
by this study, following closely the development of waiting times and number of tests requested, and
finally conducting similar surveys concerning the significance of ENMG tests. In healthcare, empirical
tests are challenging for ethical reasons, thus it is rarely feasible to test the effectiveness of single strat-
egies in isolation.
The interesting finding of primary care physicians requesting less significant tests, requires further re-
search on primary care physicians’ requesting behavior. This study did not manage to gather many sur-
vey answers from primary care physicians. Therefore, a study focusing on this group of referring phy-
sicians is needed. It would be important to have their stronger opinion about the significance of ENMG
tests. Previous studies have explored the differences between general practitioners and specialists
(Mondelli et al. 1998), but these differences are usually based solely on neurophysiologists’ opinions.
Comparison of evaluations is essential in order to understand how the valuable information is created
and transferred to customer. This study managed to gather only 33 cross-evaluated patient cases. Thus
a study with a larger number of comparable patient cases is needed to statistically verify the findings of
this study. Such studies, comparing referring physicians’ and test provider physicians’ opinions about
service effectiveness and significance, are missing in the current literature.
This study gathered data with surveys and questions presented to the actual decision-makers. However,
there may be a possible bias of subjectivity and difficulty to critically evaluate one its own actions.
Therefore, a similar study would be needed including third party actors who would give their second
opinion. This would minimize the possible bias as the data could be cross-checked.
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Finally, this study brought an interesting study topic concerning the role of financial incentives in Finn-
ish healthcare system into the spotlight. Due to the fact that the current healthcare system needs a change
in course,  a  further  study of  appropriate  economic incentives is  required in the future and in welfare
countries like Finland. Furthermore, a main challenge remains that measuring performance and effec-
tiveness is challenging within diagnostic tests, and requires also value-based decision-making. Perfor-
mance measurement is important in motivating change, thus some metrics need to be decided on. These
kind of studies would be needed to explore the ways to achieve behavioral change, because it will require
a lot more than only healthcare service provider’s actions. Namely, also healthcare service orderers have
to change their behavior. Numerous such studies have been performed in United States and United
Kingdom, but not in Finland, which still presents a fundamentally different healthcare system.
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Appendix A: Survey made for neurophysiologists
ENMG effectiveness study: survey for neurophysiologists
Choose and mark [X] the best-fitting option from the alternatives provided. In the open fields, write
your answer briefly and as clearly as possible. NOTE! There are two (2) sections in this survey form:
fill the 1st section BEFORE conducting the ENMG test, and the 2nd section AFTER conducting the
test (marked in the form). Staple the filled form together with the referral, and leave in the cardboard
box in your room.
1st SECTION: BEFORE conducting the ENMG test
1. (BEFORE ENMG) How beneficial / significant would you estimate the coming ENMG test
for the patient’s diagnosis and treatment plan decision-making, judging beforehand?
¨ Insignificant
¨ Slightly significant
¨ Somewhat significant
¨ Very significant
2. (BEFORE ENMG) Does the ENMG test referral have a clear and relevant phrasing of a re-
ferral query?
¨ The referral query is missing from the referral
¨ Unclear and ill-defined referral query
¨ Somewhat defined query, but still unclear
¨ Well defined and clear referral query, but irrelevant for the patient’s symptoms
¨ Relevant, well defined and clear referral query
3. (BEFORE ENMG) What are your diagnosis suggestions before the ENMG test? (order by
priority and answer briefly, for example minor old L5 nerve root damage) (leave blank if you
have no suggestion)
1st working diagnosis
_________________________________________________________________________
2nd working diagnosis
_________________________________________________________________________
3rd working diagnosis
_________________________________________________________________________
4. (BEFORE ENMG) How certain are you of the 1st working diagnosis you suggested?
¨ Not at all certain
¨ Slightly certain
¨ Very certain
¨ I have no ENMG diagnosis suggestion before the test
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5. (BEFORE ENMG) What is the suggested diagnosis that reads on the referral? If the referring
quarter wants to exclude a diagnosis, write “Exclusion diagnosis (what diagnosis?)”
(Leave blank if no suggested diagnosis or exclusion diagnosis suggestion).
1st diagnosis suggestion:
___________________________________________________________________
6. (BEFORE ENMG) What is your evaluation on the extent of the ENMG referral query?
¨ Appropriate
¨ Too broad
¨ Too narrow
CONDUCT THE ENMG TEST NOW, after which you can continue filling the form…
2nd SECTION: AFTER conducting the ENMG test
7. (AFTER ENMG) Was the ENMG test significant in your opinion; did the test bring out new
information that would be significant for diagnosing and treating the patient?
¨ Insignificant, because __________________________________________
¨ Insignificant, because it was an unnecessary control test
¨ Insignificant, because a very probable diagnosis was known already before the test
¨ The results of the test fall short, because the referral query was too broad or unclear
¨ Somewhat significant
¨ Significant, because the ENMG test result acts as documentation for e.g. an insurance
or pension claim
¨ Very significant
8. (AFTER ENMG) Was there something surprising in the ENMG test results; something that
you did not foresee judging by information provided by the referral, symptom map and inter-
view of the patient?
¨ No. There was nothing surprising in the ENMG test results.
¨ Something surprising, that however had no effect on the final diagnosis.
¨ Yes. The ENMG test result was surprising, and affected the final diagnosis of the pa-
tient.
Write down here the QPati sample code from the referral:
FCE14 - ☐☐☐☐☐
Thank you for participating in this study!
Return the filled form stapled together with the referral in its cardboard box found in your office.
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Appendix B: Survey made for referring physicians
ENMG effectiveness study: survey for the referring quarter
Instructions: Choose and mark [X] the best-fitting option from the alternatives provided. NOTE! An-
swer the form questions based on the ENMG test report you received. Leave the filled form in the
pigeonhole of room 2 in the policlinic (marked!).
Keep the ENMG test report open and answer the questionnaire below:
· Write down the report number (QPati sample code): found in e.g. WebLab in the upper left corner
of the referral and in Desktop (formerly Miranda) in section “Report”. The code is of the form:
FCE14-xxxxx(xx), where x is a digit. For example: FCE14-12345.
FCE14 - ☐ ☐ ☐ ☐ ☐ ☐ ☐
1. How did the ENMG test result affect the patient’s diagnosis?
¨ It excluded a suspected diagnosis
¨ It confirmed a suspected diagnosis
¨ It brought about a new diagnosis option
¨ This was a control test
¨ None of the above, what:
___________________________________________________
2. How significant was the ENMG test for the diagnosis?
¨ Insignificant
¨ Slightly significant
¨ Somewhat significant
¨ Very significant
¨ This was a control test
¨ I don’t know
3. Did the ENMG test outcome bring changes to a treatment plan made before the ENMG test?
¨ Yes
¨ No
¨ The treatment plan was to be made after the ENMG test
4. How significant do you find the ENMG test to be for treatment plan decision making?
¨ Insignificant
¨ Slightly significant
¨ Somewhat significant
¨ Very significant
¨ I don’t know
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5. Were the patient’s problems studied to an appropriate extent with the ENMG test
¨ Yes
¨ No
¨ I don’t know
6. If NOT studied to an appropriate extent, do you think the test should have been…
¨ Broader
¨ Narrower
¨ I don’t know
7. How clear and well defined do you evaluate your own referral query to be in the ENMG refer-
ral?
¨ Undefined and unclear referral query
¨ Clear and well defined referral query
¨ I don’t know
8. What is your specialty in medicine?
¨ Hand surgeon
¨ Orthopedist
¨ Other, what?
______________________________________________________________
9. How many years of work experience do you have as a doctor?
¨ Less than 1 year
¨ 1 to 5 years
¨ 5 to 10 years
¨ More than 10 years
Thank you for participating in this study!
Return the filled form in the marked pigeonhole of room 2 in the back room of the policlinic.
If you have questions about the research or this survey, we kindly ask you to contact
norma.valimaa@hus.fi.
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Appendix C: Interview questions to specialists
Interview for clinicians: general questions
9. How would you evaluate the significance of the ENMG test… (through this scale or any spe-
cial mentions)
a. … for the patient’s diagnosis?
i. Insignificant
ii. Slightly significant
iii. Somewhat significant
iv. Significant
v. Very significant
b. … for treatment plan decision making?
i. Insignificant
ii. Slightly significant
iii. Somewhat significant
iv. Significant
v. Very significant
10. If the ENMG test was not significant, what diagnostic test / referral would the referring physi-
cian have made? Or do nothing? Or make a more extensive clinical examination beforehand?
11. For what reason is the ENMG test not significant / very significant in your opinion?
12. Does the ENMG test in general study the problems of the patient to an appropriate extent?
(Or, was the question appropriately answered?)
i. Appropriately
ii. Too broadly
iii. Too narrowly
13. Do you find that the pre-ENMG test clinical examination was conducted carefully enough?
(“Was this a ‘shot in the dark’ ENMG test or not?”)
i. Yes
ii. No
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Interview for clinicians: Cases
14. How significant do you find the focal ENMG test?
i. Insignificant
ii. Slightly significant
iii. Somewhat significant
iv. Significant
v. Very significant
15. If the ENMG test was significant – WHY?
i. It excluded a diagnosis suggestion
ii. It confirmed a diagnosis suggestion
iii. Further specification of a diagnosis / confirmation for a decision for surgery
16. If the ENMG test was not significant – WHY?
What could have been done instead of the ENMG test?
i. A more extensive clinical examination
ii. Another diagnostic imaging test
1. MRI
2. Ultra sound
3. Other, what? _____________________________
iii. No need to do anything
Interview for clinicians: Meralgia Paresthetica
Is the ENMG test of the cutaneus femoris lateralis significant? Why?
Usually, even if an ENMG test confirms the diagnosis, no further operative procedures are conducted
for these patients. An ENMG test is not always technically successful and is unpleasant. A clinical ex-
amination would usually give the diagnosis.
1. What other tests would you use to examine a nerve lesion of the cutaneus femoris lat-
eralis?
2. In your opinion, does the diagnosing or treatment plan decision making of cutaneus
femoris lateralis require an ENMG test? Why?
3. Based on what findings are diagnoses made?
4. How often does the ENMG test agree / disagree with other examinations?
Interview for clinicians: Morton neuroma
What do you think about the fact that in Uppsala, Sweden (which is the pioneer in Swedish ENMG
tests) they do not conduct ENMG tests for patients with Morton?
1. Would this work in Finland?
2. Based on what findings are diagnoses made?
How often does the ENMG test agree / disagree with other examinations?
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Appendix D: Kysely KNF-lääkäreille
ENMG-vaikuttavuustutkimus: kysely KNF-lääkäreille – Lue OHJEET!
Valitse ja ruksi [X] vastausvaihtoehdoista aina yksi kyseiseen tapaukseen sopiva vastaus. Avoimissa
kohdissa kirjoita mahdollisimman selkeästi ja ytimekkäästi vastauksesi. HUOM! Kyselylomakkeessa
on kaksi (2) osoita, joista 1. osio on tarkoitus täyttää ennen ENMG-tutkimuksen tekemistä ja 2. osio
tutkimuksen tekemisen jälkeen (merkitty lomakkeeseen). 1. osio täytetään lähetteen ja oirekartan tieto-
jen perusteella. Jätä täytetty lomake lähetteeseen liitteeksi.
Lue lähete ja potilaan tekemä oirekartta, jonka jälkeen jatka vastaamista.
1. OSIO: ENNEN ENMG-tutkimuksen tekemistä
1. (ENNEN ENMG:ta) Kuinka hyödylliseksi / merkittäväksi arvioit tulevan ENMG-tutkimuk-
sen potilaan diagnoosin ja hoitopäätöksen kannalta etukäteen?
¨ Ei merkittävä
¨ Vähän merkittävä
¨ Suhteellisen merkittävä
¨ Erittäin merkittävä
2. (ENNEN ENMG:ta) Oliko ENMG-lähetteessä selkeä ja relevantti kysymyksenasettelu?
¨ Kysymyksenasettelu puuttui
¨ Epäselvä ja huonosti rajattu kysymyksenasettelu
¨ Jonkin verran rajattu kysymyksenasettelu, mutta vielä epäselvä
¨ Hyvin rajattu ja selkeä kysymyksenasettelu, mutta ei relevantti potilaan oireiden kan-
nalta
¨ Relevantti, hyvin rajattu ja selkeä kysymyksenasettelu
3. (ENNEN ENMG:ta) Mikä on sinun ENMG-diagnoosiehdotuksesi ennen ENMG-tutkimuksen te-
kemistä? (vastaa muutamalla sanalla, esim. lievä vanha L5 hermojuurivaurio) (jätä tyhjäksi, jos ei
ole diagnoosiehdotusta).
1 työdiagnoosi
_________________________________________________________________________
2 työdiagnoosi
_________________________________________________________________________
3 työdiagnoosi
________________________________________________________________________
4. ( ENNEN ENMG:ta) Kuinka varma olet arvioimastasi 1. ENMG työdiagnoosista?
¨ En lainkaan varma
¨ Melko varma
¨ Erittäin varma
¨ Ei ole ENMG-diagnoosiehdotusta ennen tutkimusta
Jatkuu =>
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5. (ENNEN ENMG:ta) Mikä on tilaajatahon diagnoosiehdotus? Jos lähettävätaho haluaa poissulkea
ehdotetun diagnoosin, niin kirjoita ”Poissulkudiagnoosi (mikä diagnoosi?”) (jätä tyhjäksi, jos ei
ole diagnoosiehdotusta)
1. diagnoosiehdotus:
________________________________________________________________
6. (ENNEN ENMG:ta) Mikä on arviosi tilaajatahon ENMG-tutkimuspyynnön laajuudesta?
¨ Sopiva
¨ Liian laaja
¨ Liian suppea
TEE ENMG-tutkimus tässä välissä, jonka jälkeen jatka vastaamista.
2. OSIO: ENMG-tutkimuksen tekemisen jälkeen
7. (ENMG:n jälkeen) Oliko tehty ENMG-tutkimus mielestäsi merkittävä ts. toiko tutkimus uutta
tietoa, joka olisi potilaan hoidon ja diagnoosin teon kannalta merkittävää
¨ Ei merkittävä, sillä __________________________________________________
¨ Ei merkittävä, sillä kyseessä turha kontrollitutkimus
¨ Ei merkittävä, sillä jo ennen ENMG-tutkimusta oli tiedossa hyvin todennäköinen diagnoosi
¨ Tutkimuksen anti jää vajaaksi, sillä kyseessä liian laaja ja epäselvä kysymyksenasettelu
¨ Jonkin verran merkittävä
¨ Merkittävä, sillä ENMG-tutkimustulos toimii dokumentaationa esim. vakuutukseen tai eläk-
keeseen
¨ Erittäin merkittävä
8. (ENMG:n jälkeen) Liittyikö ENMG-löydökseen jotain yllättävää, eli sellaista, mitä et ennalta kä-
sin epäillyt lähetteen, oirekartan ja potilaan haastattelun perusteella.
¨ Ei. ENMG-löydökseen ei liittynyt mitään yllättävää
¨ Jotain, mutta löydös ei vaikuttanut lopulliseen potilaan diagnoosiin.
¨ Kyllä. ENMG-löydös oli yllättävä, joka vaikutti myös potilaan lopulliseen diagnoosiin.
Kirjoita käsiteltävän tapauksen QPati näytenumero lausunnosta tähän alle:
FCE14 - ☐☐☐☐☐
Kiitos tutkimukseen osallistumisesta!
Palauta täytetty lomake paperiseen lähetteeseen niitattuna omaan pahvilaatikkoonsa, joka löytyy
työhuoneestasi.
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Appendix E: Kysely tilaajataholle
ENMG-vaikuttavuustutkimus: kysely tilaajataholle
Kyselyyn vastaamisen ohje: Valitse ja ruksi [X] vastausvaihtoehdoista aina yksi kyseiseen tapaukseen
sopiva vastaus. HUOM! Vastaa kyselyyn saamasi ENMG-lausunnon pohjalta. Jätä täytetyt lomak-
keet osastonhoitajan osoittamaan paikkaan. (Merkitty!).
Pidä ENMG-lausunto auki ja vastaa alla olevaan kyselyyn:
1. Kirjoita lausunnon numero (QPati näytenumerokoodi): Löytyy esim. WebLabissa lausunnon va-
semmasta yläkulmasta ja Desktopista (ent. Miranda) lausunnon kohdasta: ”Lausunto:…” lukee
lauseen viimeisenä FCE14-numero. Numero on muotoa: FCE14-xxxxx(xx), missä x on numero.
Esim: FCE14-12345.
FCE14 - ☐ ☐ ☐ ☐ ☐ ☐ ☐
2. Kuinka ENMG-tutkimus vaikutti potilaan diagnoosiin?
¨ Poissulki diagnoosiepäilyn
¨ Vahvisti diagnoosiepäilyn
¨ Tutkimus toi esiin uuden diagnoosivaihtoehdon
¨ Kontrollitutkimus
¨ Ei mikään edellä mainituista, vaan mikä: ____________________________________
3. Miten merkittävä ENMG-tutkimus oli diagnoosin kannalta?
¨ Ei lainkaan merkittävä
¨ Vähän merkittävä
¨ Suhteellisen merkittävä
¨ Erittäin merkittävä
¨ Kyseessä kontrollitutkimus
¨ En osaa sanoa
4. Muuttiko saatu ENMG-tutkimustulos ennen ENMG-tutkimusta tehtyä hoitosuunnitelmaa?
¨ Kyllä
¨ Ei
¨ Hoitosuunnitelma oli määrä tehdä ENMG-tutkimuksen jälkeen
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5. Miten merkittävä ENMG-tutkimus oli hoitopäätöksen teon kannalta ?
¨ Ei lainkaan merkittävä
¨ Vähän merkittävä
¨ Jonkin verran merkittävä
¨ Erittäin merkittävä
¨ En osaa sanoa
6. Selvitettiinkö potilaan ongelmatiikkaa sopivan laajuisesti ENMG-tutkimuksella?
¨ Kyllä
¨ Ei
¨ En osaa sanoa
7. Jos EI selvitetty ongelmatiikkaa sopivaan laajuisesti, niin olisiko tutkimuksen pitänyt olla…
¨ Laajempi
¨ Suppeampi
¨ En osaa sanoa
8. Kuinka selkeäksi ja riittävän rajatuksi arvioitte tekemänne kysymyksenasettelun?
¨ Ei rajattu ja epäselvä kysymyksenasettelu
¨ Selkeä ja tarkasti rajattu kysymyksenasettelu
¨ En osaa sanoa
9. Minkä alan erikoislääkäri olette?
¨ Käsikirurgi
¨ Ortopedi
¨ Muu, mikä? _________________________________________________________
10. Kuinka monta vuotta teillä on lääkärinä työkokemusta?
¨ Alle 1 vuosi
¨ 1 - 5 vuotta
¨ 5 - 10 vuotta
¨ Yli 10 vuotta
Kiitos tutkimukseen osallistumisesta!
Palauta täytetty lomake osastonhoitajan osoittamaan paikkaan (merkitty laatiko, johon voi jät-
tää täytetyt lomakkeet).
Jos teillä on kysyttävää tutkimuksesta tai kyselystä, pyydämme tietä olemaan yhteydessä osoitteeseen
norma.valimaa@hus.fi. KNF-yksikkö, Meilahden sairaala.
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Appendix F: Haastattelukysymykset kliinikoille
Haastattelukysymykset kliinikoille: yleiset kysymykset
1. Kuinka merkittäväksi (asteikko / erityistapaukset) arvioit ENMG-tutkimuksen
a. … potilaan diagnoosin kannalta?
i. Ei lainkaan merkittävä
ii. Vähän merkittävä
iii. Jonkin verran merkittävä
iv. Merkittävä
v. Erittäin merkittävä
b. … potilaan jatkohoitopäätöksen teon kannalta?
i. Ei lainkaan merkittävä
ii. Vähän merkittävä
iii. Jonkin verran merkittävä
iv. Merkittävä
v. Erittäin merkittävä
2. Jos ENMG-tutkimus ei ole merkittävä, niin minkä tutkimuksen / lähetteen olisi voinut ENMG-
tutkimuksen sijaan lähettävä lääkäri kirjoittaa / olla tekemättä mitään / tarkennettu kliininen
tutkimus?
3. Mistä syystä ENMG-tutkimus ei ole mielestäsi merkittävä // on erittäin merkittävä?
4. Tarkasteleeko ENMG-tutkimus keskimäärin sopivan laajuisesti potilaan ongelmatiikkaa (as-
teikko?) / saavatko vastauksen kysymykseen?
a. Sopivasti
b. Liian laajasti
c. Liian suppeasti
5. Oliko mielestäsi ENMG:ta edeltävä kliininen tutkimus tehty tarpeeksi tarkkaan (’ENMG haku-
ammuntaa vai ei’)?
a. Kyllä
b. Ei
Haastattelukysymyksen kliinikoille: potilastapaukset
1. Kuinka merkittäväksi arvioit ENMG tutkimuksen kyseisessä tapauksessa?
a. Ei lainkaan merkittävä
b. Jonkin verran merkittävä
c. Merkittävä
d. Erittäin merkittävä
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2. Jos ENMG-tutkimus oli merkittävä niin MIKSI?
a. Poissulki diagnoosivaihtoehdon
b. Vahvisti diagnoosivaihtoehdon
c. Diagnoosin tarkennus // vahvistus leikkauspäätöksen tueksi
3. Jos ENMG-tutkimus ei ollut merkittävä niin MIKSI ei ollut (mitä olisi voinut tehdä ENMG-
tutkimuksen sijaan)?
a. Tarkemman kliinisen tutkimuksen
b. Jonkin kuvantamistutkimuksen
c. MRI
d. Ultraäänitutkimus
e. Jokin muu, mikä? _____________________________
f. Olla tekemättä mitään.
Haastattelukysymykset kliinikoille: Meralgia Paresthetica
Onko reiden sivuhermon cutaneus femoris lateralis ENMG-tutkimus merkittävä? Miksi?
Tällaisille potilaille ei usein tehdä mitään operatiivista toimenpidettä, vaikka diagnoosi tähän löytyisi
ENMG-tutkimuksen avulla. ENMG-tutkimus ei aina teknisesti onnistu, on epämiellyttävä. Kliininen
tutkimus usein tuo diagnoosin.
3. Millä muulla tutkimuksella tutkisit cutaneus femoris lateralis pinnetilaa? Jos tuumorin
mahdollisuus suljetaan pois joko UÄ:llä tai MRI:llä.
4. Tarvitaanko cutaneus femoris lateralis reiden sivuhermon pinnetilan diagnosointiin /
jatkohoitopäätöksen tekoon ENMG-tutkimusta mielestäsi? Ja miksi jos tarvitaan?
5. Minkä löydöksen perusteella diagnoosi tehdään?
6. Kuinka usein ENMG on samaa / eri mieltä kuin muut tutkimukset?
Haastattelukysymykset kliinikoille: Morton neuroma
Mitä mieltä olette siitä, ettei Ruotsissa Uppsalassa (ENMG-tutkimusten edelläkävijä maassa) tehdä
Mortonin takia potilaille ENMG-tutkimusta?
7. Toimisko tällainen malli Suomessa?
8. Minkä löydöksen perusteella diagnoosi tehdään?
Kuinka usein ENMG on samaa / eri mieltä kuin muut tutkimukset
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Appendix G: Model fitting information of ordinal logistic re-
gression model
Model Fitting Information
Model -2 Log Likelihood Chi-Square df Sig.
Intercept Only 564.348
Final 415.522 148.826 19 .000
Link function: Logit.
Goodness-of-Fit
Chi-Square df Sig.
Pearson 1682.526 881 .000
Deviance 398.626 881 1.000
Link function: Logit.
Pseudo R-Square
Cox and Snell .432
Nagelkerke .483
McFadden .252
Link function: Logit.
Test of Parallel Linesa
Model -2 Log Likelihood Chi-Square df Sig.
Null Hypothesis 415.522
General 401.335b 14.187c 57 1.000
The null hypothesis states that the location parameters (slope coefficients) are the same
across response categories.
a. Link function: Logit.
b. The log-likelihood value cannot be further increased after maximum number of step-
halving.
c.The Chi-Square statistic is computed based on the log-likelihood value of the last itera-
tion of the general model. Validity of the test is uncertain.
: Pearson correlation between ordinal logistic regression model variables
Correlations
1 2 3 4 5 6 7 8 9 10 11
1 .535** .211** -.057 -.002 .380** .040 .259** .196** .046 .125*
.000 .001 .359 .970 .000 .516 .000 .001 .455 .044
263 263 263 263 263 263 263 263 263 263 263
.535** 1 .316** .010 -.002 .296** .046 .176** .163** .118 .152*
.000 .000 .869 .975 .000 .457 .004 .008 .056 .013
263 263 263 263 263 263 263 263 263 263 263
.211** .316** 1 .212** .425** .096 -.074 -.069 .137* .300** .077
.001 .000 .001 .000 .121 .231 .262 .026 .000 .211
263 263 263 263 263 263 263 263 263 263 263
-.057 .010 .212** 1 .104 -.111 -.046 .007 .106 .263** -.006
.359 .869 .001 .093 .073 .455 .908 .086 .000 .924
263 263 263 263 263 263 263 263 263 263 263
-.002 -.002 .425** .104 1 -.068 -.176** -.087 .071 .149* -.039
.970 .975 .000 .093 .275 .004 .157 .249 .015 .529
263 263 263 263 263 263 263 263 263 263 263
.380** .296** .096 -.111 -.068 1 .182** .176** .105 -.137* .164**
.000 .000 .121 .073 .275 .003 .004 .089 .026 .008
263 263 263 263 263 263 263 263 263 263 263
.040 .046 -.074 -.046 -.176** .182** 1 -.153* .158* -.116 .214**
.516 .457 .231 .455 .004 .003 .013 .010 .060 .000
263 263 263 263 263 263 263 263 263 263 263
.259** .176** -.069 .007 -.087 .176** -.153* 1 -.007 .009 .082
.000 .004 .262 .908 .157 .004 .013 .913 .880 .185
263 263 263 263 263 263 263 263 263 263 263
.196** .163** .137* .106 .071 .105 .158* -.007 1 .473** .164**
.001 .008 .026 .086 .249 .089 .010 .913 .000 .008
263 263 263 263 263 263 263 263 263 263 263
.046 .118 .300** .263** .149* -.137* -.116 .009 .473** 1 .086
.455 .056 .000 .000 .015 .026 .060 .880 .000 .164
263 263 263 263 263 263 263 263 263 263 263
.125* .152* .077 -.006 -.039 .164** .214** .082 .164** .086 1
